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Abstract	
Background	
In	 patients	 with	 coronary	 artery	 disease	 (CAD),	 multi-parametric	 cardiovascular	
magnetic	 resonance	 (CMR)	 provides	 detailed	 information	 about	 the	 myocardial	
tissue	composition	and	its	function.	This	thesis	aims	to	investigate	how	myocardial	
tissue	 composition	 characteristics	 influence	 its	 function.	 Additionally,	 this	 thesis	
aims	to	develop	methods	for	time-resolved,	three-dimensional	flow	imaging	in-vitro	
and	in	health.		
Methods		
We	 have	 prospectively	 recruited	 and	 conducted	 multi-parametric	 CMR	 in	 76	
patients	with	 ST-elevation	myocardial	 infarction	 (STEMI),	 44	 patients	with	 stable	
chest	pain	and	35	healthy	volunteers.		
Results		
Study	1	and	2	evaluated	if	CMR	derived	function	parameters	are	associated	with	the	
presence	 of	 microvascular	 obstruction	 (MVO)	 or	 intramyocardial	 haemorrhage	
(IMH)	 in	 STEMI	patients.	 Study	1	demonstrated	 the	diagnostic	 accuracy	of	mitral	
annular	 plane	 systolic	 excursion	 (MAPSE)	 to	 detect	 MVO/IMH.	 Study	 2	
demonstrated	that	peak	global	longitudinal	strain	(GLS)	is	most	strongly	associated	
with	MVO/IMH	when	compared	to	other	myocardial	deformation	parameters.	Study	
3	 demonstrated	 that	 during	 first-pass	 perfusion	 stress	 CMR,	 at	 peak	 hyperemic	
stress,	 GLS	 is	 reduced	 in	 the	 presence	 of	 a	 perfusion	 defect	 in	 patients	 being	
investigated	 for	 CAD.	 Study	 4	 demonstrated	 that	 acute	 ECV-maps	 can	 reliably	
quantify	area	at	risk	and	final	infarct	size	(at	3-month	follow)	in	reperfused	STEMI	
patients.	Study	5	investigated	3	main	acceleration	methods	for	4-dimensional	flow	
(4D	Flow)	in	phantoms	and	healthy	volunteers.	In	phantoms,	all	4D	Flow	methods	
underestimated	peak	velocity	but	their	mean	errors	were	within	reasonable	limits	
for	clinical	applications.	In	volunteers,	4D	echo	planer	imaging	(EPI)	method	had	the	
shortest	acquisition	time,	best	agreement	with	2-dimensional	phase	contrast,	best	
internal	consistency	between	mitral	and	aortic	valve	flows.	
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Conclusions	
CMR	derived	longitudinal	functional	parameters	of	the	left	ventricle	are	associated	
with	 pathologies	 predominantly	 in	 the	 sub-endocardium	 and	 could	 be	 used	 as	 a	
surrogate	 imaging	markers.	ECV-maps	offer	an	alternative	to	IS	quantification.	4D	
EPI	is	the	most	robust	acceleration	method	for	whole-heart	flow	assessment.		 	
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Abbreviations	
2D	 	 Two-dimensional	
3D	 	 Three-dimensional	
4D	 	 Four-dimensional		
4D	flow	CMR		 Four-dimensional	flow	cardiovascular	magnetic	resonance	
4D-EPI	 	 Four-dimensional	echo	planar	imaging		
4D-k-t	BLAST	 Four-dimensional	k-t	Broad-use	Linear	Acquisition	Speed-up	
Technique	
4D-TFE		 Four-dimensional	turbo	field	echo	
5SD	 	 5-standard	deviation		
A'	 	 Myocardial	late	diastolic	velocity	
AAR	 	 Area	at	risk	
ACS	 	 Acute	coronary	syndrome		
AMI	 	 Acute	myocardial	infarction	
AUC	 	 Area	under	the	curve	
AV	 	 Aortic	valve	
BLAST	 	 Broad-use	Linear	Acquisition	Speed-up	Technique	
bSSFP	 	 balanced	steady-state	free	precession		
CAD	 	 Coronary	artery	disease		
CMR	 	 Cardiovascular	magnetic	resonance		
CoV/CV	 Coefficient	of	variability	
E'	 	 Myocardial	early	diastolic	velocity	
ECG	 	 Electrocardiogram	
ECM	 	 Extracellular	matrix	
ECV	 	 Extra-cellular	volume		
EDV	 	 End-diastolic	volume	
EF	 	 Ejection	fraction	
EGE	 	 Early	gadolinium	enhancement	
EPI	 	 Echo	planar	imaging	
ESC	 	 European	Society	of	Cardiology	
ESV	 	 End-systolic	volume		
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FFR	 	 Fractional	flow	reserve		
FOV	 	 Field	of	view	
FT	 	 Feature	tracking		
FWHM		 Full	width	half	maximum		
GCS	 	 Peak	global	circumferential	strain	
GCSR	 	 Peak	global	circumferential	strain	rate	
GLS	 	 Peak	global	longitudinal	strain	
GLSR	 	 Peak	global	longitudinal	strain	rate	
GRAPPA	 Generalised	auto-calibrating	partially	parallel	acquisitions	
GRS	 	 Peak	global	radial	strain	
GRSR	 	 Peak	global	radial	strain	rate	
HLA	 	 Horizontal	long	axis		
IMH	 	 Intramyocardial	haemorrhage	
IS	 	 Infarct	size		
LGE	 	 Late	gadolinium	enhancement	
LV	 	 Left	ventricular		
LV		 	 Left	ventricle	
LVEDV	 	 Left	ventricular	end	diastolic	volume	
LVEDVi		 Left	ventricular	end	diastolic	volume	indexed	
LVESV	 	 Left	ventricular	end	systolic	volume	
LVESVi		 Left	ventricular	end	systolic	volume	indexed	
MAPSE		 Mitral	annular	plane	systolic	excursion	
MBF	 	 Myocardial	blood	flow		
MI	 	 Myocardial	infarction		
MR	 	 Magnetic	resonance	
MRI	 	 Magnetic	resonance	imaging	
MV	 	 Mitral	valve	
MVO	 	 Microvascular	obstruction	
NFF	 	 Net	forward	flow	
NT-proBNP	 N-terminal	pro	b-type	natriuretic	peptide	
PC	 	 Phase	contrast		
PCI	 	 Percutaneous	coronary	intervention	
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PEFR	 	 Peak	early	filling	rate	
PLFR	 	 Peak	late	filling	rate	
PPCI	 	 Primary	percutaneous	coronary	intervention		
RF	 	 Radiofrequency	
ROC	 	 Receiver-operator	characteristic		
ROI	 	 Region	of	interest	
RV	 	 Right	ventricular		
SD	 	 Standard	deviation	
STEMI	 	 ST-elevation	myocardial	infarction	
SV	 	 Stroke	volume	
T2*	 	 T2-star-weighted	imaging	
T2W	 	 T2-weighted		
TIMI	 	 Thrombolysis	in	Myocardial	Infarction		
VENC	 	 Velocity	encoding		
VLA	 	 Vertical	long	axis	
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1 Introduction	
Coronary	 artery	 disease	 (CAD)	 is	 the	 now	 the	 largest	 cause	 of	 death	 worldwide	
(Mortality	and	Causes	of	Death,	2015).	Acute	chest	pain	remains	one	of	the	main	
symptoms	of	presentation	and	admission	to	hospital.	It	contributes	about	20-40%	of	
all	medical	admissions.	Even	though	contemporary	biomarkers	of	myocardial	injury	
are	very	sensitive	in	detecting	acute	coronary	syndrome	(ACS),	they	can	suffer	from	
low	specificity.		
Cardiac	imaging	can	contribute	to	the	diagnosis	of	ACS,	in	particular	when	combined	
with	 the	 clinical	 history,	 12-lead	 electrocardiogram	 (ECG)	 findings	 and	 cardiac	
biomarkers.	When	cardiac	imaging	is	used	appropriately	in	this	setting,	it	can	reduce	
the	number	of	missed	ACS,	filter	out	those	who	were	wrongly	diagnosed	as	ACS	and	
guide	the	management	of	those	with	confirmed	ACS.	Different	time	points	 in	the	
ischaemic	cascade	can	be	imaged	by	various	imaging	modalities	depending	on	the	
patho-physiological	changes	in	the	coronary	arteries	and	the	ischaemic	myocardium	
(Figure	1.1).		
	
Figure	 1.1	 Timeline	 of	 patho-physiological	 changes	 in	 ischaemic	myocardium	and	
applied	imaging	techniques.		
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1	 Computed	 tomography	 coronary	 angiography;	 2	 Myocardial	 contrast	
echocardiography	 for	 the	 assessment	 of	 perfusion	 defects;	 3	 Rest	 myocardial	
perfusion	 scintigraphy;	4	Contrast	enhanced	magnetic	 resonance	angiography	 for	
detection	 of	 proximal	 coronary	 anomaly;	 5	 Stress	 cardiac	magnetic	 resonance;	 6	
Myocardial	 ischaemic	memory	 imaging	with	β-methyl-p-iodophenylpentadecanoic	
acid;	 7	 Strain	 imaging	 on	 echocardiography	 for	 heterogeneity	 of	 strain	 curves;	 8		
Myocardial	tagging	with	cardiac	magnetic	resonance	for	regional	strain	variations	in	
ischaemic	 myocardium;	 9	 Echocardiography	 to	 detect	 regional	 wall	 motion	
abnormality;	10	Cine	cardiac	magnetic	 resonance	 imaging	 to	detect	 regional	wall	
motion	 abnormality;	 11	 Ratio	 of	 peak	mitral	 inflow	 velocity	 (E)	 and	mitral	 valve	
propagation	velocity	(Vp)	for	estimating	LA	pressure	(E/Vp);	12	Native	T1-Maps	on	
cardiac	magnetic	 resonance	 imaging	 for	quantification	of	myocardial	oedema;	13	
T2-weighted	cardiac	magnetic	resonance	imaging	for	myocardial	oedema;	14	Late	
gadolinium	 enhancement	 imaging	 on	 cardiac	 magnetic	 resonance	 for	 scarred	
myocardium;	 15	 late	 gadolinium	 enhancement	 (LGE)	 imaging	 for	 microvascular	
obstruction;	 16	 T2*-imaging	 on	 cardiac	magnetic	 resonance	 for	 intra-myocardial	
haemorrhage.		
1.1 Established	role	of	CMR	in	the	assessment	of	ACS		
Cardiac	Magnetic	 Resonance	 (CMR)	 has	 an	 emerging	 role	 in	 the	 assessment	 and	
management	of	patients	with	ACS,	 in	particular	 those	who	are	clinically	stable.	 It	
provides	 structural	and	 functional	assessment	of	 regional	myocardial	motion	and	
thickening,	rest	and	stress	perfusion,	myocardial	oedema,	microvascular	obstruction	
and	intramyocardial	haemorrhage	(Lockie	et	al.,	2009).		
The	2006	American	Appropriateness	Criteria	for	Cardiac	Computed	Tomography	and	
Cardiac	Magnetic	Resonance	 Imaging	recommends	stress	CMR	as	appropriate	 for	
the	evaluation	of	intermediate	likelihood	patients	when	the	ECG	is	uninterpretable	
or	the	patient	is	unable	to	exercise	(Hendel	et	al.,	2006).	MR	coronary	angiography,	
where	 available,	 may	 be	 appropriate	 to	 detect	 coronary	 anomalies.	 Current	
European	Society	of	Cardiology	(ESC)	guidelines	highlight	in	particular	the	ability	of	
CMR	to	detect	myocarditis,	assess	viability	and	perfusion	defects	in	suspected	ACS	
patients	 (Hamm	et	al.,	 2011)	 (Figure	1.2).	Additionally,	 the	ESC	guidelines	on	 the	
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management	of	suspected	non-ST	elevation	MI	also	recommend	stress	CMR	(Class	
I,	 Level	 A	 evidence)	 in	 patients	 without	 recurrent	 pain,	 normal	 ECG,	 negative	
troponin	and	a	low	(≤108)	‘Global	Registry	of	Acute	Coronary	Events’	(GRACE)	risk	
score.	
	
Figure	1.2	Multi-parametric	CMR	in	suspected	ACS	
This	is	a	case	of	a	67-year-old	female	with	takotsubo	cardiomyopathy	(Garg,	John	P	
Greenwood	 and	 Plein,	 2015).	 	 T2-weighted	 imaging	 demonstrated	 corresponding	
high	signal	suggestive	of	myocardial	oedema	(Panel	1a-c).	Native-T1	maps	(Panel	2a-
c,	using	cut-off	of	1000msec)	and	extra-cellular	volume	(ECV)	maps	(Panel	3a-c,	using	
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cut-off	 of	 29%)	 demonstrated	 high	 native-T1	 and	 mildly	 raised	 ECV	 in	 the	 same	
segments.	LGE	imaging	(Panel	4a-c)	showed	no	evidence	of	infarction.	
	
CMR	imaging	is	feasible,	robust	and	safe	in	patients	with	recent	non-ST	elevation	MI	
(Plein	et	al.,	2004).	In	the	same	study,	Plein	et	al	demonstrated	that	CMR	imaging	
within	 3	 days	 of	 the	 acute	 event	 had	 sensitivity	 96%	 and	 specificity	 83%	 for	
significant	CAD	defined	by	invasive	angiography.	It	was	also	more	accurate	than	the	
Thrombolysis	in	Myocardial	Infarction	(TIMI)	risk	score	(P<0.001).	In	a	study	of	161	
patients	 presenting	 to	 the	 emergency	 department	within	 12	 hours	 of	 symptoms	
suggestive	of	ACS	but	without	ST	elevation	on	initial	ECG,	total	imaging	time	was	38	
minutes	and	patients	were	absent	from	the	emergency	department	for	less	than	1	
hour	(Kwong	et	al.,	2003).	Although	the	sensitivity	and	specificity	for	the	diagnosis	
of	ACS	as	defined	by	troponin-I	and	invasive	angiography	for	this	CMR	protocol	was	
only	 84%	 and	 85%,	 respectively,	 CMR	 added	 incremental	 value	 over	 clinical	
parameters.	 A	 study	 of	 135	 low-risk	 patients	 presenting	 to	 the	 emergency	
department	with	chest	pain	showed	that	no	patients	with	a	normal	adenosine	CMR	
study	had	 a	 subsequent	 diagnosis	 of	 CAD	or	 an	 adverse	outcome	after	 one	 year	
(Ingkanisorn	et	al.,	2006).	In	the	same	study,	the	sensitivity	of	stress-CMR	was	100%	
with	a	specificity	of	93%	for	predicting	adverse	outcomes	during	a	one-year	follow-
up	 period.	 In	 two	 similar	 separate	 studies	 evaluating	 192	 patients	who	 received	
adenosine	stress	and	rest	CMR,	none	of	the	patients	with	normal	CMR	had	clinical	
events	 during	 9-months	 of	 follow-up	 (Lerakis	 et	 al.,	 2009;	 Hartlage	 et	 al.,	 2012).	
Lastly,	 in	 a	 randomised	 trial	 evaluating	 cost-effectiveness	 of	 stress	 CMR	 in	 110	
intermediate-	and	high-risk	ACS	patients,	stress	CMR	led	to	a	cost	saving	of	over	20%	
compared	with	standard	inpatient	care	($3101	vs	$4742;	P	=	0.004)	due	to	reduced	
coronary	artery	revascularization,	readmissions	and	further	cardiac	testing	without	
an	increase	in	post	discharge	ACS	at	90-days	(Miller	et	al.,	2011).	
1.2 CMR	Techniques	used	in	the	assessment	of	patients	with	ACS	
A	 typical	 CMR	 study	 takes	 between	 30	 and	 60	minutes	 and	 typically	 includes	 T1	
weighted	black	blood	 images	 for	assessment	of	anatomy,	cine	 images	 in	multiple	
planes	for	assessment	of	left	ventricular	(LV)	and	right	ventricular	(RV)	volumes	as	
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well	 as	 LGE	 imaging	 for	 delineation	 of	 scar	 and	 fibrosis	 (Figure	 1.2).	 This	 basic	
protocol	can	be	complemented	with	stress	perfusion	for	 ischaemia	detection,	T2-
weighted	imaging	to	detect	myocardial	oedema	or	intra-myocardial	haemorrhage.	
Additionally,	pre-/post-	contrast	T1	mapping	techniques	can	be	used	for	assessment	
of	the	extracellular	volume	(ECV)	fraction.					
The	 basic	 principles	 of	 CMR	 assessment	 of	 cardiac	 structure,	 function	 and	 tissue	
composition	 are	 debated	 in	 detail	 before	 an	 appraisal	 of	 how	 each	 of	 these	
techniques	can	be	applied	to	the	research	questions	investigated	in	this	thesis.		
1.3 Left	ventricular	functional	assessment	
1.3.1 Volumetric	analysis		
Assessment	of	LV	chamber	volumes	and	ejection	fraction	(EF)	forms	the	cornerstone	
of	assessment	of	cardiac	structure	by	CMR.	Echocardiography	is	the	most	broadly	
available	and	utilised	non-invasive	imaging	modality	for	the	evaluation	of	ventricular	
volumes.	When	suboptimal	imaging	quality	does	not	allow	for	assessment	of	EF	or	
more	accurate	assessment	of	EF	is	required,	both	American	(Yancy	et	al.,	2013)and	
European	(McMurray	et	al.,	2012)	guidelines	recommend	the	use	of	CMR.		
EF	is	usually	measured	by	CMR	with	the	acquisition	of	a	two-dimensional	continuous	
stack	of	short	axis	gradient-echo	cine	images	covering	the	full	length	of	the	LV.	The	
total	number	of	slices,	and	subsequently	the	number	of	breath-holds,	depends	on	
the	length	of	the	left	ventricle	and	the	chosen	imaging	parameters,	in	particular	slice	
thickness	and	gap.	In	patients	with	poor	breath-hold	capacity,	the	acquisition	can	be	
shortened	 close	 to	 real-time	 with	 acceleration	 techniques	 (such	 as	 sensitivity	
encoding	 [SENSE],	 simultaneous	 acquisition	 of	 spatial	 harmonics	 [SMASH]	 and	
generalized	auto-calibrating	partially	parallel	acquisitions	[GRAPPA]),	usually	at	the	
expense	of	signal-to-noise	ratio,	spatial	or	temporal	resolution	(Larkman	and	Nunes,	
2007).	The	EF	is	typically	calculated	from	these	images	by	the	“summation	of	discs”	
method	(Utz	et	al.,	1987).	On	each	cine	image	within	the	stack,	endocardial	contours	
are	 drawn	 at	 end-systole	 and	 end-diastole.	 As	 the	 slice	 thickness	 is	 known,	 the	
volume	of	each	disc	can	be	calculated	and	by	adding	the	volumes	of	each	slice	end-
diastolic	 volume	 (EDV),	 end-systolic	 volume	 (ESV)	 and	 consequently	 EF	 can	 be	
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calculated.	This	technique	has	been	shown	to	be	highly	reproducible	with	inter-study	
reproducibility	 that	 is	 significantly	better	 than	two-dimensional	echocardiography	
(Grothues	et	al.,	2002).	It	has	been	projected	that	to	detect	a	3%	change	in	EF	by	
echocardiography	87	patients	are	needed	whereas	only	11	patients	are	needed	by	
CMR.		
Measurement	 of	 EF	 by	 CMR	 inform	 diagnosis	 and	 prognosis.	 The	 degree	 of	 LV	
impairment	is	associated	with	adverse	outcomes	and	increased	mortality	(Gradman	
et	 al.,	 1989).	 In	 the	 Candesartan	 in	 Heart	 Failure:	 Assessment	 of	 Reduction	 in	
Mortality	and	Morbidity	(CHARM)	study,	every	10%	decrease	in	the	EF	below	45%	
was	accompanied	with	a	39%	increase	in	all-cause	mortality	(Solomon	et	al.,	2005).	
For	a	more	comprehensive	assessment	of	prognosis,	EF	can	also	be	incorporated	as	
one	of	several	factors	in	a	risk	score	(Ketchum	and	Levy,	2011).	
Right	ventricular	(RV)	volumes	and	RV	EF	can	also	be	calculated	by	CMR	using	the	
summation	 of	 discs	 method	 described	 previously.	 In	 patients	 with	 previous	
myocardial	 infarction	 (MI),	 RV	 EF	 <40%	 was	 associated	 with	 adverse	 outcomes	
independently	of	other	 factors	 including	 LV	EF	 (Larose	et	 al.,	 2007).	 Impaired	RV	
function	is	associated	with	adverse	outcomes	in	diseases	that	primarily	affect	the	RV	
such	 as	 pulmonary	 arterial	 hypertension	 and	 arrhythmogenic	 right	 ventricular	
cardiomyopathy	 and	 in	 patients	 with	 heart	 failure	 (Valsangiacomo	 Buechel	 and	
Mertens,	2012).		
From	the	same	continuous	short	axis	LV	stack	used	to	measured	EF;	LV	mass	can	also	
be	computed.	Contours	are	drawn	on	the	endocardial	and	epicardial	borders	at	one	
point	in	the	cardiac	cycle,	usually	end	diastole	and	the	LV	mass	calculated	using	the	
‘summation	of	discs'	principle	(Schulz-Menger	et	al.,	2013).		
Post	ACS,	adverse	left	ventricular	remodelling	is	associated	significant	morbidity	and	
mortality	 (Frangogiannis,	 2006).	 Animal	 studies	 have	 revealed	 that	 post-infarct	
remodeling	 is	 the	 consequence	 of	 an	 interplay	 between	 numerous	 mechanical,	
neuro-hormonal,	 microvascular,	 and	 macrovascular	 factors	 (Sutton	 and	 Sharpe,	
2000).	 Post	 MI,	 European	 Society	 of	 Cardiology	 guidelines	 recommend	 CMR	 for	
viability	assessment	and	in	patients	with	poor	echocardiographic	windows	(Steg	et	
al.,	2012).	CMR	derived	LV	volumetric	measurements	of	left	ventricular	end-diastolic	
volume,	EF	and	infarct	size	are	increasingly	used	as	surrogate	endpoints	in	clinical	
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trials	 post-MI	 (Desch	 et	 al.,	 2011).	 The	 current	 standard	 criteria	 for	 adverse	 LV	
remodelling	on	follow-up	CMR	study	is	a	20%	increase	in	LV	end	diastolic	volume	at	
follow-up	(Carrick	et	al.,	2015).		
1.3.2 Myocardial	deformation	analysis	
Volume	based	assessment	of	EF	is	the	most	widely	used	and	best	validated	measure	
of	 left	 ventricular	 function.	 However,	 this	 method	 doesn’t	 inform	 us	 about	
‘myocardial’	 regional	 or	 global	 function	 and	 is	 extremely	 sensitive	 to	 loading	
conditions.	 Importantly,	 in	 several	 cardiomyopathies	 including	 hypertrophic	
cardiomyopathy,	the	EF	remains	preserved	and	if	anything,	the	EF	increases	in	mild	
to	moderate	 concentric	 hypertrophy.	 However,	 in	 these	 patients	 left	 ventricular	
longitudinal	 function	 is	 markedly	 reduced	 (Young	 et	 al.,	 1994).	 Hence	 these	
limitations	 of	 volumetric	 assessment,	 have	 led	 to	 an	 interest	 in	 techniques	 that	
provide	more	objective	measures	of	contractile	function.		
The	LV	myocardium	simultaneously	contracts	in	the	longitudinal	and	circumferential	
planes	and	thickens	in	the	radial	plane	in	systole,	with	reciprocal	changes	in	diastole.	
Myocardial	 deformation/strain	 imaging	 allows	 for	 more	 direct	 assessment	 of	
myocardial	muscle	shortening	and	lengthening	throughout	the	cardiac	cycle.	Strain	
is	defined	as	the	change	in	length	of	a	segment	of	myocardium	relative	to	its	resting	
length	and	is	expressed	as	a	percentage;	strain	rate	is	the	rate	of	this	deformation.	
Longitudinal	 and	 circumferential	 shortening	 results	 in	 negative	 strain	 values,	
whereas	radial	thickening	results	in	a	positive	strain	value	(Shah	and	Solomon,	2012).	
Myocardial	strain	assessment	by	CMR	provides	important	diagnostic	and	prognostic	
information	and	has	been	used	to	detect	subclinical	impairment	of	both	regional	and	
global	cardiac	function	in	a	wide	variety	of	conditions	(Parsai	et	al.,	2012).	
Feature	 tracking	 is	 a	 new	post	 processing	 technique	which	 allows	 for	 tracking	of	
myocardial	 features	during	 the	30-60	phases	of	 the	 cine	 imaging	 throughout	 the	
cardiac	cycle.	This	technique	is	comparable	and	provides	similar	results	to	speckle	
tracking,	which	is	a	well	validated	echocardiography	measure	of	strain	(Onishi	et	al.,	
2015).	Feature	tracking	allows	for	quantification	of	strain	without	the	need	for	the	
acquisition	 of	 separate	 tagged	 cine	 imaging.	 Feature	 tracking	 derived	 strain	 has	
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demonstrated	similar	high	reproducibility	to	strain	measured	by	CMR	tissue	tagging	
(Khan	et	al.,	2015).	
1.4 Multi-parametric	tissue	characterization	
1.4.1 Myocardial	oedema	and	area	at	risk	analysis		
Abrupt	 occlusion	 of	 coronary	 artery	 results	 in	 initiation	 of	 several	 structural,	
metabolic	 and	 functional	 pathways	 within	 the	 subtended	 myocardium	 which	
eventually	 results	 in	 myocardial	 necrosis.	 Necrosis	 is	 initiated	 from	 the	 sub-
endocardium	 to	 the	 epicardium	 in	 a	 wave-front	 manner	 (Reimer	 and	 Jennings,	
1979).	Myocardial	 oedema	 develops	 before	 ischaemic	 necrosis	 or	 even	 troponin	
release	 (Abdel-Aty	 et	 al.,	 2009)	 and	 can	 persist	 even	 when	 ECG	 changes	 and	
myocardial	dysfunction	have	resolved	(h-Ici	et	al.,	2014)	(Figure	1.1).	Post	ischaemic	
injury,	myocardial	oedema	can	persist	up	to	six	month	(Dall’Armellina	et	al.,	2011).		
In	 CMR	 study,	 T2-weighted	 imaging	 (T2W-imaging)	 is	 the	 standard	 imaging	
technique	 for	 detecting	 acute	myocardial	 edema.	 It	 is	 used	 for	 differentiation	 of	
acute	from	chronic	MI	(Abdel-Aty	et	al.,	2004),	assessment	of	the	area	at	risk	(AAR)	
(Payne	 et	 al.,	 2011),	 myocarditis	 (Friedrich	 et	 al.,	 2009)	 and	 increasingly	 as	 a	
surrogate	end-point	in	clinical	trials.	T2W-imaging	improves	the	overall	accuracy	of	
CMR	protocol	to	diagnose	ACS	often	before	cardiac	biomarkers	were	elevated		(Cury	
et	al.,	2008).		
Emerging	CMR	methods	for	ACS	imaging	include	in	particular	parametric	mapping	
techniques.	 T1-mapping	 can	 quantify	 the	 extent	 and	 severity	 of	 acute	 ischaemic	
injury.	 In	 an	 early	 study,	 non-contrast	 T1-maps	 had	 96%	 sensitivity	 and	 91%	
specificity	for	detecting	acute	MI	(Messroghli	et	al.,	2007).		In	a	more	recent	study,	
T1-mapping	was	 superior	 to	T2W-imaging	 in	detecting	non-ST-elevation	MI	 (area	
under	the	curve	0.91	±	0.02	versus	0.81	±	0.04,	respectively	P=0.004)	(Dall’Armellina	
et	al.,	2012).	T1-mapping	is	also	superior	to	T2W	and	LGE-imaging	in	detecting	acute	
myocarditis,	 which	 is	 one	 of	 the	 key	 differential	 diagnoses	 in	 acute	 chest	 pain	
patients	(Ferreira	et	al.,	2013;	Garg,	John	P	J.P.	Greenwood	and	Plein,	2015).		
Post	ACS,	area	at	risk	(AAR)	is	defined	as	total	area	of	the	myocardium	subtended	by	
the	 culprit	 occluded	 vessel.	 If	 no	 reperfusion	 occurs	 in	 the	 occluded	 vessel,	 this	
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whole	area	potentially	can	necrose	resulting	 into	permanent	 transmural	 scar	and	
also	 potentially	 leading	 to	 adverse	 LV	 remodeling.	 Urgent	 reperfusion	 therapy,	
reduces	necrosis	and	limits	the	overall	 infarct	burden.	On	CMR	imaging	post	ACS,	
AAR	is	identified	as	total	hyper-enhanced	area	on	T2W	imaging,	which	includes	the	
infarcted	myocardium.	Salvaged	myocardium	is	the	area	of	myocardium	which	has	
been	 saved	 because	 of	 reperfusion	 therapy,	 that	 is,	 AAR	 minus	 the	 infarcted	
myocardium.		
1.4.2 Infarct	size	and	viability	analysis		
Gadolinium	based	CMR	contrast	agents	are	exclusively	extracellular	and	can	only	
passively	enter	damaged	cells	with	a	 leaky	cell	membrane.	These	contrast	agents	
therefore	 accumulate	 in	 areas	 with	 damaged	 cells	 and	 avascular	 extracellular	
regions.	This	phenomenon	is	exploited	in	LGE	CMR	imaging.	LGE	imaging	involves	
administration	of	 typically	0.1-0.2mmol/kg	of	a	gadolinium	based	contrast	agent.	
After	a	delay	of	5-20	minutes	the	contrast	agent	is	retained	to	a	greater	extent	in	
areas	of	scar	or	fibrosis	than	in	normal	myocardium.	An	inversion	recovery	sequence	
with	an	inversion	time	specified	to	null	“normal”	myocardium	then	displays	scarred	
myocardium	 as	 bright	 when	 compared	 to	 the	 reference.	 The	 pattern	 of	 hyper-
enhancement	 on	 LGE	 can	 aid	 in	 the	 diagnosis	 of	 the	 aetiology	 of	 many	 cardiac	
pathologies.	 For	 example,	 sub-endocardial	 or	 transmural	 LGE	 is	 seen	 in	 ischemic	
cardiomyopathy,	 mid	 wall	 LGE	 in	 dilated	 and	 hypertrophic	 cardiomyopathies,	
epicardial	LGE	in	myocarditis	and	global	diffuse	sub-endocardial	LGE	in	amyloidosis.	
The	presence	of	hyper-enhancement	on	LGE	imaging	is	shown	to	match	well	with	
discrete	 fibrosis	 on	 histology	 and	 is	 associated	 with	 adverse	 prognosis	 in	 many	
cardiomyopathies	(Ismail	et	al.,	2012).	
Post	myocardial	infarction,	LGE	imaging	plays	an	important	role	in	defining	infarct	
size	 (IS)	 and	 the	 assessment	 of	 viability	 in	 the	 infarcted	 segments	 (Kwong	 and	
Korlakunta,	 2008).	 IS	 and	 viability	 assessment	 are	 important	 measures	 of	
reperfusion	success	and	predictors	of	remodeling	and	prognosis	(Klem	et	al.,	2011).		
Both	IS	and	AAR	are	quantified	with	semi-automated	thresholding	methods	applied	
on	LGE	imaging.	For	AAR,	full	width	half	maximum	(FWHM)	has	been	validated	in	
histopathological	study	(Aletras	et	al.,	2006).	For	acute	IS,	5-standard	deviation	(5SD)	
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or	 FWHM	 thresholding	methods	 have	 been	 shown	 to	 provide	 reliable	 results	 of	
quantification	 (Flett	 et	 al.,	 2011;	 Heiberg	 et	 al.,	 2008).	 These	 semi-quantitative	
methods	have	important	limitations	and	manual	contouring	is	still	one	of	the	best	
methods	for	quantification	of	IS	and	AAR	(McAlindon	et	al.,	2015).	
1.4.3 Microvascular	obstruction	and	intra-myocardial	haemorrhage	
Microvascular	 obstruction	 (MVO)	 occurs	 post	 ST-elevation	 myocardial	 infarction	
(STEMI)	 in	 a	 certain	 group	 of	 patients	 who	 receive	 reperfusion	 therapy	 after	
prolonged	myocardial	 ischaemia	(Moens	et	al.,	2005).	 It	has	been	associated	with	
‘no-reflow’	 on	 invasive	 coronary	 angiogram	 in	 the	 culprit	 vessel.	 No-reflow	 is	
characterized	 by	 the	 additional	 important	 contributing	 factors	 of	 micro-
embolization	and	the	resultant	inflammation	(Schwartz	and	Kloner,	2012).	Rupture	
or	erosion	of	epicardial	coronary	artery	plaques,	either	spontaneously	or	 induced	
mechanically	by	percutaneous	coronary	intervention,	can	result	in	distal	showering	
of	 embolic	 debris,	 consisting	 of	 atherosclerotic	 plaque	 components	 and/or	
thrombotic	material.	 Distal	 embolization	may	 not	 only	 contribute	 to	mechanical	
obstruction	of	the	micro-vessels	but	also	causes	an	inflammatory	response	with	the	
elaboration	of	vasogenic	and	thrombogenic	factors	that	further	exacerbate	existing	
microvascular	 dysfunction.	 Therefore,	 patho-physiologically,	MVO	 is	 the	 result	 of	
the	complex	interplay	of	a	number	of	related	processes.		
Reperfusion	may	also	lead	to	intramyocardial	haemorrhage	(IMH)	in	the	infarct	core	
(Roberts	 et	 al.,	 1983)	 via	 extravasation	 of	 blood	 through	 damaged	 endothelium	
(Basso	and	Thiene,	2006).	Both	MVO	and	IMH	are	gradually	being	recognized	as	a	
poor	 prognostic	 marker	 and	 an	 indicator	 of	 subsequent	 adverse	 LV	 remodeling,	
independently	of	IS	(Morishima	et	al.,	2000;	Wu	et	al.,	1998;	Mather	et	al.,	2011).  
In	pre-clinical	and	human	studies	post-acute	reperfused	infarction	(Judd	et	al.,	1995;	
Lima	 et	 al.,	 1995),	 regions	 of	 myocardial	 hypo-enhancement	 within	 the	 first	 2	
minutes	 of	 contrast	 administration	were	 observed	within	 the	 infarct	 region	 that	
were	characterized	by	significantly	 reduced	regional	blood	 flow	and	correlated	 in	
size	with	anatomic	no-reflow	zones	measured	by	thioflavin-S.	Subsequently,	these	
hypoenhanced	areas	seen	on	CMR	were	termed	MVO.	Therefore,	MVO	represents	
the	hypo-intense	core	within	the	infarcted	zone	on	LGE	imaging.	Volumes	of	MVO	
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can	be	calculated	from	manually	planimetered	areas	through	the	whole	short-axis	
LV	LGE	stack	by	the	modified	Simpson’s	method.	The	presence	and	extent	of	IMH	is	
assessed	 by	 combined	 analysis	 of	 T2W	and	 T2*	 images	 (Figure	 1.3).	 IMH	 can	 be	
visualized	 by	 T2-weighted	 (T2W)	 sequences	 because	 hemorrhage	 and	 the	
breakdown	products	of	oxygenated	hemoglobin	 influence	magnetic	properties	of	
the	surrounding	tissue.	On	T2W	images,	areas	with	mean	signal	intensity	less	than	2	
standard	deviation	below	the	periphery	of	the	area	at	risk	(AAR)	is	considered	to	be	
haemorrhage	 (Kidambi,	 Adam	 N	 Mather,	 et	 al.,	 2013).	 On	 the	 T2*	 images,	 the	
presence	of	a	dark	core	within	the	infarcted	area	by	visual	inspection	of	the	images	
can	confirm	myocardial	haemorrhage.	The	standardized	imaging	method	or	protocol	
for	assessment	of	IMH	is	still	debated.	However,	concordant	results	between	T2w	
and	T2*	are	now	used	in	research	studies	to	confirm	haemorrhage	reliably	(Kidambi	
et	al.,	2014).	
	
	
	
	
	
	
	
	
	
Figure	1.3	Tissue	characterization	in	STEMI.		
This	is	a	case	of	inferior	STEMI	patient	who	received	urgent	reperfusion	therapy.	T2W	
imaging	 demonstrates	 hyper-enhancement	 in	 the	 inferio-lateral	 segments	with	 a	
dark	core	within	it.	LGE	imaging	demonstrates	extensive	inferio-lateral	myocardial	
infarction.	 The	 dark	 core	 on	 T2W	 is	 located	 exactly	 in	 the	 dark	 core	 on	 the	 LGE	
imaging	and	is	this	would	be	consistent	with	a	diagnosis	of	MVO	with	IMH.	T1-maps	
and	ECV-maps	demonstrate	pseudo-normalization	of	values	within	this	‘dark’	core.		
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1.4.4 Left	ventricular	thrombus	assessment	
LV	thrombus	formation	is	one	of	the	worst	complications	of	myocardial	infarction	
and	can	lead	to	fatal	systemic	embolization	(Delewi	et	al.,	2012).		In	current	era	of	
urgent	 reperfusion	 therapy,	 the	 incidence	 is	 around	 5-7%.	 Early	 gadolinium	
enhancement	 (EGE)	 imaging	 is	 superior	 to	 transthoracic/transesophageal	
echocardiography	 for	 the	 detection	 of	 LV	 thrombus	 (Mollet	 et	 al.,	 2002).	 EGE	
imaging	 is	 done	 immediately	 post	 contrast	 administration	 in	 multiple	 planes	 to	
detect	the	presence	of	LV	thrombus		(Goyal	and	Weinsaft,	2013).	On	EGE	imaging,	
thrombus	 is	 seen	 as	 a	 dark	 hypo-intense	 area	 with	 the	 left	 ventricle.	 Patients	
diagnosed	with	LV	thrombus	are	routinely	started	on	anti-coagulation	with	warfarin	
for	at	least	3-6	months.		
1.4.5 Extracellular	volume	quantification	
Extracellular	fibrosis	is	a	common	pathological	finding	in	many	aetiologies	of	heart	
failure.	 As	 described	 in	 the	 preceding	 section,	 LGE	 imaging	 is	 a	 well-established	
method	 to	 assess	 and	 quantify	 the	 size	 and	 transmurality	 of	 discrete	 areas	 of	
fibrosis/infarction.	However,	this	process	relies	on	nulling	the	healthy	myocardium	
and	 on	 comparing	 the	 enhancement	 of	 healthy	 and	 diseased	 myocardium	
qualitatively.	When	 the	myocardium	 is	 more	 diffusely	 diseased,	 techniques	 that	
characterize	 the	 myocardium	 quantitatively	 provide	 incremental	 insights	 into	
myocardial	disease.		
There	has	been	renewed	recent	interest	in	methods	that	quantify	the	inherent	T1	
(Messroghli	et	al.,	2004)	and	T2	(Verhaert	et	al.,	2011)	signal	of	the	myocardium	and	
create	an	intuitive	visual	map	of	their	values.	Native	tissue	maps	alone	can	be	used	
for	 tissue	 characterization	 or	 can	 be	 combined	 with	 post	 contrast	 acquisitions.	
Native	 (non-contrast)	 T1-maps	 can	 detect	 pathology	 related	 to	 excess	 water	 in	
oedema,	protein	deposition,	changes	in	lipid/iron	content	in	the	myocardium	(Moon	
et	 al.,	 2013).	 However,	 native	 T1-maps	 do	 not	 inform	 us	 about	 the	 intra-/extra-	
cellular	composition	of	the	myocardium.	Additionally,	even	though	quantification	of	
native	 T1	 is	 highly	 reproducible,	 it	 varies	 with	 different	 field	 strengths,	 vendor	
platforms	and	mapping	sequences	(Dabir	et	al.,	2014).		
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Gadolinium-based	contrast	agents	shorten	the	T1	relaxation	time	and	tissues	with	
an	 expanded	 extracellular	 space	 due	 to	 fibrosis,	 infiltration	 or	 scar	 have	 a	 larger	
distribution	 volume	 for	 the	 extracellular	 contrast	 agent.	 In	 these	 tissues,	 the	
reduction	in	T1	relaxation	time	is	therefore	more	pronounced	than	in	normal	tissue	
and	is	correlated	with	the	extent	of	the	extracellular	space.	Post-contrast	myocardial	
T1	has	been	shown	to	significantly	correlate	with	histological	areas	of	fibrosis	(Iles	
et	al.,	2008).		
Post	 contrast	 T1	 mapping	 makes	 assumptions	 about	 the	 kinetics	 of	 gadolinium	
contrast	agents	and	the	results	can	be	influenced	by	renal	function,	haematocrit	and	
body	 composition.	 These	 assumptions	 can	be	overcome	by	 combining	pre-/post-
contrast	T1	mapping	of	both	myocardium	and	blood	and	correcting	for	the	blood	
volume	of	distribution	(1-haematocrit).	From	these	data,	maps	of	the	extracellular	
volume	 (ECV)	 fraction	 can	 be	 calculated	 which	 show	 significant	 correlation	 with	
histological	degree	of	fibrosis	and	volume	of	collagen	in	the	myocardium	(Flett	et	al.,	
2010).	ECV	is	calculated	using	the	formula:	
	𝐸𝐶𝑉 = 1 − 𝐻𝑐𝑡 *+ ,-.	012 3*+(,-.	0.56)*+ 89..:	012 3*+(89..:	0.56)						 where	R1=1/T1	
	
ECV	 is	 a	 promising	 measure	 of	 extracellular	 matrix	 (ECM)	 expansion,	 which	 is	
adversely	 related	 to	 mechanical,	 electrical	 and	 vasomotor	 dysfunction	 of	 the	
myocardium	 (Moon	 et	 al.,	 2013).	 Increased	 ECV	 have	 been	 reported	 in	 several	
cardiomyopathies	including	amyloidosis,	dilated	cardiomyopathy	and	hypertrophic	
cardiomyopathy	(Dass	et	al.,	2012;	Puntmann	et	al.,	2013;	Sado	et	al.,	2012).	Hence,	
ECV-maps	 add	 incremental	 diagnostic	 value	 to	 quantify	 global/focal	 myocardial	
fibrosis,	which	is	mainly	a	process	in	the	ECM.	ECV	values	are	independent	of	the	
field	strength	of	the	CMR	scanners.		
In	 a	 recent	 study	 of	 1172	 subjects,	 Schelbert	 and	 Wong	 demonstrated	 that	
myocardial	 fibrosis	 quantified	 by	 ECV-maps	 is	 associated	 with	 subsequent	
hospitalization	for	heart	failure	(hazard	ratio	1.77;	95%	CI	1.32	to	2.36	for	every	5%	
increase	in	ECV),	death	(hazard	ratio	1.87	95%	CI	1.45	to	2.40),	or	both,	even	after	
adjusting	for	age,	sex,	renal	function,	myocardial	 infarction	size,	ejection	fraction,	
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hospitalization	status,	and	heart	failure	stage	(Schelbert	et	al.,	2015).	Another	study	
which	investigated	the	use	of	ECV	quantification	in	diabetes,	also	demonstrated	that	
higher	ECV	 is	associated	with	mortality	and	 incidence	of	hospitalization	 for	heart	
failure	in	diabetic	individuals	when	adjusted	for	demographics,	infarct	size	by	LGE-
imaging	and	other	CMR	parameters	(T.C.	Wong	et	al.,	2014).		
Recent	studies	have	investigated	ECV	rise	in	different	segments	of	myocardium	post	
STEMI	 (Carberry	 et	 al.,	 2016;	 Bulluck	 et	 al.,	 2016).	 In	 these	 studies,	 the	 remote	
myocardium	was	defined	as	the	AHA	segment	180	degrees	from	the	infarct	territory	
with	normal	motion	and	no	LGE.	Carberry	et	al	demonstrated	 that	acute	 remote	
zone	ECV	post	STEMI	is	associated	with	few	baseline	patient	characteristics	(male	
gender,	body	mass	index	and	history	of	diabetes).	Also,	in	their	study	they	showed	
that	 the	 remote	 zone	 ECV	 is	 associated	 with	 baseline	 N-terminal	 pro	 b-type	
natriuretic	peptide	(NT-proBNP).	Bulluck	et	al	demonstrated	that	mean	segmental	
ECV	value	 in	the	remote	myocardium	is	raised	acutely	post	STEMI	and	also	acute	
infarct	segmental	ECV	predicted	functional	recovery.			
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1.5 Role	of	haemodynamic	assessment	post	MI	
Post	myocardial	infarction,	haemodynamic	assessment	by	routine	echocardiography	
informs	about	LV	filling	pressures	and	the	likelihood	of	heart	failure	(Hozumi	et	al.,	
1999).	This	non-invasive	haemodynamic	assessment	can	guide	therapy	and	inform	
about	prognosis	(Iwahashi	et	al.,	2012;	Hillis	et	al.,	2004).		
Routine	haemodynamic	assessment	by	echocardiography	is	predominantly	done	by	
pulse-wave	 Doppler	 echocardiography	 (DE)	 technique.	 However,	 DE	 has	 several	
limitations	 due	 to	 2D-planar	 assessment,	 through-plane	motion,	 high	 intra-inter-
operator	variability	and	a	recent	meta-analysis	queries	the	diagnostic	accuracy	of	
this	method	 (Sharifov	 et	 al.,	 2016).	 Therefore,	 new	 quantitative	measures	 of	 LV	
haemodynamics	and	flow	are	warranted	post	MI.		
The	development	of	four-dimensional	flow	cardiac	magnetic	resonance	imaging	(4D	
flow	CMR)	now	allows	mapping	and	quantification	of	intra-left	ventricular	flow	and	
its	kinetic	energy	(KE).	This	method	is	uniquely	placed	to	provide	new	insight	into	
the	distribution	of	intra-left	ventricular	flow	in	health	and	disease.	As	this	technology	
is	 less	operator	dependant,	and	allows	to	quantify	 intra-cardiac	 flow	using	 three-
dimensional	plane,	it	has	the	potential	to	reduce	intra-/inter-observer	variability	and	
importantly,	measure	flow	indices,	with	higher	accuracy	and	precision.		
Hence,	in	this	thesis,	we	take	the	first	step	in	validating	the	best	four-dimensional	
flow	CMR	imaging	method	for	clinical	applications	on	Philips	1.5	Tesla	systems.			
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1.6 Aims	of	thesis		
Myocardial	 deformation	 analysis	 using	 CMR	 feature	 tracking	 offers	 mechanistic	
insights	 into	 regional	 myocardial	 function.	 Additionally,	 it	 can	 discriminate	 and	
quantify	 the	 function	of	 the	 three	main	different	 types	of	myofiber	orientations:	
longitudinal,	 circumferential	 and	 radial	 orientation.	 In	 patients	with	 ACS	 or	 CAD,	
there	remains	limited	understanding	on	how	the	presence	of	MVO,	IMH	or	perfusion	
defect	 on	 first-pass	 perfusion	 CMR	 influences	 the	 function	 of	 the	 three	 main	
myofiber	 orientations	 or	 myocardial	 deformation.	 Alteration	 in	 myocardial	
deformation	 could	 potentially	 be	 used	 clinically	 or	 as	 a	 surrogate	 end-point	 in	
research	across	other	imaging	modalities.		
Quantification	of	ECV	in	acute	infarct	patients	seems	to	add	incremental	information	
above	 LGE-imaging.	 Moreover,	 LGE	 imaging	 overestimates	 acute	 infarct	 size.	
Quantitative	 maps	 which	 offer	 more	 reliable	 assessment	 of	 IS	 and	 AAR	 are	
warranted.	Additionally,	there	is	a	need	for	newer	methods	to	assess	and	quantify	
intra-cardiac	flow	reliably,	so	that	in	future	studies,	a	more	comprehensive	insight	
into	adverse	LV	remodelling	can	be	attained.		
The	 subsequent	 chapters	 each	 have	 a	 specific	 aim	 with	 individual	 introduction,	
methods,	results	and	discussion:	
Study	1:	To	establish	whether	acute	mitral	annular	plane	systolic	excursion	(MAPSE)	
is	associated	with	MVO	or	IMH		
Study	 2:	 To	 investigate	 the	 association	 of	 MVO,	 IMH	 and	 convalescent	 left	
ventricular	 (LV)	 remodelling	with	strain	parameters	measured	by	 feature	 tracking	
CMR		
Study	3:	To	 investigate	how	first-pass	adenosine	stress	perfusion	CMR	affects	 left	
ventricular	longitudinal	deformation		
Study	4:	To	investigate	if	acute	ECV-maps	can	reliably	quantify	myocardial	area	at	
risk	(AAR)	and	final	infarct	size	(IS)		
Study	5:	To	investigate	which	is	the	most	reliable	and	robust	acceleration	method	in	
four-dimensional	(4D)	flow	CMR	in	phantoms	and	in-vivo	
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2 Methods	
2.1 Study	Populations	
Details	of	specific	patients	populations	by	chapter	are	listed	in	the	individual	sections	
below.			
Exclusion	criteria	common	to	all	patient	groups	are	detailed	in	Table	2.1.	
Number	 Contraindications	
1	 Contraindication	 to	 CMR	 (e.g.	 non-CMR	 conditional	 permanent	
pacemaker	or	defibrillator,	intra-orbital	metal,	claustrophobia	etc.)	
2	 Pregnant	or	breastfeeding	patients	
3	 Weight	≥120kg	
4	 Inability	to	lie	flat	for	the	duration	of	the	CMR	scan		
5	 Inability	to	give	written,	informed	consent	
6	 Previous	AMI	or	coronary	artery	bypass	grafting	
Table	2.1	List	of	exclusion	criteria.	
2.1.1 Patient	population	for	Chapter	3,	4,	6	and	7	
Patients	presenting	with	first	ST-segment	elevation	AMI	who	were	revascularized	by	
primary	percutaneous	intervention	(PCI)	within	12	hours	of	onset	of	chest	pain	were	
prospectively	 recruited	 from	 a	 single	 tertiary	 centre	 between	 January	 2011	 to	
August	2014.	AMI	was	defined	as	per	current	guidelines	(Thygesen,	Joseph	S.	Alpert,	
et	al.,	2012).	After	PPCI,	patients	received	standard	post-AMI	secondary	prevention	
therapy	and	were	enrolled	in	a	cardiac	rehabilitation	programme(Steg	et	al.,	2012).		
For	 chapter	 4,	 age	 and	 sex	matched	healthy	 volunteers	 serving	 as	 controls	were	
recruited.	 Importantly,	 for	 chapter	 6,	 patient	 population	 is	 different	 to	 patient	
population	to	Chapter	3	and	4.	For	chapter	7,	healthy	volunteers	were	recruited	only	
from	two	sites:	Leeds	and	Leiden.	Healthy	volunteers	had	no	history	or	symptoms	of	
cardiovascular	disease,	were	on	no	cardiovascular	or	other	relevant	medication	and	
had	no	contraindications	to	CMR.		
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2.1.2 Patient	population	for	Chapter	5	
Patients	presenting	to	the	rapid	access	chest	pain	clinic	and	who	were	referred	for	a	
stress	CMR	study	for	the	evaluation	of	coronary	artery	disease	in	a	single	tertiary	
cardiology	centre	were	prospectively	recruited	in	this	prospective	cohort	study.	
2.2 Ethics	and	approvals		
For	chapter	3,4	and	6,	the	study	protocol	was	approved	by	the	National	Research	
Ethics	Service	(12/YH/0169).	For	chapter	5	and	7,	the	study	protocol	was	approved	
by	the	National	Research	Ethics	Service	(12/YH/0551).	For	chapter	7,	at	Leiden,	the	
institutional	Medical	Ethical	Committee	(P11.136)	approved	the	study.	All	patients	
and	health	volunteers	gave	written	 informed	consent	to	participate	 in	all	studies.	
Research	studies	complied	with	the	Declaration	of	Helsinki.	
2.3 MRI	Scanner	Hardware	
All	scans	at	1.5T	were	conducted	using	the	same	1.5T	system	(Ingenia,	Philips,	Best,	
The	Netherlands)	using	the	same	32-channel	coil,	vectorcardiographic	triggering	and	
multi-transmit	technology	(Philips,	Best,	The	Netherlands).	Chapter	5,	6	and	7	were	
done	on	1.5T	system.	
All	scans	at	3.0T	were	conducted	using	the	same	3.0T	system	(Achieva,	Philips,	Best,	
The	Netherlands)	using	the	same	32-channel	coil,	vectorcardiographic	triggering	and	
multi-transmit	technology	(Philips,	Best,	The	Netherlands).	Chapter	3,	4	and	6	were	
done	on	3T	system.	
2.4 Common	CMR	Protocol	
Key	components	of	common	CMR	protocol	all	described	in	this	section.	At	the	start	
of	any	CMR	protocol,	free	breathing	low-resolution	survey	scan	of	the	chest	were	
done	to	mark	anatomical	landmarks.	For	each	pulse	sequence,	images	with	artefact	
were	 repeated	until	 any	artefact	was	 removed	or	minimized.	 The	highest	quality	
images	were	used	for	analysis.	
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2.4.1 Cine	imaging		
Long-axis	cines:	Vertical	long	axis	(VLA	or	2-chamber),	horizontal	long	axis	(HLA	or	4-
chamber)	acquired	with	a	balanced	steady-state	free	precession	(bSSFP),	single-slice	
breath-hold	sequence.	Typical	parameters	for	bSSFP	cine	were	as	follows:	echo	time	
1.3	milliseconds,	repetition	time	2.6	milliseconds,	flip	angle	40°,	field	of	view	320-
420	mm	according	to	patient	size,	SENSE	acceleration,	slice	thickness	10	mm,	and	30	
phases	per	cardiac	cycle.		
Short-axis	 LV	 cine	 stack:	 Resting	 wall	 motion	 and	 left	 ventricular	 function	 were	
assessed	with	a	contiguous	stack	of	multiphase	ventricular	short-axis	bSSFP	cines	
(10-12	 slices,	 30	 phases,	 10-mm	 slice	 thickness,	 0-mm	 gap	 and	 pulse	 sequence	
parameters	were	same	as	the	long-axis	cines).		
2.4.2 Early	gadolinium	enhancement	imaging	(EGE)	
EGE-imaging	was	done	immediately	post	gadolinium	based	contrast	administration.	
EGE	 was	 done	 by	 inversion	 recovery	 spoiled	 gradient	 echo	 pulse	 sequence.	
Comprehensive	information	on	pulse	sequence	parameters	are	detailed	in	Table	2.2.	
EGE-imaging	 1.5	Tesla		 3	Tesla		
Short-axis	
contiguous	 slices,	
2-chamber		
and		
4-chamber	
IR	spoiled	GE	
SENSE	factor	1.7	
Typical	TE/TR	=	2.8/5.7	ms	
Flip	angle	=	25°	
Typical	BW	=	300	Hz/pix	
Typical	in-plane	resolution	=	
1.5	mm	acq/0.8	mm	recon	
Look-Locker	 scout	
determined	TI		
Slice	thickness	=	8	mm	
IR	 spoiled	 GE	
SENSE	factor	1.5	
Typical	TE/TR	=	2.0/3.8	ms	
Flip	angle	=	25°	
Typical	BW	=	700	Hz/pix	
Typical	in-plane	resolution	=	1.5	
mm	acq/0.7	mm	recon	
Look-Locker	scout	determined	TI	
Slice	thickness	=	10	mm	
Table	2.2	Pulse	sequence	parameters	for	EGE-imaging.		
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2.4.3 Late	gadolinium	enhancement	imaging	(LGE)	
LGE-imaging	was	performed	10-15	minutes	after	 the	bolus	contrast	 injection	 (0.1	
mmol/kg	gadolinium-DTPA:	gadopentetate	dimeglumine;	Magnevist,	Bayer,	Berlin,	
Germany)	was	then	administered	using	a	power	injector	(Spectris,	Solaris,	PA).using	
phase-sensitive	 inversion	 recovery	 (PSIR)	 or	 inversion	 recovery	 (IR)	 prepared	
gradient	echo.	 	A	modified	Look-Locker	(MOLLI)	approach	was	used	to	determine	
the	optimal	inversion	time	(ms)	required	to	adequately	null	the	LV	myocardium.			
	
LGE-imaging	 1.5	Tesla		 3	Tesla		
Short-axis	
contiguous	slices,	
2-chamber		
and		
4-chamber	
PSIR	spoiled	GE	
SENSE	factor	1.7	
Typical	TE/TR	=	3.0/6.1	ms	
Flip	angle	=	25°	
Typical	BW	=	250	Hz/pix	
Typical	in-plane	resolution	=		
1.6	mm	acq/0.8	mm	recon	
Look-Locker	scout	
determined	TI	
Slice	thickness	=	10	mm	
	
IR	spoiled	GE	
SENSE	factor	1.5	
Typical	TE/TR	=	2.0/3.7	ms	
Flip	angle	=	25°	
Typical	BW	=	800	Hz/pix	
Typical	in-plane	resolution	=		
1.6	mm	acq/0.7	mm	recon	
Look-Locker	scout	determined	
TI	
Slice	thickness	=	10	mm	
Table	2.3	Pulse	sequence	parameters	for	LGE-imaging.		
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2.5 Common	CMR	analysis		
Images	 were	 evaluated	 offline	 using	 the	 following	 software’s:		
1)	Commercially	available	software	(cvi42	v4.1.5,	Circle	Cardiovascular	Imaging	Inc.,	
Calgary,	Canada):	Chapter	3,4	and	5.	2)	In-house	research	software	developed	with	
collaborators:	MASS	 (Version	2016EXP,	 Leiden	University	Medical	Center,	 Leiden,	
The	Netherlands):	Chapter	6	and	7.	
2.5.1 LV	Ejection	fraction	analysis			
Left	ventricular	endocardial	and	epicardial	borders	were	manually	contoured	from	
the	short	axis	LV	cine	stack	at	both	end	systole	and	end	diastole	in	order	to	generate	
LV	 end	 systolic	 and	 end	 diastolic	 volumes	 according	 to	 the	 summation	 of	 discs	
methodology	(Vogel-Claussen	et	al.,	2006).	 	LV	ejection	fraction	was	derived	from	
the	 equation:	 LVEF	 (%)	 =	 ((LVEDV-LVESV)/LVEDV)	 x	 100.	 	 Both	 trabeculation	 and	
papillary	muscles	were	 excluded.	 	 LV	mass	 values	were	 calculated	 from	 the	 end	
diastolic	 myocardial	 volume	 according	 to	 established	 methods	 (Myerson	 et	 al.,	
2002).			
2.6 Statistical	analysis		
All	statistical	analysis	was	performed	using	the	PASW	software	package	(V21,	SPSS,	
IBM,	Chicago,	Illinois,	USA).		Data	are	presented	as	mean±SD,	median	(interquartile	
range,	 IQR)	 or	 frequency	 (percentage).	 Data	were	 tested	 for	 normality	 using	 the	
Shapiro-Wilks	test.	 	For	normally	distributed	data,	two-tailed	unpaired	Student’s	t	
tests	were	used	for	comparisons	between	groups,	and	paired	Students	t	tests	were	
used	 for	 intragroup	comparisons.	For	non-normally	distributed	data,	 the	Related-
Samples	Wilcoxon	Signed	Rank	Test	and	independent	samples	Mann-Whitney	U	test	
were	used.	To	compare	between	groups	an	analysis	of	variance	(ANOVA)	and	Tukey	
post-hoc	tests	were	used.	The	Chi-squared	test	was	used	for	comparing	categorical	
variables.	Pearson’s	correlation	coefficients	were	used	to	assess	the	correlation	of	
dependent	and	independent	variables.		P	values	<0.05	were	considered	statistically	
significant.			
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2.6.1 Generic	sample	size	estimations	
Based	 on	 the	 published	 data	 (Bellenger	 et	 al.,	 2000),	 the	 group	 size	 required	 to	
detect	a	10ml	change	in	LVEDV	is	12	patients,	10	patients	to	detect	a	10ml	change	
in	LVESV,	15	to	detect	a	3%	change	in	LVEF	and	9	to	detect	a	10g	change	in	LV	mass.	
Therefore,	 on	 the	 assumption	 that	 around	 25%	 patient	 post-STEMI	 will	 develop	
adverse	 LV	 remodelling,	 we	 need	 to	 recruit	 a	 minimum	 of	 40-44	 patients,	 to	
investigate	adverse	remodelling	in	chapter	3,4	and	6.	Chapter	5	and	7	were	mainly	
mechanistic	 and	 validation	 studies	 investigating	 mean	 error	 or	 correlation	 on	
continuous	datasets.	They	did	not	investigate	any	hard	end-points	and	hence	sample	
size	estimations	were	not	made.	However,	the	total	recruitment	size	was	informed	
by	previous	studies	in	similar	study	populations	to	demonstrate	changes	(Zaman	et	
al.,	2015;	Kidambi,	Adam	N.	Mather,	et	al.,	2013).	
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3 		Study	 1-	 Ventricular	 Longitudinal	 Function	 is	
Associated	 with	 Microvascular	 Obstruction	 and	
Intramyocardial	Haemorrhage	
3.1 Abstract	
3.1.1 Background	
Microvascular	 obstruction	 (MVO)	 and	 intramyocardial	 haemorrhage	 (IMH)	 are	
associated	with	adverse	prognosis,	independently	of	infarct	size	after	reperfused	ST-
elevation	 myocardial	 infarction	 (STEMI).	 Mitral	 annular	 plane	 systolic	 excursion	
(MAPSE)	 is	 a	 well-established	 parameter	 of	 longitudinal	 function	 on	
echocardiography.	We	 aimed	 to	 investigate	 how	 acute	MAPSE,	 assessed	 by	 a	 4-
chamber	cine-cardiovascular	magnetic	 resonance	 (CMR),	 is	associated	with	MVO,	
IMH	and	convalescent	left	ventricular	(LV)	remodelling.	
3.1.2 Methods		
54	consecutive	patients	underwent	CMR	at	3T	(Intera	CV,	Philips	Healthcare,	Best,	
The	Netherlands)	within	3	days	of	reperfused	STEMI.	Cine,	T2-weighted,	T2*	and	late	
gadolinium	enhancement	(LGE)	 imaging	were	performed.	 Infarct	and	MVO	extent	
were	 measured	 from	 LGE	 images.	 The	 presence	 of	 IMH	 was	 investigated	 by	
combined	 analysis	 of	 T2w	 and	 T2*	 images.	 Averaged	 MAPSE	 (medial-MAPSE	 +	
lateral-MAPSE/2)	was	calculated	from	4-chamber	cine	imaging.	
3.1.3 Results		
44	patients	completed	baseline	scan	and	38	patients	completed	3-month	scans.	26	
(59%)	patients	had	MVO	and	25	(57%)	patients	had	IMH.	Presence	of	MVO	and	IMH	
were	 associated	 with	 lower	 averaged-MAPSE	 (11.7±0.4mm	 versus	 9.3±0.3mm;	
p<0.001	and	11.8±0.4mm	versus	9.2±0.3mm;	p<0.001,	respectively).	IMH	(beta=-
0.655,	 p<0.001)	 and	 MVO	 (beta=-0.567,	 p<0.001)	 demonstrated	 a	 stronger	
correlation	to	MAPSE	than	other	demographic	and	infarct	characteristics.	MAPSE	≤
10.6mm	demonstrated	89%	sensitivity	and	72%	specificity	for	the	detection	of	MVO	
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and	92%	sensitivity	and	74%	specificity	 for	 IMH.	LV	remodelling	 in	convalescence	
was	not	associated	with	MAPSE	(AUC	0.62,	95%	CI	0.44-0.77,	p=0.22).		
3.1.4 Conclusions	
Post	 reperfused	 STEMI,	 LV	 longitudinal	 function	 assessed	 by	 MAPSE	 can	
independently	predict	the	presence	of	MVO	and	IMH.	
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3.2 Introduction	
Following	 reperfused	 acute	 myocardial	 infarction	 (AMI),	 the	 left	 ventricle	 (LV)	
undergoes	 structural	 adaptations	 both	 within	 and	 outside	 of	 the	 infarct	 zone,	
referred	 to	 as	 LV	 remodelling.	 In	 approximately	 50%	 of	 patients,	 coronary	
reperfusion	is	associated	with	microvascular	obstruction	(MVO)	(Moens	et	al.,	2005).	
Reperfusion	may	also	lead	to	intramyocardial	haemorrhage	(IMH)	in	the	infarct	core	
(Roberts	 et	 al.,	 1983)	 associated	with	 extravasation	 of	 blood	 (Basso	 and	 Thiene,	
2006).	Both	MVO	and	IMH	are	associated	with	adverse	prognosis	and	adverse	LV	
remodelling,	independently	of	infarct	size	(Morishima	et	al.,	2000;	Wu	et	al.,	1998;	
Mather	et	al.,	2011).		
Acute	myocardial	ischaemia	initially	affects	the	subendocardium	and	progresses	to	
the	subepicardial	layers	in	a	‘wave	front’	manner	(Ambrosio	et	al.,	1989;	Judd	et	al.,	
1995).	 Similarly,	 MVO	 and	 IMH	 predominantly	 affect	 the	 subendocardial	 layer.	
Endocardial	fibres	are	structurally	longitudinal	fibres	(Greenbaum	et	al.,	1981)	and	
therefore	predominantly	 contribute	 to	 longitudinal	 contractile	 function	of	 the	 LV	
(Birkeland	et	al.,	1992).	MVO	and	IMH	are	therefore	likely	to	affect	predominantly	
longitudinal	function	(Reimer	et	al.,	1977)	(Figure	3.1).		
-	44	-	
	
	
	
	
Figure	 3.1	 Illustration	 of	 orientation	 of	 myocardial	 fibres	 with	 corresponding	
representation	of	infarct	related	zones.	
	
Mitral	 annular	 plane	 systolic	 excursion	 (MAPSE)	 is	 a	 well-established	 and	 easily	
obtained	echocardiographic	parameter	for	the	assessment	of	longitudinal	function	
and	has	been	shown	to	correlate	with	LV	systolic	function	(Hu	et	al.,	2013).	Post	AMI,	
MAPSE	has	prognostic	importance	in	the	risk	stratification	of	patients,	for	example	
a	MAPSE	of	<8mm	is	associated	with	a	>3x	higher	incidence	of	hospitalization	and	
mortality	(p=0.0001)	(Brand	et	al.,	2002).		
Traditionally,	longitudinal	functional	assessment	using	MAPSE	has	been	based	on	M-
mode	transthoracic	echocardiography.	It	can	also	be	evaluated	from	a	standard	four-
chamber	cardiovascular	magnetic	resonance	(CMR)	cine	image.		CMR	based	MAPSE	
is	easily	measured,	reproducible	and	strongly	correlates	with	the	echocardiographic	
equivalent	(Bulluck	et	al.,	2014;	Abdel-Aty	et	al.,	2012).		
We	sought	 to	 investigate	 the	effect	of	MVO	and	 IMH	on	MAPSE	 in	patients	with	
acute	 STEMI	 and	 to	 determine	 correlations	 of	 CMR	 derived	 MAPSE	 with	 other	
markers	of	adverse	outcome.	
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3.3 Study	specific	methods	
3.3.1 CMR	protocol	
T2w,	T2*	and	late	gadolinium	enhancement	(LGE)	imaging	were	performed	using	the	
‘3-of-5’	approach	by	acquiring	the	central	3	slices	of	5	parallel	short-axis	slices	spaced	
equally	from	mitral	valve	annulus	to	LV	apical	cap	(Messroghli	et	al.,	2005).		
3.3.2 CMR	interpretation	
Cine,	T2w,	T2*	and	LGE	images	were	evaluated	offline	using	commercially	available	
software	(cvi42	v4.1.5,	Circle	Cardiovascular	Imaging	Inc.,	Calgary,	Canada).	Infarct	
location	 was	 determined	 by	 LGE	 imaging,	 according	 to	 standard	 guidelines	
(Cerqueira	et	al.,	2002).	The	presence	and	size	of	infarction	and	MVO	were	measured	
from	LGE	images.	Infarct	was	defined	as	an	area	of	LGE	≥2	standard	deviations	(SD)	
above	remote	myocardium,	and	infarct	volume	estimation	included	any	hypointense	
core.	We	used	the	2	SD	method	over	the	full-width	halve	maximum	(FWHM)	method	
as	there	are	more	prognostic	data	for	the	2	SD	infarct	size	estimation	(Kwon	et	al.,	
2014).	The	2	SD	cut-off	was	chosen	for	consistency	with	analysis	of	T2w	images.	MVO	
was	defined	visually	as	a	hypointense	core	within	the	infarcted	zone	on	LGE	images	
and	 planimetered	 manually.	 Volumes	 of	 infarct	 and	 MVO	 were	 calculated	 from	
planimetered	areas	across	the	whole	LV	stack	by	the	modified	Simpson’s	method.	
The	presence	 and	extent	 of	myocardial	 haemorrhage	was	 assessed	by	 combined	
analysis	 of	 T2w	 and	 T2*	 sequences	 [8].	 On	 T2w	 images,	 areas	with	mean	 signal	
intensity	 more	 than	 2	 SD	 below	 the	 periphery	 of	 the	 area	 at	 risk	 (AAR)	 were	
considered	to	represent	haemorrhage	(Kidambi,	Adam	N	Mather,	et	al.,	2013).	On	
the	 T2*	 images,	 the	 presence	 of	 a	 dark	 core	within	 the	 infarcted	 area	 by	 visual	
inspection	of	the	images	was	used	as	confirmation	of	myocardial	haemorrhage.	Only	
when	T2w	and	T2*	images	showed	concordant	findings	was	an	area	considered	to	
represent	haemorrhage.	Presence	of	both	MVO	and	IMH	were	scored	in	a	binominal	
mode.	
For	 longitudinal	 functional	 assessment,	 the	 4-chamber	 cine	 images	 were	 used	
(Figure	3.2).	A	region-of-interest	(ROI)	line	was	drawn	across	both	the	medial	and	
lateral	mitral	annulus	as	a	reference	point	in	end-diastole	(just	after	closure	of	mitral	
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valve).	A	second	of	ROI	line	was	drawn	across	the	same	plane	on	an	image	taken	just	
after	 closure	 of	 the	 aortic	 valve,	 assessed	 from	 the	 LV	 outflow	 tract	 cine.	 The	
longitudinal	distance	between	the	two	lines	parallel	to	the	left	ventricular	walls	was	
measured	for	both	medial	and	lateral	walls.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 3.2	 Multi-parametric	 CMR	 examination	 of	 two	 cases	 of	 ST-elevation	
myocardial	infarction.		
Case	1	(top	row):	Case	of	inferior-lateral	MI	with	presence	of	MVO	on	EGE	(A)	and	
LGE	(B).	IMH	within	MVO	was	confirmed	on	T2-weighted	maps	(C)	and	T2*-maps	(D).	
4-chamber	cine	imaging	(E)	confirmed	reduced	averaged	MAPSE	(overlay	of	systolic	
and	diastolic	annular	position	shown	in	green).	Case	2:	Case	of	inferior	MI	without	
the	 presence	 of	MVO	 (F,	 G)	 or	 IMH	 (H,	 I)	 and	 comparatively	 better	 longitudinal	
displacement	than	Case	1	(J).	
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For	 MAPSE,	 three	 parameters	 were	 assessed	 –	 septal	 wall	 MAPSE;	 lateral	 wall	
MAPSE	 and	 averaged	 MAPSE	 (medial	 MAPSE	 +	 lateral	 MAPSE)/2).	 It	 takes	
approximately	1-2	minutes	to	measure	MAPSE	on	4-chamber	cine.		
Longitudinal	functional	assessment	was	carried	out	independently	by	two	physicians	
experienced	in	both	echocardiography	and	CMR	imaging	(PG,	five-year	experience;	
JRJF,	four-year	experience).	For	intra-observer	variability	assessment,	one	observer	
(PG)	repeated	the	analysis	after	90-days,	blinded	to	the	original	results.	Patients	with	
sub-optimal	4-chamber	cine	images	were	excluded	from	analysis.		
Follow-up	scans	were	planned	at	3	months	following	the	indexed	event.	For	analysis,	
patients	 were	 divided	 into	 2	 groups	 based	 on	 the	 presence	 of	 LV	 remodelling,	
defined	 by	 the	 following:	 a)	 an	 increase	 of	 LV	 end-diastolic	 volume	 >	 20%	 at	 3	
months’	 follow-up	 scan	 or	 b)	 as	 increase	 of	 LV	 end-systolic	 volume	 >	 20%	 at	 3	
months’	follow-up	scan.	
3.3.3 Statistical	analysis	
Multivariate	 linear	 regression	 was	 used	 for	 variables	 with	 statistical	 significance	
from	 univariate	 analysis	 (p<0.1).	 The	 accuracy	 of	 averaged-MAPSE	 in	 predicting	
presence	 of	 MVO	 and	 IMH	 was	 examined	 using	 receiver-operator	 characteristic	
(ROC)	curve	analyses,	using	Medcalc	(v14.12.0).	Intra-/inter-observer	variability	was	
tested	using	coefficient	of	variation	(CoV).		
3.4 Results	
54	patients	met	the	inclusion	criteria.	In	5	patients	the	infarct	size	was	too	small	for	
accurate	 analysis;	 in	 another	 5	 patients	 the	 4-chamber	 cine	 was	 of	 insufficient	
quality	for	longitudinal	functional	analysis	due	to	breathing	artefact.	Therefore	44	
patients	were	included	in	the	statistical	analysis.	Patient	characteristics	are	shown	
in	Table	3.1.	Infarct	characteristics	on	CMR	are	listed	in	Table	3.2.	No	gender-based	
differences	in	characteristics	were	present	(p>0.1	for	all).	
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Patient	characteristic	 	
n	 44	
Age,	years	 58.3	±	11.4	
Male	 37	(84%)	
Body	mass	index,	kg/m2	 28.2	±	3.5	
Current	smoker	 24	(55%)	
Hypertension	 11	(25%)	
Hypercholesterolemia	 13	(30%)	
Diabetes	mellitus	 6	(14%)	
Pain	to	balloon	time,	min	(median	(IQR*))	 213	(268)	
TIMI	flow	grade	0	or	1	pre-PCI		 40	(91%)	
TIMI	flow	grade	3	post	PCI	 42	(95%)	
Peak	troponin	I,	ng/L	(median)	 >50000	
Peak	CK†,	iu/L	(median	(IQR))	 615	(1510)	
Infarct	territory	 	
	 Anterior	 20	(45%)	
	 Inferior	 18	(41%)	
	 Lateral	 6	(14%)	
	
Table	 3.1	 Study	 population	 characteristics.	 Data	 as	 mean	 ±	 SD	 or	 n	 (%)	 unless	
indicated.	*IQR	interquartile	range,	†CK	creatine	kinase.	
	 	
-	49	-	
	
	
	
3.4.1.1 Baseline	Data	
The	mean	 ejection	 fraction	 of	 the	 study	 cohort	was	 48±10%,	 septal	MAPSE	was	
9.6±2.9mm,	lateral	MAPSE	11±2.3mm	and	averaged	MAPSE	of	10.3±2.1mm	(Table	
3.2).	
Twenty-six	 (59%)	patients	had	MVO	and	25	 (57%)	had	 IMH.	No	patient	had	 IMH	
without	MVO.	Averaged	MAPSE	for	patients	with	MVO	was	significantly	lower	than	
for	patients	without	MVO	(9.3±0.3mm	versus	11.7±0.4mm;	p<0.001).	Similarly,	 in	
patients	 with	 IMH,	 MAPSE	 was	 significantly	 lower	 than	 in	 those	 without	 IMH	
(9.2±0.3mm	versus	11.8±0.4mm;	p<0.001)	(Figure	3.3).		
	
	
Characteristic	 First	Scan	
Ejection	fraction,%	 48	±	10	
LV	EDVi*,	ml/m2	 82	±	16	
LV	ESVi†,	ml/m2	 42	±	12	
LV	indexed	mass,	g/m2	 65	±	14	
LGE	infarct	volume,	ml	 15	±	12	
LGE	MVO	volume,	ml	 3	±	5	
MAPSE	(septal),	mm	 9.6	±	2.9	
MAPSE	(lateral),	mm	 11	±	2.3	
MAPSE	(averaged),	mm	 10.3	±	2.1	
MVO	present	 26	(59%)	
	
Table	3.2	Infarct	characteristics	at	baseline.		
Data	 as	mean	 ±	 SD.	 LV	measurements	 are	 indexed	 to	 body	 surface	 area,	 infarct	
volumes	are	unindexed.	*LV	EDVi	Left	ventricular	end	diastolic	volume	(indexed),	†LV	
ESVi	Left	ventricular	end	systolic	volume	(indexed).	
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Figure	3.3	Box-plot	of	averaged	MAPSE	with	or	without	the	presence	of	(a)	MVO	or	
(b)	IMH.	
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On	linear	regression	analysis,	using	the	variables	in	Table	3.3,	the	presence	of	IMH	
(beta=	-0.65,	p<0.001)	and	MVO	(beta=-0.57,	p<0.001)	demonstrated	the	strongest	
association	 with	 averaged-MAPSE.	 The	 size	 of	 MVO	 correlated	 negatively	 with	
averaged	MAPSE	(r=-0.420,	p=0.03).	Infarct	location	did	not	influence	medial	MAPSE	
(p=0.316),	lateral	MAPSE	(p=0.770)	or	averaged	MAPSE	(p=0.391).	The	area	under	
the	curve	(AUC)	for	determining	the	presence	of	MVO	by	averaged	MAPSE	was	0.84	
(95%	CI:	0.70	to	0.93;	p<0.001)	and	for	IMH	was	0.88	(95%	CI:	0.77	to	0.96;	p<0.001)	
(Figure	3.4).	The	optimal	cut-off	value	determined	by	the	Youden	index	for	averaged-
MAPSE	 was	 10.6mm	 for	 the	 detection	 of	MVO	 (sensitivity	 88.5%	 and	 specificity	
72.2%)	and	IMH	(sensitivity	92.0%	and	specificity	73.7%)	(Ruopp	et	al.,	2008).	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.4	Receiver	operator	characteristics	curve	for	the	detection	of	(A)	IMH,	(B)	
MVO	using	averaged	MAPSE.	
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	 	 MAPSE		
(Septal)	
p-value	
MAPSE		
(Lateral)	
p-value	
MAPSE	
(Averaged)	
p-value	
(beta)	
	 	 UV	 MV	 UV	 MV	 UV	 MV	
De
m
og
ra
ph
ics
	
Diabetes	Mellitus	 0.002	 0.006	 0.60	 	 0.01	 0.05	
Age	 0.36	 	 0.11	 	 0.13	 	
CK	 0.26	 	 0.72	 	 0.33	 	
Pain-Balloon	Time	 0.0	 0.004	 0.26	 	 0.45	 	
Sex	 0.27	 	 0.44	 	 0.74	 	
Smoking	History	 0.79	 	 0.86	 	 0.77	 	
Hypertension	 0.64	 	 0.65	 	 0.94	 	
Hypercholesterolemia	 0.81	 	 0.69	 	 0.95	 	
Im
ag
in
g	
	b
io
m
ar
ke
rs
	
MVO	 0.002	 0.415	 0.001	 0.36	 <0.01	
(-0.57)	
0.229	
	
IMH	 <0.01	 <0.01	 <0.01	 <0.01	 <0.01	
(-0.65)	
<0.001	
Ejection	Fraction	 0.02	 0.246	 0.09	 0.82	 0.01	 0.293	
SVi	 0.06	 0.187	 0.27	 	 0.06	 0.207	
Infarct	Volume	 0.69	 	 0.23	 	 0.35	 	
Infarct	Mass	 0.11	 	 0.49	 	 0.48	 	
Anterior	Infarct	 0.33	 	 0.91	 	 0.54	 	
LVEDVi	 0.95	 	 0.97	 	 0.98	 	
	 Abbreviations:	UN,	univariate;	MV,	multivariate	
Table	 3.3	 Univariate	 and	 multivariate	 analysis	 of	 longitudinal	 parameters	 of	 LV	
function	to	CMR	derived	clinical	and	prognostic	markers	
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3.4.1.2 Follow-up	data	
Thirty-eight	of	44	patients	underwent	day-90	CMR,	while	6	patients	refused	follow-
up	 scans.	 All	 38	 patients	 scans	 were	 of	 good	 quality	 and	 could	 be	 analysed.	 All	
patients	had	complete	resolution	of	MVO	and	IMH	on	90-day	scans.	Infarct	volume	
reduced	 from	 14.1±11.8mls	 at	 baseline	 to	 8.2±6.7mls	 (p<0.001)	 at	 follow	 up.	 As	
compared	to	baseline,	EF	improved	by	21±22%	and	averaged-MAPSE	improved	by	
28±22%	(p<0.001	for	each).	On	linear	regression	analysis	taking	into	account	day-2	
CMR	 parameters	 (LVEDV,	 LVESV,	 averaged-MAPSE,	 MVO,	 IMH),	 LVESV	 at	 day-2	
showed	the	strongest	correlation	with	day-90	EF	(r=0.717,	p<0.001).		
Out	of	38	patients	with	follow-up	data,	nine	patients	(24%)	demonstrated	adverse	
left	ventricular	remodelling.	LV	remodelling	showed	no	significant	association	with	
day-2	averaged-MAPSE	(AUC	0.62,	95%	CI	0.44-0.77,	p=0.22).	
3.4.1.3 Observer	variability	
On	 intra	 observer	 analysis,	 the	 means	 of	 septal	 MAPSE	 (8.52±2.2mm	 versus	
8.54±2.1mm;	 p=0.87,	 CoV	 4%),	 lateral	MAPSE	 (9.97±2.2mm	 versus	 9.99±1.9mm;	
p=0.92,	CoV	5.9%)	and	septal	MAPSE	(9.24±1.8mm	versus	9.27±1.8mm;	p=0.88,	CoV	
4.1%)	were	similar.		
On	 inter	 observer	 analysis,	 the	means	 of	 septal	MAPSE	were	 (9.1±2.4mm	versus	
9.3±2.2mm;	p=0.49,	CoV	of	8.3%),	 lateral	MAPSE	(11.1±2.4mm	versus	11.5±2mm;	
p=0.37,	CoV	8.4%)	and	averaged	MAPSE	(10.4±1.8mm	versus	10.1±1.8mm;	p=0.25,	
CoV	5.9%).	
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3.5 Discussion	
This	study	demonstrates	that	longitudinal	LV	function	measured	by	averaged	MAPSE	
on	CMR	is	strongly	associated	with	the	presence	of	MVO	and	IMH.	Moreover,	the	
size	of	MVO	adversely	affects	averaged	MAPSE.		
MAPSE	 is	 a	 well-established	 and	 endorsed	 parameter	 of	 global	 LV	 longitudinal	
function	in	echocardiography.	A	lower	absolute	value	of	MAPSE	in	post	AMI	is	a	poor	
prognostic	 marker	 (Hu	 et	 al.,	 2013).	 Previous	 studies	 using	 speckle	 tracking	
echocardiography	 in	 AMI	 patients	 have	 shown	 that	 MVO	 determined	 on	 CMR	
adversely	affects	global	longitudinal	strain	(GLS)	on	echocardiography	(Bergerot	et	
al.,	 2014;	 Bière	 et	 al.,	 2014).	 However,	 with	 current	 technology,	 there	 remains	
marked	variability	in	GLS	depending	on	the	measurement	algorithms	on	the	vendor’s	
software	and	also	on	the	sample	volume	definition.	Therefore,	no	specific	vendor	
independent	 normal	 ranges	 are	 provided	 in	 current	 American	 and	 European	
guidelines	 (Thomas	 and	 Badano,	 2013).	 MAPSE,	 on	 the	 contrary,	 is	 a	 vendor	
independent	parameter	of	global	longitudinal	function,	which	can	also	be	measured	
from	standard	cine	CMR	images	[18,33].	Limited	data	are	available	in	the	literature	
on	 the	 association	 of	MAPSE	 assessed	 by	 CMR	 to	microvascular	 obstruction	 and	
none	for	IMH.	This	study	demonstrated	that	reduced	averaged-MAPSE	is	associated	
the	presence	of	MVO/IMH.		
Myocardial	 deformation,	 including	 global	 longitudinal	 function	 (GLS),	 can	 also	 be	
studied	on	CMR	using	strain	measurements	derived	from	tissue	tagging	or	feature	
tracking	(FT).	Tagging	derived	strain	requires	longer	scanning	time	and	both	methods	
need	dedicated	post-processing	software	to	analyse	the	data.	In	a	post	AMI	study	
comparing	 tagging	 to	 FT-derived	 strain,	 FT-derived	 strain	was	quicker	 to	 analyse,	
tracked	 myocardium	 better,	 had	 better	 inter-observer	 variability	 and	 stronger	
correlations	with	 infarct	and	oedema	 (Khan	et	al.,	 2015).	 Furthermore,	 similar	 to	
echocardiography,	 there	 remains	 significant	 inter-vendor	 and	 inter-software	
variability	 in	FT-derived	strain	(Almutairi	et	al.,	2015).	Hence,	MAPSE	remains	the	
quickest,	vendor-software	independent	and	reproducible	method	to	assess	global	
longitudinal	function	from	routinely	acquired	cine	images.		
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Our	data	confirm	previous	observations	of	a	weak	association	of	LV	remodelling	with	
LV	global	longitudinal	function	(Bochenek	et	al.,	2011;	Buss	et	al.,	2015),	due	to	the	
fact	that	longitudinal	function	of	the	left	ventricle	is	driven	mainly	by	the	endocardial	
fibres	(Figure	3.1).	Also,	longitudinal	fibres	contribute	only	19%	to	the	total	stroke	
volume	 of	 the	 left	 ventricle	 versus	 circumferential	 fibres	 which	 contribute	 43%	
(Maciver,	 2012).	 Hence,	 even	 though	MAPSE	may	 be	more	 adversely	 affected	 in	
patients	with	MVO	or	IMH,	MAPSE	does	not	necessarily	result	in	LV	remodelling.	LV	
remodelling	is	directly	proportional	to	the	infarct	transmural	extent	and	hence	more	
related	 to	 strain	 parameters,	 which	 involve	more	mid,	 and	 epicardial	 fibres,	 for	
example,	circumferential	strain.			
3.5.1 Clinical	Implications	
Our	 findings	 have	 potential	 clinical	 implications	 and	 suggest	 that	MAPSE	 can	 be	
performed	easily	on	standard	cine	CMR	images,	without	the	need	for	additional	MR	
tissue	characterisation	techniques	(T2W	and	T2*)	and	analysis	methods.	As	shown,	
MAPSE	can	potentially	predict	the	presence	of	MVO/IMH	early	after	primary	PCI	for	
STEMI.	 MVO	 and	 IMH	 are	 independent	 histo-pathological	 and	 cardiac	 imaging	
markers	of	adverse	prognosis	and	their	early	detection	from	routinely	acquired	CMR	
images	 by	 MAPSE	 may	 help	 tailor	 appropriate	 pharmacological	 interventions.	
Patients	with	previous	history	of	allergy	 to	gadolinium-based	contrast	or	patients	
with	 end-stage	 renal	 failure	may	 also	 benefit	 from	 this	 technique	 to	 predict	 the	
likelihood	of	presence	of	MVO	or	IMH.	MAPSE	can	also	be	evaluated	by	bedside	M-
Mode	 echocardiography	 in	 post	 infarct	 patients	 and	 it	 could	 potentially	 act	 as	 a	
gatekeeper	for	further	assessment	by	CMR.		
3.5.2 Study	limitations	
The	 study	 sample	 size	 is	 relatively	 small	 and	 the	 results	 are	 therefore	 mainly	
hypothesis	generating.	In	this	study,	we	also	excluded	patients	who	were	unstable	
post	PPCI	(higher	Killip	class,	not	able	to	lie	flat	because	of	shortness	of	breath	and	
use	of	invasive	monitoring).	These	patients	are	more	likely	to	represent	a	higher	risk	
group	with	more	adverse	prognosis.	In	our	study	population,	the	majority	of	patients	
with	MVO	had	IMH	and	only	one	patient	with	MVO	had	no	IMH.	Hence,	it	was	not	
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possible	 to	 investigate	 whether	 there	 remains	 an	 incremental	 value	 of	 using	
averaged-MAPSE	 for	 the	detection	of	 IMH.	Additionally,	 the	absolute	measure	of	
MAPSE	does	not	take	the	total	length	of	the	LV	into	account,	which	is	potentially	a	
better	 measure	 of	 LV	 longitudinal	 function	 as	 it	 measures	 absolute	 change	 in	
longitudinal	parameters.	In	some	diseases,	like	apical	pericardial	effusion,	the	apex	
may	be	mobile	and	this	may	influence	the	longitudinal	function	independently.		
3.6 Conclusions	
Averaged-MAPSE,	evaluated	using	cine	CMR	is	strongly	associated	with	the	presence	
of	MVO	and	IMH	when	compared	to	advanced	MR	relaxometry	techniques	(T2w	and	
T2*),	 in	 patients	with	 recent	 reperfused	 AMI.	 Global	 left	 ventricular	 longitudinal	
function,	assessed	by	averaged	MAPSE,	is	feasible	and	shows	high	reproducibility.	In	
this	study,	the	size	of	MVO	adversely	affected	averaged	MAPSE.	However,	averaged	
MAPSE	did	not	show	any	significant	correlation	with	left	ventricular	remodelling.	
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4 Study	2-	The	Role	of	Left	Ventricular	Deformation	in	
the	 Assessment	 of	 Microvascular	 Obstruction	 and	
Intramyocardial	Haemorrhage	
4.1 Abstract	
4.1.1 Introduction	
In	 the	 setting	of	 STEMI,	 it	 remains	unclear	which	 strain	parameter	most	 strongly	
correlates	 with	 MVO	 or	 IMH.	 	 Therefore,	 the	 objective	 of	 this	 study	 was	 to	
investigate	 the	 association	 of	 MVO,	 IMH	 and	 convalescent	 left	 ventricular	 (LV)	
remodelling	 with	 strain	 parameters	 measured	 with	 cardiovascular	 magnetic	
resonance	(CMR).		
4.1.2 Methods		
43	patients	with	reperfused	STEMI	underwent	CMR	within	3-days	and	at	3-months	
following	 reperfused	 STEMI.	 10	 age	 and	 gender	 matched	 healthy	 controls	 were	
recruited	and	received	baseline	CMR	only.	Cine,	T2-weighted,	T2*-imaging	and	late	
gadolinium	enhancement	(LGE)	imaging	were	performed.	Infarct	size,	MVO	and	IMH	
were	 quantified.	 Peak	 global	 longitudinal	 strain	 (GLS),	 global	 radial	 strain	 (GRS),	
global	 circumferential	 strain	 (GCS)	 and	 their	 strain	 rates	were	derived	by	 feature	
tracking	analysis	of	LV	short-axis,	4-chamber	and	2-chamber	cines.		
4.1.3 Results		
All	 43	 patients	 and	 10	 controls	 completed	 the	 baseline	 scan	 and	 34	 patients	
completed	 3-month	 scans.	 In	 multivariate	 regression,	 GLS	 demonstrated	 the	
strongest	association	with	MVO	or	 IMH	(beta=0.53,	P<0.001).	The	optimal	cut-off	
value	 for	GLS	was	 -13.7%	 for	 the	 detection	 of	MVO	or	 IMH	 (sensitivity	 76%	 and	
specificity	 77.8%).	 At	 follow	 up,	 17%	 (n=6)	 patients	 had	 adverse	 LV	 remodeling	
(defined	 as	 an	 absolute	 increase	 of	 LV	 end-diastolic/end-systolic	 volumes	 >20%).	
Baseline	GLS	also	demonstrated	the	strongest	diagnostic	performance	in	predicting	
adverse	LV	remodelling	(AUC=0.79;	95%	CI	0.60	–	0.98;	p=0.03).		
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4.1.4 Conclusion	
Post-reperfused	STEMI,	baseline	GLS	was	most	closely	associated	with	the	presence	
of	 MVO	 or	 IMH.	 Baseline	 GLS	 was	 more	 strongly	 associated	 with	 adverse	 LV	
remodelling	than	other	CMR	parameters.	
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4.2 Introduction		
Microvascular	 obstruction	 (MVO)	 and	 intra-myocardial	 haemorrhage	 (IMH)	 as	
detected	by	cardiovascular	magnetic	resonance	(CMR)	are	established	independent	
adverse	prognostic	markers	following	reperfused	ST-elevation	myocardial	infarction	
(STEMI).	The	presence	of	MVO	has	been	associated	with	‘no	re-flow’	on	coronary	
angiography	after	revascularisation	(Jaffe	et	al.,	2008).	IMH	is	invariably	associated	
with	 MVO	 and	 is	 caused	 by	 endothelial	 dysfunction	 following	 prolonged	
ischaemia/reperfusion	 injury	 with	 disruption	 of	 inter-endothelial	 junctions	 and	
extravasation	of	erythrocytes	(Betgem	et	al.,	2015).		
Myocardial	 systolic	 function	after	STEMI	 is	 conventionally	assessed	by	calculating	
left	 ventricular	 ejection	 fraction	 (EF)	 from	 left	 ventricular	 volumes	 (Burns	 et	 al.,	
2002;	 Gibbons	 et	 al.,	 2004;	 Møller	 et	 al.,	 2006).	 However,	 global	 EF	 is	 load-
dependent	 and	 neglects	 regional	 function	 (Vartdal	 et	 al.,	 2007).	 Myocardial	
deformation	may	be	a	more	accurate	parameter	of	LV	function,	but	its	assessment	
is	more	challenging,	due	in	part	to	the	complex	spatial	orientation	and	distribution	
of	muscle	fibres	in	the	longitudinal	and	circumferential	direction	(Greenbaum	et	al.,	
1981).	 Emerging	 technologies	 have	 made	 it	 possible	 to	 study	 myocardial	
deformation	 by	 CMR	 using	myocardial	 tagging	 and	 feature	 tracking	 (FT)	 derived	
strain	 (Hor	et	al.,	2011;	 Ibrahim,	2011).	Strain	 (S)	and	strain	 rate	 (SR)	are	already	
established	 as	 more	 accurate	 measures	 of	 both	 regional	 and	 the	 global	 left	
ventricular	 function	 when	 compared	 to	 ejection	 fraction	 and	 allow	 quantitative	
assessment	 of	 myocardial	 deformation	 (Shah	 and	 Solomon,	 2012).	 From	 strain	
analysis,	several	parameters	can	be	derived	and	it	is	currently	not	known	which	of	
these,	 if	 any,	 are	 associated	 with	 the	 presence	 of	 MVO,	 IMH	 and	 adverse	 LV	
remodelling.		
This	study	aimed	to	investigate	the	association	of	FT	derived	peak	global	longitudinal	
strain	(GLS),	peak	global	circumferential	strain	(GCS),	peak	global	radial	strain	(GRS),	
peak	global	 longitudinal	strain	rate	 (GLSR),	peak	global	circumferential	strain	rate	
(GCSR)	and	peak	global	radial	strain	rate	(GRSR)	with	the	presence	of	MVO,	IMH	and	
adverse	LV	remodelling	in	acute	reperfused	STEMI.		
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4.3 Study	specific	methods	
4.3.1 Cardiac	catheterization		
Coronary	angiography	and	revascularisation	were	performed	in	a	standard	fashion	
as	per	current	best	practice	guidelines	 (Windecker	et	al.,	2014).	TIMI	 flow	grades	
were	assessed	visually	as	described	previously	after	coronary	angioplasty.	
4.3.2 CMR	examination	
T2	weighted	(T2w)	and	T2*	imaging	were	performed	using	the	‘3-of-5’	approach	by	
acquiring	 the	 central	 3	 slices	 (base,	mid	 and	 apical)	 of	 5	 parallel	 short-axis	 slices	
(Messroghli	et	al.,	2005).		
4.3.3 CMR	interpretation	
Cine,	 T2w,	 T2*	 and	 LGE	 images	 were	 evaluated	 offline.	 Infarct	 location	 was	
determined	 by	 LGE	 imaging,	 according	 to	 standard	 guidelines	 (Cerqueira	 et	 al.,	
2002).	 The	 presence	 and	 size	 of	 infarction	 and	 MVO	 were	 measured	 from	 LGE	
images.	Infarcted	myocardium	was	defined	as	an	area	of	LGE	≥2	standard	deviations	
(SD)	 above	 remote	 myocardium,	 and	 infarct	 volume	 estimation	 included	 any	
hypointense	core.	We	used	the	2SD	method	as	there	are	prognostic	data	for	the	2SD	
infarct	size	estimation	in	similar	populations	(Kwon	et	al.,	2014),	and	for	consistency	
with	 analysis	 of	 T2w	 images.	MVO	was	 defined	 visually	 as	 the	 hypointense	 core	
within	the	infarcted	zone	and	planimetered	manually.	Volumes	of	infarct	and	MVO	
were	calculated	from	planimetered	areas	through	the	whole	short-axis	LV	LGE	stack	
by	 the	modified	 Simpson’s	method.	 The	presence	and	extent	of	 intra-myocardial	
haemorrhage	was	assessed	by	combined	analysis	of	T2w	and	T2*	sequences	[8].	On	
T2w	images,	areas	with	mean	signal	intensity	less	than	2	SD	below	the	periphery	of	
the	area	at	risk	(AAR)	were	considered	to	be	haemorrhage	(Kidambi,	Adam	N	Mather,	
et	al.,	2013).	On	the	T2*	images,	the	presence	of	a	dark	core	within	the	infarcted	
area	 by	 visual	 inspection	 of	 the	 images	was	 used	 as	 confirmation	 of	myocardial	
haemorrhage.	Concordant	results	between	T2w	and	T2*	were	needed	to	confirm	
haemorrhage.	If	there	was	inconsistency	between	them,	agreement	between	two	
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experts	informed	the	results.	Presence/absence	of	both	MVO	and	IMH	were	scored	
in	a	binary	manner.		
4.3.3.1 Strain	Analysis	
Strain	analysis	was	performed	in	a	semi-automated	manner	using	cvi42	v5.1	(Figure	
4.1).	The	observer	(PG)	performing	the	strain	analysis	was	blinded	to	the	baseline	
CMR	parameters	and	advanced	tissue	characterization.	Left	ventricular	endocardial	
and	epicardial	borders	were	manually	contoured	in	end-diastole	from	both	long-axis	
cines	 (4-chamber	 and	 2	 chamber).	 Endocardial	 borders,	 epicardial	 borders	 and	
reference	 points	 at	 both	 RV	 insertion	 points	 (anterior/inferior)	 were	 contoured	
manually	for	each	slice	at	end-diastole	from	the	short	axis	LV	cine	stack.	GLS	and	
GLSR	were	derived	from	the	long-axis	images	and	GRS,	GRSR,	GCS	and	GCSR	were	
derived	 from	 the	 short-axis	 LV	 cine	 stack	 using	 published	 methods	 (Swoboda,	
McDiarmid,	et	al.,	2016;	Swoboda,	Erhayiem,	et	al.,	2016).	Peak	GLS,	peak	GLSR,	GRS,	
peak	GRSR,	peak	GCS	and	peak	GCSR	were	quantified.		
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Figure	4.1	Multi-parametric	CMR	examination.	
Two	 case	 studies	 with	 STEMI:	 Case	 1	 (A	 to	 D):	 Anterior	 MI	 without	 MVO.	 (A)	
Epicardial	 (green)	 and	 endocardial	 (red)	 contours	 on	 a	 4-chamber	 cine.	 (B)	 Voxel	
derived	 feature	 tracking	 (FT)	 of	 the	 myocardium	 at	 end-systole.	 (C)	 Global	
longitudinal	 strain	 (GLS)	 curve	 demonstrating	 a	 GLS	 of	 -16.5%	 (D)	 LGE	 short-axis	
demonstrating	infarct	in	anterior	wall.	Case	2	(E	to	H):	(E)	demonstrates	the	contours	
and	(F)	shows	the	end-systolic	FT-derived	strain	myocardial	points	in	a	case	of	lateral	
infarction	 with	 MVO.	 (G)	 demonstrates	 a	 significantly	 lower	 GLS,	 -9%.	 (H)	
demonstrates	infarct	and	presence	of	MVO	on	LGE-images.	
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4.3.4 Follow-up	scans	
Follow-up	scans	were	planned	at	3	months	following	the	index	event.	Patients	were	
divided	 into	 2	 groups	 based	 on	 the	 presence	 of	 LV	 remodelling.	 Adverse	 LV	
remodelling	was	defined	as	an	absolute	increase	of	LV	end-diastolic	or	end-systolic	
volumes	>20%	at	3	months	follow-up	(Korosoglou	et	al.,	2008;	Warren	et	al.,	1988;	
Pfeffer	and	Braunwald,	1990).	Analysis	of	all	follow-up	data	was	performed	blinded	
to	acute	scans.		
4.3.5 Statistical	analysis	
Step-wise	multivariate	 linear	 regression	was	 used	 for	 parameters	with	 statistical	
significance	from	one-way	analysis	(p<0.1).	The	accuracy	of	myocardial	deformation	
parameters	 in	predicting	presence	of	MVO	or	 IMH	was	examined	using	 receiver-
operator	 characteristic	 (ROC)	 curve	 analyses,	 using	 Medcalc	 (v15.8).	 To	 reduce	
transfer	 bias,	 baseline	 demographics	 and	 CMR	 parameters	 of	 the	 followed-up	
patients	were	compared	to	patients	who	did	not	receive	follow-up	CMR	by	ANOVA.				
4.4 Results	
43	 acute	 STEMI	 patients	met	 the	 inclusion	 criteria	 (Figure	 4.2).	 Demographics	 of	
patients	and	10	healthy	volunteers	are	shown	in	Table	4.1.	Infarct	characteristics	on	
CMR	are	listed	in	Table	4.2.	No	gender	and	age	based	differences	in	characteristics	
were	present	between	patient	groups	(p>0.1).		
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Figure	4.2	Study	design	
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Characteristic	 MI		
(n=43)	
Healthy	Volunteers	
(n=10)	
P	value	
Ejection	fraction,%	 48	±	10	 63	±	4	 <0.001	
LV	EDVi*,	ml/m2	 82	±	16	 78	±	20	 0.47	
LV	ESVi†,	ml/m2	 42	±	12	 28	±	8	 <0.001	
LV	stroke	volume	indexed,	ml	 40	±	11	 49	±	12	 0.023	
LGE	infarct	volume,	ml	 15	±	12	 NA	 NA	
LGE	MVO	volume,	ml	 3	±	5	 NA	 NA	
GRS,	%	 25	±	8	 38	±	7	 <0.001	
GRSR,	%/sec	 164	±	50	 268	±	125	 <0.001	
GCS,	%	 -13	±	4	 -20	±	2	 <0.001	
GCSR,	%/sec	 -106	±	132	 -107	±	12	 0.99	
GLS,	%	 -13	±	4	 -20	±	2	 <0.001	
GLSR	%/sec	 -128	±	314	 -88	±	13	 0.68	
	
Table	 4.2	 Imaging	 parameters	 at	 baseline	 CMR	 study.	 Data	 as	 mean	 ±	 SD.	 LV	
measurements	are	indexed	to	body	surface	area;	infarct	volumes	are	unindexed.	*LV	
EDVi;	Left	ventricular	end	diastolic	volume	(indexed),	†LV	ESVi;	Left	ventricular	end	
systolic	volume	(indexed),	GCS;	peak	global	circumferential	strain,	GCSR;	peak	global	
circumferential	strain	rate,	GLS;	peak	global	 longitudinal	strain,	GLSR;	peak	global	
longitudinal	 strain	 rate,	 GRS;	 peak	 global	 radial	 strain,	 GRSR;	 peak	 global	 radial	
strain	rate.	
4.4.1 Baseline	data		
Left	ventricular	EF,	left	ventricular	end-systolic	volume	(LVESV),	GLS,	GCS,	GRS	and	
GRSR	 were	 significantly	 altered	 in	 infarct	 patients	 versus	 healthy	 volunteers	
(p<0.001	for	all	parameters	individually)	(Table	4.2).		
Stroke	volume	was	also	reduced	 in	the	 infarct	subjects	 (p=0.023	versus	controls).	
Among	the	43	infarct	patients,	25	patients	(58%)	had	MVO	and	24	patients	(56%)	
had	confirmed	IMH.	GRS	was	significantly	lower	in	patients	with	MVO	or	IMH	than	
those	without	(22.7±7%	versus	29±7%;	p=0.02).	Additionally,	both	GCS	and	GLS	were	
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significantly	lower	in	patients	with	compared	with	those	without	MVO	or	IMH	(GCS:	
-11.6±3%	 versus	 -15.6±3%,	 p<0.001;	 GLS:	 -11±3%	 versus	 -15.2±3.3%,	 p<0.001)	
(Figure	4.3).	
On	 linear	 regression	 analysis,	 using	 all	 the	 demographics	 and	 imaging	 variables	
including	infarct	size,	GLS	demonstrated	the	strongest	association	with	presence	of	
MVO	or	IMH	(beta	=0.53,	p<0.001)	(Table	4.3).		
Additionally,	GCS	demonstrated	stronger	correlation	to	the	volume	of	MVO	than	GLS	
(r=	 0.57,	 P<0.001	 versus	 r=	 0.46,	 P=0.002)	 (Table	 4.4).	 The	 area	 under	 the	 curve	
(AUC)	for	the	diagnostic	performance	of	determining	the	presence	of	MVO	or	IMH	
by	 GLS	 was	 0.82	 (95%	 CI:	 0.69	 to	 0.94;	 p<0.001).	 The	 optimal	 cut-off	 value	
determined	by	Youden	index	for	GLS	was	-13.7%	for	the	presence	of	MVO	or	IMH	
(sensitivity	76%	and	specificity	78%)	(Ruopp	et	al.,	2008).		
	 	
-	68	-	
	
	
	
	
Figure	4.3	M
ultiple	com
parison	bars	of	m
yocardial	strain	in	the	study	population		
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hiskers:	standard	deviations;	SD)	
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	 Microvascular	Obstruction	and	Intra-myocardial	haemorrhage	
	 Univariate	 Multi-variate	(Stepwise)	
	 beta	 p-value	 beta	 p-value	
De
m
og
ra
ph
ics
	
Age	 0.07	 0.62	 	 	
Sex	 0.13	 0.38	 	 	
Smoking		 0.06	 0.70	 	 	
Hypertension	 0.07	 0.67	 	 	
Hypercholesterolemia	 0.05	 0.77	 	 	
Diabetes	Mellitus	 0.21	 0.19	 	 	
Pain-Balloon	Time	 -0.15	 0.33	 	 	
CM
R	
pa
ra
m
et
er
s	
	 	
LVEDVi	 0.09	 0.57	 	 	
LVESVi	 0.38	 0.01*	 0.17	 0.26	
EF	 -0.50	 0.001*	 -0.27	 0.13	
GRS	 -0.39	 0.01*	 -0.07	 0.67	
Infarct	size	 0.50	 0.001*	 0.36	 0.01*	
GCS	 0.52	 <0.001*	 0.29	 0.16	
GLS	 0.53	 <0.001*	 0.53	 <0.001**	
GRSR	 -0.24	 0.122	 	 	
GCSR	 -0.12	 0.44	 	 	
GLSR	 0.18	 0.26	 	 	
Abbreviations:	 EF;	 ejection	 fraction,	 LVEDVi;	 left	 ventricular	 end-diastolic	 volume	
indexed,	 LVESVi;	 left	 ventricular	 end-systolic	 volume	 indexed,	 GCS;	 peak	 global	
circumferential	strain,	GCSR;	peak	global	circumferential	strain	rate,	GLS;	peak	global	
longitudinal	strain,	GLSR;	peak	global	longitudinal	strain	rate,	GRS;	peak	global	radial	
strain,	GRSR;	peak	global	radial	strain	rate.	
	
Table	4.3	Uni-/multi-variate	analysis	of	strain	parameters	to	CMR	derived	clinical	and	
prognostic	markers	
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	 LOCATION	OF	
INFARCT	
INFARCT	VOLUME	
(%)	
MICROVASCULAR	
OBSTRUCTION	
VOLUME	
(%)	
	 r	 P-value	 r	 P-value	 r	 P-value	
EF	 0.29	 0.06	 -0.37	 0.01	 -0.37	 0.02	
LVEDVI	 -0.18	 0.24	 0.20	 0.20	 0.08	 0.60	
LVESVI	 -0.24	 0.12	 0.41	 0.01	 0.30	 0.05	
SVI	 0.03	 0.87	 -0.19	 0.23	 -0.24	 0.13	
GRS	 0.19	 0.21	 -0.32	 0.03	 -0.39	 0.01	
GRSR	 0.04	 0.79	 -0.24	 0.13	 -0.13	 0.41	
GCS	 -0.18	 0.25	 0.54	 <0.001	 0.57	 <0.001	
GCSR	 0.21	 0.18	 -0.01	 0.94	 -0.30	 0.06	
GLS	 -0.33	 0.03	 0.34	 0.02	 0.46	 0.002	
GLSR	 0.12	 0.44	 0.20	 0.20	 0.10	 0.52	
Abbreviations:	EF;	ejection	fraction,	GCS;	peak	global	circumferential	strain,	GCSR;	
peak	global	circumferential	strain	rate,	GLS;	peak	global	 longitudinal	strain,	GLSR;	
peak	global	longitudinal	strain	rate,	GRS;	peak	global	radial	strain,	GRSR;	peak	global	
radial	strain	rate,	LVEDVi;	left	ventricular	end-diastolic	volume	indexed,	LVESVi;	left	
ventricular	end-systolic	volume	indexed;	r,	Pearson	correlation	coefficient.	
	
Table	4.4	Association	of	baseline	CMR	volumetric	and	strain	parameters	to	size	of	
microvascular	obstruction		
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4.4.2 Follow-up	data	
Thirty-four	of	the	43	patients	underwent	3	month	follow	up	CMR;	6	patients	declined	
further	follow-up	and	in	3	patients	the	scan	quality	of	cines	on	follow	up	was	not	
suitable	 for	 FT	 analysis.	 Demographics	 parameters	 (age,	 gender,	 hypertension,	
hypercholesterolaemia,	 smoking	 history,	 diabetes	 mellitus)	 and	 baseline	 CMR	
parameters	 (presence	of	MVO	or	 IMH,	 LVEDVi,	 LVESVi	 and	all	 strain	parameters)	
were	not	significantly	different	in	the	9	patients	who	did	not	attend	for	follow-up	
scans	compared	with	the	overall	study	population	(p>0.1).	 	All	34	follow	up	scans	
showed	complete	 resolution	of	MVO	and	 IMH.	As	compared	 to	baseline,	 relative	
improvement	 in	 EF	was	 19±24.5%.	 Of	 all	 the	 baseline	 CMR	 parameters	 (LVEDVi,	
LVESVi,	 GLS,	 GCS,	 GRS,	 MVO,	 IMH),	 LVESVi	 (r=0.99,	 p<0.002)	 and	 GLS	 (r=0.97,	
p<0.006)	demonstrated	the	strongest	correlation	with	improvement	in	EF	at	follow-
up	 scan.	GCS	 (r=0.95,	 p=0.01)	 and	GRS	 (r=0.91,	 p=0.02)	 also	 demonstrated	 good	
correlations	with	improvement	in	EF	at	follow-up.	
4.4.3 Adverse	LV	Remodelling	
Out	of	34	patients	with	follow-up	data,	6(17%)	patients	demonstrated	adverse	left	
ventricular	remodelling.	From	all	CMR	baseline	parameters,	GLS	demonstrated	the	
strongest	diagnostic	performance	in	predicting	adverse	LV	remodelling	(AUC=0.79;	
95%	CI	0.60	–	0.98;	p=0.03)	(Table	4.5).			
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	 ADVERSE	LV	REMODELLING	
LVEDVI	 AUC=0.60;	95%	CI	0.34	–	0.86;	p=0.44	
LVESVI	 AUC=0.60;	95%	CI	0.32	–	0.87;	p=0.47	
LV	EF	 AUC=0.26;	95%	CI	0.00	–	0.52;	p=0.07	
GLS	 AUC=0.79;	95%	CI	0.60	–	0.98;	p=0.03*	
GLSR	 AUC=0.68;	95%	CI	0.42	–	0.95;	p=0.16	
GRS	 AUC=0.32;	95%	CI	0.11	–	0.54;	p=0.18	
GRSR	 AUC=0.34;	95%	CI	0.16	–	0.52;	p=0.22	
GCS	 AUC=0.71;	95%	CI	0.48	–	0.87;	p=0.11	
GCSR	 AUC=0.57;	95%	CI	0.35	–	0.78;	p=0.62	
Abbreviations:	 AUC;	 area	 under	 the	 curve,	 CI;	 confidence	 interval,	 EF;	 ejection	
fraction,	GCS;	peak	global	circumferential	strain,	GCSR;	peak	global	circumferential	
strain	rate,	GLS;	peak	global	longitudinal	strain,	GLSR;	peak	global	longitudinal	strain	
rate,	 GRS;	 peak	 global	 radial	 strain,	 GRSR;	 peak	 global	 radial	 strain	 rate,	 LV;	 left	
ventricle,	 LVEDVI;	 left	 ventricular	 end-diastolic	 volume	 indexed,	 LVESVI;	 left	
ventricular	end-systolic	volume	indexed;	r,	Pearson	correlation	coefficient.	
	
Table	 4.5	 Association	 of	 baseline	 CMR	 parameters	 to	 adverse	 LV	 remodelling	 at	
follow-up	visit.	
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4.5 Discussion	
The	main	findings	of	this	study	are	as	follows:	first,	myocardial	deformation	imaging	
by	CMR	reliably	detects	changes	 in	acute	 infarct	patients	versus	healthy	controls.	
Second,	the	presence	of	MVO	or	 IMH	in	acute	reperfused	STEMI	 is	most	strongly	
associated	 with	 GLS.	 Third,	 GLS	 showed	 modest	 association	 with	 adverse	 LV	
remodelling.		
Our	data	complement	the	results	of	several	previous	 investigations	of	 the	role	of	
CMR-derived	strain	imaging	in	reperfused	STEMI	patients	(Kidambi,	Adam	N	Mather,	
et	al.,	2013;	Kidambi,	Adam	N.	Mather,	et	al.,	2013;	Khan	et	al.,	2015;	Buss	et	al.,	
2015).	Kidambi	et	al	studied	the	role	of	myocardial	deformation	using	tissue	tagging	
derived	strain	in	an	acute	reperfused	infarct	population	(Kidambi,	Adam	N	Mather,	
et	 al.,	 2013).	 They	 demonstrated	 that	 regional	 functional	 recovery	 is	 poor	 in	
myocardial	 segments	 with	 MVO	 and	 IMH.	 Wong	 et	 al	 demonstrated	 that	
circumferential	strain	(CS)	using	tissue	tagging	correlates	better	than	circumferential	
strain	rate	with	regional	functional	recovery	(D.T.L.	Wong	et	al.,	2014).	Both	of	these	
studies	 used	 tissue	 tagging,	 which	 has	 a	 relatively	 low	 temporal	 resolution	 (<30	
frames/s),	potentially	limiting	its	accuracy,	especially	in	patients	with	higher	heart	
rates.	Moreover,	acquisition	of	 tissue	tagged	 images	often	requires	 long	series	of	
breath	 holds,	 and	 tag	 fading	 during	 diastole	 limits	 the	 assessment	 of	myocardial	
relaxation.	FT	analysis	of	cine	loops	may	overcome	these	limitations.	A	study	by	Khan	
et	 al	 compared	 tissue	 tagging	 to	 FT-derived	 strain	 in	 24	 acute	 reperfused	 STEMI	
patients.	FT-derived	strain	was	quicker	to	analyse,	tracked	the	myocardium	better,	
had	 better	 inter-observer	 variability	 and	 stronger	 correlations	 with	 infarct	 and	
oedema	(Khan	et	al.,	2015).	
In	a	study	of	74	patients,	Buss	et	al	demonstrated	that	FT-derived	GCS	is	strongly	
associated	with	infarct	size	and	trans-murality	of	scar	on	LGE	imaging	(Buss	et	al.,	
2015).	This	study	also	demonstrated	that	FT-derived	GCS	was	more	accurate	than	
GLS	for	predicting	preserved	LV	function	at	 follow-up.	Notably,	 this	study	did	not	
evaluate	LV	remodelling,	presence	of	MVO,	presence	of	IMH	or	functional	recovery	
of	LV	defined	by	improvement	in	EF.	Additionally,	in	this	study,	the	FT-derived	strain	
analysis	algorithm	tracked	only	the	endo-/epi-myocardium	to	compute	strain,	and	
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did	not	track	pixels	within	the	myocardium	(Garg,	Kidambi	and	Plein,	2015).	Tracking	
pixels	 within	 the	 myocardium	 is	 important,	 especially	 in	 the	 setting	 of	 acute	
reperfused	infarct	where	each	layer	of	myocardium	(endo-,	mid-	and	epi-)	is	going	
through	different	pathophysiological	processes.	
Our	study	adds	to	the	growing	body	of	literature	on	the	ability	of	CMR	to	quantify	
left	 ventricular	 deformation	with	 FT.	We	have	 shown	 that	 FT-derived	myocardial	
deformation	parameters	(GCS,	GRS	and	GLS)	are	altered	significantly	in	patients	with	
MVO	or	 IMH	(p<0.05).	MVO	and	IMH	affect	predominantly	the	sub-endocardium,	
where	most	of	the	longitudinal	myocardial	fibres	are	located.	It	is	thus	plausible	that	
GLS	 is	 the	 strongest	 predictor	 of	MVO	and	 IMH	as	 shown	 in	 our	 study.	GLS	 also	
demonstrated	modest	diagnostic	performance	to	predict	adverse	LV	remodelling	at	
follow-up	more	than	any	other	deformation	parameter.	In	this	study,	the	volume	of	
MVO	and	infarct	size	were	more	strongly	associated	with	GCS	than	GLS	(Table	4.4).	
These	 results	 are	 not	 unexpected	 as	 larger	 infarcts	 with	MVO	will	 involve	more	
myocardium	transmurally.		
4.5.1 Role	of	Echocardiography		
It	 is	 acknowledged	 that	 strain	 examination	 is	 more	 readily	 available	 by	
echocardiography	 than	 CMR.	 All	 modern	 echocardiographic	 systems	 come	 with	
strain	 packages	 (Sutherland	 et	 al.,	 n.d.;	 Heimdal	 et	 al.,	 1998).	 Early	 changes	 of	
microvascular	obstruction	 (MVO)	after	AMI	have	been	demonstrated	by	 contrast	
echocardiography	(Rinkevich	et	al.,	2005;	Senior	et	al.,	2013;	Gibson	et	al.,	2014).	In	
patients	with	AMI,	echocardiographic	studies	can	be	performed	at	the	bedside	and	
GLS	assessment	may	be	used	as	a	 ‘gatekeeper’	 for	 further	advanced	 imaging,	 for	
example,	 multi-parametric	 tissue	 characterization	 on	 CMR.	 Further	 studies	 are	
needed	 to	 explore	 how	 echocardiography	 derived	 strain	 parameters	 compare	 to	
CMR-FT	derived	strain.		
4.5.2 MAPSE	or	FT	–	which	one	to	use?		
In	 this	 thesis,	we	demonstrate	 that	 longitudinal	 function	of	 LV	 is	 associated	with	
MVO	or	IMH.	This	has	been	demonstrated	by	two	different	methods:	MAPSE	and	FT	
derived	GLS.	Both	methods	of	assessment	of	LV	longitudinal	function	have	pros	and	
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cons.	 For	 example,	MAPSE	 is	 a	manual	method	 and	 hence	 prone	 to	 intra/inter-
observer	variations.	On	the	other	hand,	different	vendors	use	different	algorithms	
to	derive	GLS,	making	it	less	translational.	MAPSE	remains	a	quick	method	which	can	
be	done	on	any	imaging	modality.		
4.5.3 Clinical	Implications	
Our	 findings	 have	 possible	 clinical	 implications	 as	 FT-strain	 analysis	 can	 be	
performed	rapidly	from	standard	cine	CMR	images	and	allows	the	detection	of	the	
functional	 effects	 of	MVO	 and	 IMH	without	 the	 need	 for	 additional	 CMR	 tissue	
characterisation	techniques	(T2W	and	T2*)	and	analysis	methods.	From	our	single-
center	 experience,	 the	 time	 for	 total	 left	 ventricular	 strain	 analysis	 by	CMR	FT	 is	
approximately	7	minutes.	As	demonstrated,	a	cut	off	value	of	-13.7%	for	GLS	detects	
MVO	or	IMH	with	a	sensitivity	of	76%	and	specificity	of	77.8%.	GLS	can	potentially	
predict	the	presence	of	MVO	or	IMH	early	after	PPCI	for	STEMI.	MVO	and	IMH	are	
independent	histopathological	 and	 cardiac	 imaging	markers	of	 adverse	prognosis	
and	we	speculate	that	their	early	detection	from	routinely	acquired	CMR	cines	may	
help	 tailor	 appropriate	pharmacological	 interventions	or	 guide	 stem	cell	 therapy.	
Patients	with	known	allergy	to	gadolinium-based	contrast	agents	or	patients	with	
end-stage	renal	failure	may	also	benefit	from	this	technique.		
4.5.4 Study	limitations	
In	this	study,	we	excluded	patients	who	were	unstable	post-PPCI	(higher	Killip	class,	
not	able	to	lie	flat	because	of	shortness	of	breath	and	use	of	invasive	monitoring).	
These	 patients	 are	more	 likely	 to	 represent	 a	 higher	 risk	 group	with	 an	 adverse	
prognosis.	In	our	study	population,	the	majority	of	patients	with	MVO	had	IMH	and	
only	one	patient	with	MVO	had	no	IMH.	Hence,	the	data	on	GCS	for	IMH	detection	
should	be	interpreted	with	caution.		
Another	 important	 limitation	of	our	study	was	that	9	of	43	patients	did	not	have	
follow-up	 CMR	 scans.	 This	 may	 have	 introduced	 transfer	 bias	 although	 the	 two	
groups	were	not	different	for	demographic	and	standard	CMR	parameters.		
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In	our	study,	at	 follow-up,	only	6	 (17%)	patients	had	adverse	LV	remodelling	and	
hence	 the	 demonstrated	 diagnostic	 performance	 of	 GLS	 to	 predict	 remodelling	
should	be	interpreted	with	caution.	Females	were	more	represented	in	the	HVs.	
In	the	present	study,	only	global	parameters	of	strain	were	investigated.	Assessment	
of	 regional	 left	 ventricular	 strain	 parameters	 by	 CMR	 FT	 demonstrates	 regional	
variations	and	their	clinical	role	remains	very	speculative	(Pedrizzetti	et	al.,	2016).		
4.6 Conclusions	
Myocardial	deformation	changes	adversely	in	patients	with	acute	STEMI.	Baseline	
GLS	by	FT-analysis	of	cine	CMR	is	strongly	associated	with	the	presence	of	MVO	or	
IMH	 and	 could	 be	 used	 as	 surrogate	 functional	 imaging	 marker	 of	 these	 acute	
myocardial	 pathological	 changes	 in	 patients	 with	 acute	 STEMI.	 Baseline	 GLS	
demonstrated	 stronger	 association	with	 adverse	 LV	 remodelling	 than	 other	 CMR	
parameters.				 	
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5 Study	 3-	 Effects	 of	 hyperaemia	 on	 left	 ventricular	
longitudinal	 strain:	 A	 first-pass	 stress	 perfusion	
cardiovascular	magnetic	resonance	imaging	study.	
5.1 Abstract	
5.1.1 Background	
Myocardial	perfusion	imaging	during	hyperaemic	stress	is	commonly	used	to	detect	
coronary	 artery	 disease.	 Although	 hyperaemic	 stress	 is	 not	 thought	 to	 induce	
myocardial	ischaemia	per	se,	it	has	differential	effects	on	the	myocardial	layers	that	
may	lead	to	local	changes	in	contractility.	The	aim	of	this	study	was	to	investigate	
the	relationship	between	left	ventricular	global	longitudinal	strain	(GLS),	strain	rate	
(GLSR),	myocardial	early	(E’)	and	late	diastolic	velocities	(A’)	with	adenosine	stress	
first-pass	perfusion	cardiovascular	magnetic	resonance	imaging	(CMR).			
5.1.2 Methods		
50	patients	with	stable	chest	pain	were	recruited	out	of	which	44	patients	met	the	
inclusion	 criteria	 and	 underwent	 CMR	 imaging.	 The	 CMR	 protocol	 included:	
rest/stress	4-chamber	cine,	rest/stress	first	pass	adenosine	perfusion	imaging	and	
late	gadolinium	enhancement	imaging.	Rest	and	stress	4-chamber	cine	CMR	images	
were	 analysed	 using	 feature-tracking	 software	 for	 the	 assessment	 of	myocardial	
deformation.	The	presence	of	perfusion	defects	was	scored	on	a	binomial	scale.				
5.1.3 Results		
In	patients	with	hyperaemia	induced	perfusion	defects,	rest	GLS	(P-value=0.02),	E’	
(P-value=0.02),	 GLSR	 (P-value=0.01)	 and	 stress	 GLS	 (P<0.001)	 were	 significantly	
reduced	when	compared	to	patients	with	no	perfusion	defects.	The	absolute	change	
in	rest	versus	stress	GLS	increased	in	patients	without	perfusion	defect	versus	a	drop	
in	patients	with	perfusion	defects	(-1.6±3.1	versus	0.5±3.8,	P-value=0.05).	Stress	GLS	
was	the	strongest	independent	predictor	of	perfusion	defects	(OR	1.43	95%	CI	1.14-
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1.78,	 P-value<0.001).	 A	 threshold	 of	 -19.8%	 for	 stress	 GLS	 demonstrated	 78%	
sensitivity	 and	 73%	 specificity	 for	 the	 presence	of	 hyperaemia-induced	perfusion	
defects.	
5.1.4 Conclusions		
At	peak	hyperemic	stress,	GLS	is	reduced	in	the	presence	of	a	perfusion	defect.	This	
reduction	 is	 most	 likely	 caused	 by	 reduced	 endocardial	 blood	 flow	 at	 maximal	
hyperaemia	as	a	result	of	transmural	redistribution	of	blood	flow	in	the	presence	of	
significant	coronary	stenosis.	 	
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5.2 Introduction	
Cardiovascular	magnetic	resonance	(CMR)	imaging	can	detect	obstructive	coronary	
artery	disease	(CAD)	by	imaging	the	left	ventricular	(LV)	passage	of	a	contrast	bolus	
during	 pharmacologically	 induced	 myocardial	 hyperaemia	 (Wolff	 et	 al.,	 2004).	
Although	 hyperaemic	 stress	 does	 not	 usually	 induce	 myocardial	 ischaemia,	
myocardium	 supplied	 by	 a	 significantly	 stenosed	 coronary	 artery	 shows	 reduced	
contrast	 uptake	 compared	 to	 normal	 myocardium.	 Hyperaemia	 also	 leads	 to	 a	
redistribution	 of	 myocardial	 blood	 flow	 (MBF)	 between	 the	 endocardial	 and	
epicardial	 layers	 (Pan	 et	 al.,	 2015),	 contributing	 to	 the	 detection	 of	 functionally	
significant	CAD	by	imaging	tests	with	sufficient	spatial	resolution	to	differentiate	the	
myocardial	 layers.	 An	 endo-	 to	 epicardial	 gradient	 of	 blood	 flow	 exists	 at	 rest,	
reflecting	 the	 higher	metabolic	 activity	 of	 the	 endocardial	 layer	 (Muehling	 et	 al.,	
2004;	 Radjenovic	 et	 al.,	 2010).	 In	 health,	 pharmacologically	 induced	 maximal	
hyperaemia	increases	MBF	in	all	myocardial	layers	although	the	endo	to	epicardial	
gradient	 diminishes	 as	MBF	maximizes	 in	 all	myocardial	 layers.	 In	 the	 context	 of	
functionally	significant	epicardial	CAD,	hyperaemia	leads	to	a	redistribution	of	MBF	
from	the	endo-	 to	 the	epicardium,	 leading	 to	 relative	endocardial	 ischaemia	–	or	
transmural	myocardial	steal	(Algranati	et	al.,	2011)	(Figure	5.1).		
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Figure	 5.1	 Illustration	 demonstrating	 how	 fiber	 orientation	 of	 the	 left	 ventricle	
corresponds	 to	 perfusion	 defect	 gradient	 (high	 in	 sub-endocardium	 and	 lower	 in	
epicardium).	
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Thanks	to	its	high	in-plane	spatial	resolution,	this	transmural	perfusion	gradient	can	
be	demonstrated	in	vivo	with	first	pass	myocardial	perfusion	CMR	and	a	transmural	
perfusion	gradient	of	20%	can	accurately	predict	hemodynamically	significant	CAD	
as	 defined	 by	 fractional	 flow	 reserve	 (FFR)	 on	 invasive	 coronary	 angiography	
(Chiribiri	et	al.,	2013).		
Myocardial	strain	imaging	allows	quantification	of	subtle	changes	of	left	ventricular	
function	that	typically	precede	a	reduction	in	left	ventricular	ejection	fraction	(EF)	
(Panaich	 et	 al.,	 2016).	Myocardial	 deformation	 can	 be	 studied	with	 CMR	 feature	
tracking	(FT),	 in	which	strain	is	derived	from	routine	cine	acquisitions	without	the	
need	 for	 tagging	 (Hor	 et	 al.,	 2011;	 Swoboda,	McDiarmid,	 et	 al.,	 2016).	 FT	 allows	
accurate	and	robust	assessment	of	mainly	left	ventricular	global	longitudinal	strain	
(Pedrizzetti	et	al.,	2016).	Because	longitudinal	myocardial	fibers	are	predominantly	
located	in	the	sub-endocardium,	they	may	be	preferentially	affected	in	myocardial	
ischaemia	and	transmural	steal	during	hyperaemia.	The	association	of	differential	
abnormalities	 in	 local	 left	 ventricular	 function	 assessed	 by	myocardial	 strain	 and	
peak	myocardial	hyperaemia	in	the	presence	or	absence	of	perfusion	defect	has	not	
been	established	yet.		
Therefore,	the	purpose	of	this	study	was	to:	1)	investigate	the	relationship	between	
left	ventricular	global	longitudinal	strain	(GLS),	strain	rate	(GLSR),	myocardial	early	
(E’)	and	late	diastolic	velocities	(A’)	with	adenosine	stress	first-pass	perfusion	CMR	
and	 2)	 determine	 which	 strain	 parameter	 is	 most	 strongly	 associated	 with	 the	
presence	of	a	perfusion	defect.	
5.3 Study	specific	methods	
5.3.1 Cardiac	Magnetic	Resonance	Protocol	
CMR	scan	included	usual	cines	described	in	Chapter	2	and	the	following:		
1.	 Stress	 perfusion	 imaging:	 This	 was	 performed	 with	 adenosine	 administered	
initially	at	140	μg	kg−1	min−1.	Adequate	hemodynamic	response	was	assessed	by	
either	≥10%	heart	rate	increase	or	≥10	mm	Hg	decrease	in	systolic	blood	pressure.	
If	 there	 was	 an	 inadequate	 hemodynamic	 response,	 the	 dose	 was	 increased	
incrementally	 to	170	μg	kg−1	min−1	and	 then	210	μg	kg−1	min−1	 for	a	 further	2	
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minutes	 until	 hemodynamic	 response	was	 achieved.	 Perfusion	 image	 acquisition	
used	 a	 2-dimensional,	 T1-weighted	 saturation	 recovery–prepared	 gradient	 echo-
pulse	sequence	in	3	short-axis	slices,	planned	using	the	3/5	technique,	using	parallel	
imaging	acceleration	(SENSE)	(Messroghli	et	al.,	2005).	A	bolus	intravenous	injection	
of	 0.05	 mmol/kg	 dimeglumine	 gadopentetate	 (Magnevist®,	 Schering	 AG,	 West	
Sussex,	UK)	followed	by	a	15	ml	saline	flush	was	delivered	through	an	arm	vein	at	5	
ml/s	using	a	power	 injector	 (Spectris®,	Medrad,	Pittsburgh,	Pennsylvania),	during	
breath	hold	in	end-expiration.	
2.	Stress	HLA:	First-pass	perfusion	imaging	was	immediately	followed	by	repeat	HLA	
cine	(all	parameters	similar	to	the	resting	pre-stress	HLA)	while	adenosine	was	still	
being	infused.		
3.	Rest	perfusion	imaging:	This	study	was	done	using	identical	pulse	sequence,	slice	
positioning,	injection	characteristics	to	the	stress	perfusion	scan	and	was	performed	
after	waiting	for	15	minutes.		
4.	LGE-imaging	
5.3.2 Image	Analysis	
Perfusion	scan	and	LGE	images	were	evaluated	offline	using	commercially	available	
software	 (cvi42	 v5.1,	 Circle	 Cardiovascular	 Imaging	 Inc.,	 Calgary,	 Canada).	 Infarct	
location	 was	 determined	 by	 LGE	 imaging,	 according	 to	 standard	 guidelines	
(Cerqueira	et	al.,	2002).	
5.3.2.1 Feature	Tracking	Strain	Analysis	(Rest	and	Stress)	
Strain	analysis	was	performed	using	a	cvi42	(v5.1)	feature	tracking	(FT)	module	in	a	
semi-automated	manner	(Figure	5.2).	For	resting	cines,	left	ventricular	endocardial	
and	epicardial	borders	were	manually	contoured	in	end-diastole	from	both	long-axis	
cines	(HLA	and	VLA).	Stress	global	longitudinal	strain	parameters	were	derived	from	
HLA	cines	only	as	no	VLA	images	were	acquired	in	order	to	minimize	the	duration	of	
adenosine	 infusion.	 Peak	 GLS	 (peak	 LV	 shortening	 during	 systole),	 GLSR	 (LV	
shortening	rate	 in	systole),	E’	 (peak	early	 filling	myocardial	 strain	during	diastole)	
and	A’	(peak	late	filling	myocardial	strain	during	diastole)	were	recorded	per	case.		
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Figure	5.2	Two	cases	of	first	pass	perfusion	CMR.		
Case	1(A	–	D).	The	top	row	shows	CMR	images	of	a	63-year-old	female	who	presented	
with	a	history	of	chest	pain.	Panel	A	illusrates	endo/epi	contours	on	4-chamber	cine	
acquisition	 at	 peak	 stress.	 Panel	 B	 demonstrates	 the	 derived	myocardial	 feature	
tracking	and	computed	systolic	GLS	at	peak	stress.	Panel	C	shows	the	corresponding	
stress	 perfusion	 image	 at	 the	 time	 of	 peak	 myocardial	 contrast	 enhancement,	
showing	no	inducible	perfusion	defects.	Panel	D	shows	that	there	is	no	infarction	on	
late	gadolinium	enhancement	(LGE)	imaging.	Case	2(E	–	H).		The	bottom	row	shows	
CMR	images	of	a	59-year-old	male	who	presented	with	a	history	of	chest	pain.		This	
is	a	case	with	a	perfusion	defect	in	mid	ventricular	septum	(orange	arrows	in	panel	
G)	on	first-pass	perfusion	with	no	evidence	of	previous	myocardial	infarction	on	LGE	
imaging	(Panel	H).	Notably,	the	peak	stress	GLS	was	significantly	lower	in	this	case.	
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5.3.2.2 Perfusion	Analysis	
CMR	images	were	anonymised,	which	included	the	removal	of	dates	of	acquisition	
and	any	identifiable	data.	The	randomised	images	were	independently	analysed	by	
two	experts	in	perfusion	analysis	with	greater	than	3-years’	experience	each	(TAM	
and	DPR).	Each	expert	reported	on	the	presence	of	inducible	stress	perfusion	defects	
that	were	not	present	on	rest	perfusion	images	and	with	no	corresponding	scar	on	
LGE	 images.	 In	 case	 of	 disagreement	 between	 the	 two	 observers,	 a	 third	
independent	expert	analysed	the	images,	and	a	discussion	of	the	study	commenced	
in	order	to	reach	a	unanimous	decision	(PG).	Studies	in	which	a	unanimous	decision	
could	 not	 be	 reached	 were	 excluded.	 On	 stress	 perfusion	 imaging,	 an	 area	 of	
decreased	signal	intensity	when	compared	to	remote	myocardium	and	the	presence	
of	 an	 endocardial	 to	 epicardial	 perfusion	 gradient	 were	 classified	 as	 a	 perfusion	
defect	(Plein	et	al.,	2008).		
5.3.3 Statistical	Analysis	
The	accuracy	of	myocardial	deformation	parameters	in	predicting	the	presence	of	a	
perfusion	 defect	 was	 examined	 using	 the	 receiver-operator	 characteristic	 (ROC)	
curve	 analyses	 described	 by	 Delong	 for	 comparison	 of	 the	 area	 under	 the	 curve	
(AUC),	using	Medcalc	(v15.8).	Forward	(conditional)	multivariable	logistic	regression	
was	used	for	all	strain	parameters	with	statistical	significance	from	one-way	analysis	
(p<0.1).	 A	 linear	 regression	 model,	 comprising	 of	 the	 predictive	 values	 was	
generated	for	all	the	strain	parameters	which	demonstrated	significant	association	
to	the	presence	of	perfusion	defect	in	univariate	analysis.		
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5.4 Results	
5.4.1 Study	demographics	and	characteristics		
A	 total	of	50	patients	were	 recruited.	4	patients	had	equivocal	perfusion	 results,	
resulting	in	exclusion	from	the	study	and	2	patients	were	claustrophobic.	From	the	
rest	 44	patients	 recruited,	 22	patients	had	an	 inducible	perfusion	defect,	 and	22	
patients	had	no	inducible	perfusion	defects.	The	two	independent	graders	agreed	
on	the	categorization	of	all	cases	with	no	arbitration	required.	The	demographics,	
clinical	data	and	baseline	CMR	results	are	shown	 in	Table	5.1.	No	gender,	age	or	
characteristic	based	differences	were	present	between	 the	groups.	Baseline	CMR	
characteristics,	 including	myocardial	 infarction,	were	 not	 significantly	 different	 in	
both	the	groups.		
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Characteristics	 All	patients	 Perfusion	
defect	
No	
perfusion	
defect	
P-
value	
Demographics	 (n=44)	 (n=22)	 (n=22)	 	
Age	(years)	 64±12	 64±12	 63±13	 0.53	
Gender	(male/female)	 31/13	 16/6	 15/7	 0.75	
Current	smoker	[no.	(%)]	 13	(30)	 7	(16)	 6	(14)	 0.75	
Hypertension	[no.	(%)]	 13	(30)	 7	(16)	 6	(14)	 0.75	
Diabetes	Mellitus	[no.	(%)]	 12	(27)	 6	(14)	 7	(16)	 0.45	
Dyslipidaemia	[no.	(%)]	 7	(16)	 3	(7)	 4	(9)	 0.69	
Myocardial	 Infarction	 [no.	
(%)]	
17	(39)	 10	(23)	 6	(14)	 0.22	
CABG	[no.	(%)]	 6	(14)	 4	(9)	 1	(2)	 0.13	
Abnormal	ECG	[no.	(%)]	 13	(30)	 8	(18)	 5	(11)	 0.33	
Baseline	CMR	parameters	 	 	 	 	
LV	EDV,	(ml/m2)	 143	±45	 151±46	 133±43	 0.19	
LV	ESV,	(ml/m2)	 55±32	 63±39	 45±21	 0.06	
LV	SV,	(ml/m2)	 86±29	 87.6±18	 84.4±37	 0.72	
LV	EF,	(%)	 64±13	 61±13	 67±12	 0.07	
LV	Mass	(grams)	 111±35	 112±26	 109±43	 0.76	
Presence	of	Infarction	(%)	 25	(57%)	 15	(34%)	 10	(23%)	 0.13	
Rest	strain	parameters	
GLS	(%)	 -18±4	 -16.9±3.7	 -19.6±3.4	 0.02	
GLSR	(s-1)	 -98±11	 -86±22	 -109±38	 0.02	
E’	(s-1)	 80±39	 69±31	 93±38	 0.04	
A’	(s-1)	 80±29	 74.5±25	 86.7±33	 0.18	
Stress	strain	parameters	
GLS	(%)	
-19±4	 -16.5±4	 -21.2±3.1	
<0.00
1	
GLSR	(s-1)	 -104±54	 -98±45	 -112±60	 0.36	
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E’	(s-1)	 97±41	 90±50	 106±32	 0.21	
A’	(s-1)	 93±50	 88±43	 113±81	 0.20	
	
Table	5.1		Study	demographics	and	baseline	CMR	parameters	
Abbreviations:	A’,	myocardial	 late	diastolic	velocity;	CABG,	coronary	artery	bypass	
grafting;	E’,	myocardial	early	diastolic	 velocity;	ECG,	electrocardiogram	EDV,	end-
diastolic	 volume;	 EF,	 ejection	 fraction;	 ESV,	 end-systolic	 volume;	 GLS,	 global	
longitudinal	strain;	GLSR,	global	longitudinal	strain	rate;	SV,	stroke	volume.	Data	as	
mean	±	SD	or	n(%)	unless	indicated.	P-value	<0.05	was	taken	as	significant.	
5.4.2 Feature	tracking	analysis	
All	cine	 images	were	of	adequate	quality	for	FT	analysis.	Figure	5.2	demonstrates	
two	cases	from	the	study.	Rest	GLS,	GLSR,	E’	and	stress	GLS	were	significantly	lower	
in	the	group	with	perfusion	defect	compared	to	the	no	perfusion	defect	group	(Table	
4.1).	Notably,	rest	GLS	was	not	significantly	different	 in	patients	without	previous	
myocardial	infarction	and	with/without	ischaemia	(Table	5.2)	(Figure	5.3).		
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Figure	5.3	Multiple	comparison	bars.	Multiple	comparison	bars	of	rest	(Panel	A)	and	
stress	 (Panel	 B)	 global	 longitudinal	 function	 strain	 in	 patients	 with/without	
myocardial	infarction	and	perfusion	defect	(whiskers:	standard	deviations;	SD).	
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	 Presence	
of	MI	
Strain	
parameters	
With	perfusion	
defect	
Without	
perfusion	defect	
P-
value	
Rest	 LGE	-ve	 GLS	(%)	 -19±5	 -20±3	 0.59	
GLSR	(s-1)	 -101±19	 -119±53	 0.41	
E’	(s-1)	 94±32	 102±52	 0.69	
A’	(s-1)	 93±15	 97±36	 0.75	
LGE	+ve	 GLS	(%)	 -16±3	 -19±4	 0.04	
GLSR	(s-1)	 -78±20	 -99±13	 0.01	
E’	(s-1)	 56±21	 81±30	 0.02	
A’	(s-1)	 66±24	 74±25	 0.45	
Stress	 LGE	-ve	 GLS	(%)	 -18±4	 -22±3	 0.02	
GLSR	(s-1)	 -136±55	 -102±77	 0.32	
E’	(s-1)	 128±62	 111±24	 0.39	
A’	(s-1)	 113±46	 113±69	 0.99	
LGE	+ve	 GLS	(%)	 -16±4	 -20±3	 0.01	
GLSR	(s-1)	 -80±27	 -125±27	 <0.001	
E’	(s-1)	 72±32	 101±40	 0.06	
A’	(s-1)	 76±36	 114±97	 0.18	
	
Table	5.2		Myocardial	deformation	parameters	in	the	two	groups	of	patients.	
Data	as	mean	±	SD	or	n	(%)	unless	indicated.	P-value	<0.05	was	taken	as	significant.	
	
The	absolute	change	in	rest	versus	stress	GLS	demonstrated	an	increase	in	GLS	in	
patients	without	perfusion	defects	but	a	reduction	in	GLS	at	stress	in	patients	with	a	
perfusion	defect	(-1.6±3.1	versus	0.5±3.8,	P-value=0.05).	Other	strain	parameters,	
GLSR	(-2.8±77	versus	-12±31,	P-value=0.60),	E’	(13±45	versus	22±40,	P-value=0.45),	
A	(27±65	versus	13±29,	P-value=0.43)	did	not	show	significant	changes	between	rest	
and	stress.				
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5.4.3 Influence	of	previous	Myocardial	Infarction		
Patients	with	previous	MI	on	LGE-imaging	had	lower	rest	GLS	than	patients	with	no	
MI	(-16±3%	vs.	-20±4%,	P-value	=	0.007)	and	stress	GLS	(-17±4%	vs.	-20±4%,	P-value	
=	0.02).	However,	patients	with	previous	MI	did	not	show	more	inducible	perfusion	
defects	than	those	without	previous	MI	(OR	0.38,	P-value=0.13).		
5.4.4 Receiver	operator	characteristics	(ROC)	analysis	
Table	5.3	details	the	diagnostic	performance	for	each	of	the	parameters.	Figure	5.4	
displays	the	ROC	plots.	Stress	GLS	displayed	a	slightly	better,	though	not	statistically	
significant	diagnostic	performance	compared	to	rest	GLS	(Table	5.3,	Figure	5.4).	A	
strain	 model	 comprising	 of	 rest	 GLS,	 GLSR,	 E’	 and	 stress	 GLS	 demonstrated	
significant	superiority	to	rest	GLS	alone.	The	strain	model	displayed	a	sensitivity	of	
95%	and	specificity	of	68%	to	detect	perfusion	defects.		
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	 Youden	
Cut-off	
Sensitivity	
(%)	
Specificity	
(%)	
AUC	 95%	CI	 P-value	
Re
st
	
GLS	(%)	 >-18.55	 77.27	 68.18	 0.72	 0.56	 0.87	 0.006	
GLSR	(s-1)	 >-91.09	 68.18	 72.73	 0.75	 0.60	 0.89	 0.0008	
E’	(s-1)	 ≤84.53	 86.36	 54.55	 0.70	 0.54	 0.86	 0.01	
A’	(s-1)	 ≤108.8
6	
100	 32	 0.59	 0.42	 0.77	 0.28	
	
St
re
ss
	
GLS	(%)	 >-19.80	 77.3	 72.7	 0.82	 0.70	 0.94	 <0.001	
GLSR	(s-1)	 >-99.7	 63.6	 86.4	 0.74	 0.58	 0.89	 0.003	
E’	(s-1)	 ≤81.65	 50	 82	 0.67	 0.50	 0.83	 0.04	
A’	(s-1)	 ≤58.65	 36.36	 86.36	 0.58	 0.41	 0.76	 0.34	
	
Strain	model@	 ---	 96	 68	 0.87	 0.76	 0.97	 <0.000
1	
	
Table	5.3		C-statistics	for	myocardial	strains	at	rest	and	stress	CMR.	Data	as	mean	±	
SD	 or	 n	 (%)	 unless	 indicated.	 P-value	 <0.05	 was	 taken	 as	 significant.	
@	Model	 comprising	of	 strain	parameters	 associated	 to	 the	presence	of	 perfusion	
defect	in	univariate	analysis:	rest	GLS,	rest	GLSR,	rest	E’	and	stress	GLS	
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Figure	5.4	Receiver	operator	curves	(RO
C).	RO
C	analysis	of	different	strain	m
odels	to	predict	the	presence	of	m
yocardial	perfusion	defect:	
Resting	global	longitudinal	strain	(GLS)	m
odel	(I),	stress	GLS	(II)	and	strain	m
odel	versus	rest	GLS	(III).	
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	 Variable	 UV	 MV	(without	
model)	
MV	(with	
model)	
	 	 OR	 95%	CI	 P-
value	
P-value	 P-value	
Rest	 GLS	 1.25	 1.03	-	1.52	 0.02	 0.74	 0.86	
GLSR	 1.04	 1.01	-	1.07	 0.02	 0.06	 0.77	
E’	 0.98	 0.96	-	1.00	 0.05	 0.32	 0.72	
A’	 0.99	 0.96	-	1.01	 0.18	 …	 …	
Stress	 GLS	 1.43	 1.14	-	1.78	 0.002	 <0.001		 0.68	
GLSR	 1.01	 0.99	-	1.02	 0.37	 …	 …	
E’	 0.99	 0.97	-	1.01	 0.21	 …	 …	
A’	 0.99	 0.98	-	1.00	 0.22	 …	 …	
Strain	
Model@	
	 	 	 <0.001	 …	 <0.0001	
	
Table	5.4		Predictors	of	perfusion	defect	in	univariable	(UV)	and	multivariable	(MV)	
logistic	 regression	analysis.	 P-value	<0.05	was	 taken	as	 significant.	 CI,	 confidence	
interval;	 OR,	 odds	 ratio;	 UV,	 univariable;	 MV,	 @	 Model	 comprising	 of	 strain	
parameters	associated	to	the	presence	of	perfusion	defect	in	univariate	analysis:	rest	
GLS,	rest	GLSR,	rest	E’	and	stress	GLS.	
5.4.5 Regression	analysis	
In	 the	 logistic	 regression	analysis,	 stress	GLS	demonstrated	 the	best	 independent	
association	with	the	presence	of	a	perfusion	defect	of	the	parameters	tested	(OR	
1.43	95%	CI	 1.14	 -	 1.78,	 P-value<0.001)	 (Table	 5.4).	 The	 logistic	 regression	 strain	
model	 was	 independently	 associated	 with	 presence	 of	 perfusion	 defect	 (P-
value<0.001)	when	compared	with	other	individual	myocardial	strain	parameters.		
5.5 Discussion	
The	main	novel	findings	of	this	study	are:	1)	at	peak	myocardial	hyperaemia	GLS	is	
reduced	 in	 patients	with	 perfusion	 defects	 on	 simultaneously	 acquired	 first-pass	
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perfusion	 CMR	 2)	 among	 several	 strain	 parameters	 tested,	 stress	 GLS	 is	 most	
strongly	associated	with	the	presence	of	a	perfusion	defect	3)	a	cut-off	value	of	-
19.8%	 for	 stress	 GLS	 demonstrates	 77%	 sensitivity	 and	 73%	 specificity	 for	 the	
presence	of	a	perfusion	defect.	
Myocardial	ischaemia	initially	affects	the	endocardium	and	progresses	to	the	sub-
epicardial	 layers	 in	 a	 ‘wave	 front’	 manner.	 High	 resolution	 adenosine	 stress	
myocardial	 perfusion	 CMR	 can	 demonstrate	 a	 transmural	 gradient	 of	myocardial	
perfusion	 in	 patients	 with	 flow	 limiting	 CAD,	 representing	 the	 redistribution	 of	
myocardial	 blood	 flow	 from	 the	 sub-endocardium	 to	 the	 sub-epicardium.	 Sub-
endocardial	fibers	are	structurally	longitudinal	fibers	(Greenbaum	et	al.,	1981)	and	
therefore	predominantly	contribute	to	the	longitudinal	function	of	the	LV	(Birkeland	
et	al.,	1992).	The	main	findings	of	the	present	study	are	consistent	with	these	known	
concepts.	We	found	that	global	longitudinal	function	assessed	by	GLS	was	adversely	
affected	 during	 adenosine	 stress	 in	 patients	 with	 perfusion	 defects	 while	 GLS	 in	
patients	with	 no	 perfusion	 defects	 increased	 during	 hyperaemia.	 The	most	 likely	
mechanism	 underpinning	 this	 observation	 is	 that	 relative	 ischaemia	 of	 the	 sub-
endocardial	 myocardial	 layer	 (‘transmural	 myocardial	 steal’)	 affects	 longitudinal	
fibre	 function	 during	 hyperaemia	 and	 thus	 differentially	 reduces	 longitudinal	 LV	
function.		
In	patients	with	evidence	of	MI	on	LGE	 imaging,	 rest	GLS,	GLSR	and	E’	were	also	
correlated	 with	 the	 presence	 of	 perfusion	 defects,	 however	 these	 resting	 strain	
parameters	 did	 not	 discriminate	 between	 patients	 with	 and	 without	 perfusion	
defects	in	the	absence	of	previous	MI.	Like	ischaemia,	MI	predominantly	affects	the	
endocardial	layer	and	thus	longitudinal	myocardial	strain	and	a	reduction	in	resting	
myocardial	 deformation	 can	 therefore	 be	 expected.	 The	 correlation	 with	 the	
presence	of	an	inducible	perfusion	defect	is	likely	to	be	caused	by	co-existing	CAD	in	
other	 territories	 or	 peri-infarct	 ischaemia,	 both	 of	 which	 were	 common	 in	 the	
present	population	in	patients	with	prior	MI.	Resting	strain	parameters	are	however	
not	reliable	markers	of	inducible	ischaemia	as	shown	by	the	lack	of	correlation	with	
perfusion	defects	in	patients	without	MI.		
A	strain	model,	comprising	of	rest	GLS,	GLSR,	E’	and	stress	GLS	performed	slightly	
better	than	stress	GLS	alone	in	linear	regression	(Table	5.3)	but	was	not	statistically	
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superior	 to	 individual	 parameters	 in	 AUC	 analysis	 (P>0.05).	 As	 the	 strain	 model	
required	multiple	strain	analyses,	the	use	of	stress	GLS	alone	may	be	a	more	practical	
approach	for	clinical	studies.	
Previous	echocardiographic	studies	have	reported	findings	that	are	consistent	with	
our	observations.	Liang	et	al	found	that	rest	peak	systolic	strain	rate	(equivalent	to	
GLSR	 in	 our	 study)	 and	 peak	 early	 diastolic	 strain	 rate	 (E’	 in	 our	 study)	 were	
significantly	 lower	 in	 patients	 with	 significant	 coronary	 artery	 disease	 (>70%	
stenosis)	than	controls	(Liang	et	al.,	2006).	Our	study	demonstrated	similar	global	
resting	strain	rate	findings	to	Liang	et	al	(Table	5.1).	However,	our	study	was	able	to	
accurately	differentiate	patients	with	previous	MI	on	LGE-imaging	and	demonstrate	
the	clear	differences	of	strain	rate	at	rest	in	patients	with/without	previous	MI	(Table	
5.2).	 A	 pre-clinical	 porcine	 study	 by	 Reant	 et	 al	 also	 demonstrated	 that	 flow	
reduction	 in	 the	 coronary	 artery	 achieved	 by	 adenosine	 induced	 myocardial	
hyperaemia	 (flow	 reduction	 by	 70%)	 adversely	 affected	 myocardial	 deformation	
parameters	(mainly	 longitudinal	and	circumferential	strain)	at	stress	(Reant	et	al.,	
2008).	 In	 a	 multi-centre	 study	 of	 102	 patients	 who	 underwent	 concomitant	
dobutamine	stress	echocardiography	and	coronary	angiography,	longitudinal	strain	
at	peak	stress	demonstrated	better	diagnostic	accuracy	than	wall	motion	score	(Ng	
et	 al.,	 2009).	 In	 the	 same	 study,	 a	 dobutamine	 stress	 GLS	 cut-off	 of	 -20%	
demonstrated	84%	sensitivity	and	87%	specificity	for	significant	CAD.	The	optimum	
cut-off	for	stress	GLS	in	our	study	was	very	similar	at	-19.8%.		
5.5.1 Practical	implications	
If	confirmed	in	larger	prospective	populations,	our	data	suggest	that	non-contrast	
adenosine	stress	cine	imaging	with	FT	analysis	of	GLS	may	be	an	alternative	to	first	
pass	perfusion	CMR	for	the	detection	of	CAD	in	selected	populations.	Although	the	
method	cannot	localize	disease	to	a	coronary	territory,	it	may	be	useful	in	patients	
with	 contraindications	 to	MR	 contrast	 agents	 such	 as	 those	with	 advanced	 renal	
failure.	Compared	with	dobutamine	stress	CMR,	adenosine	stress	has	a	lower	risk	
and	 imaging	 protocols	 are	much	 faster	 as	 only	 one	 stress	 stage	 is	 required.	 The	
analysis	 time	 to	 compute	GLS	 from	one	 4-chamber	 cine	 at	 stress	 is	minimal	 and	
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provides	valuable	quantitative	information	which	is	less	susceptible	to	subjectivity	
(McDonald	et	al.,	2015).		
5.5.2 Study	limitations		
Our	study	has	limitations.	In	this	proof	of	concept	study	we	investigated	only	a	small	
study	population.	However,	we	found	statistically	significant	differences	on	logistic	
regression,	justifying	larger	studies	to	investigate	this	concept	further.	Secondly,	for	
practical	 and	 conceptual	 reasons	 we	 did	 not	 use	 coronary	 stenosis	 on	 invasive	
angiograpy	 as	 the	 primary	 end-point	 (Chow	 et	 al.,	 2009).	 Nevertheless,	
contemporary	CMR	sequences	for	first-pass	perfusion	defect	are	highly	accurate	in	
the	diagnosis	of	significant	ischaemia	(Greenwood	et	al.,	2012).	Thirdly,	the	present	
study	 did	 not	 evaluate	 regional	 myocardial	 function	 using	 standard	 quantitative	
methods	including	regional	and	global	wall	motion	scores.	Hence,	we	were	not	able	
to	compare	these	with	the	strain	parameters	obtained.	Fourthly,	our	results	need	to	
be	used	with	 caution	 in	 patients	with	 infiltrative	 cardiomyopathies	 (hypertrophic	
cardiomyopathy,	cardiac	amyloidosis,	sarcoidosis	etc.),	which	are	characterized	by	
stiffening	of	the	left	ventricle,	and	may	affect	myocardial	deformation	(Seward	and	
Casaclang-verzosa,	 2010).	 Several	 papers	 have	 demonstrated	 that	 the	
aforementioned	 infiltrative	cardiomyopathies	 lead	 to	 reduced	GLS	and	hence	our	
results	are	not	implacable	in	these	disease	states	(Kristen	et	al.,	2012;	Afonso	et	al.,	
2012;	Kul	et	al.,	2014).		
5.6 Conclusion	
At	 peak	 myocardial	 hyperaemic	 stress,	 GLS	 is	 reduced	 in	 the	 presence	 of	 a	
myocardial	perfusion	defect,	most	 likely	 secondary	 to	 reduced	endocardial	blood	
flow	as	a	result	of	hyperaemia	induced	redistribution	of	transmural	perfusion	in	the	
presence	of	significant	coronary	stenosis.		Additionally,	this	study	demonstrates	the	
feasibility	of	adenosine	stress	myocardial	strain	CMR	in	this	demographic	which	may	
provide	 clinically	 relevant	 information	 and	 justifies	 further	 larger	 studies	 to	
investigate	the	accuracy	of	using	CMR	FT-derived	strain	to	predict	the	presence	of	
CAD.		
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6 Study	4-	Acute	Infarct	Extracellular	Volume	Mapping	
to	 Quantify	 Myocardial	 Area	 at	 Risk	 and	 Chronic	
Infarct	 Size	 on	 Cardiovascular	 Magnetic	 Resonance	
Imaging		
6.1 Abstract		
6.1.1 Background	
Late	gadolinium	enhancement	(LGE)	imaging	overestimates	acute	infarct	size.	The	
main	aim	of	 this	study	was	 to	 investigate	 if	acute	ECV-maps	can	reliably	quantify	
myocardial	area	at	risk	(AAR)	and/or	final	infarct	size	(IS).				
6.1.2 Methods	
50	patients	underwent	cardiovascular	magnetic	resonance	(CMR)	 imaging	acutely	
(24hrs-72hrs)	and	at	convalescence	(3	months).	The	CMR	protocol	included:	cines,	
T2-weighted	(T2W)	imaging,	native	T1-maps,	15-minute	post-contrast	T1-maps	and	
LGE.	Optimal	AAR	and	IS	ECV	thresholds	were	derived	 in	a	validation	group	of	10	
cases.	800	segments	(16-per-patient)	were	analysed	to	quantify	AAR/IS	by	ECV-maps	
(ECV	thresholds	for	AAR:	33%	and	IS:	46%),	T2W-imaging	and	acute	LGE.	Follow-up	
LGE-imaging	was	used	as	the	reference	standard	for	final	IS	and	viability	assessment.		
6.1.3 Results	
AAR	quantified	from	ECV-maps	demonstrated	the	best	correlation	and	agreement	
with	AAR	by	T2W-imaging	at	an	ECV	threshold	of	>33%	(R=0.96,	95%	CI	0.93-0.98;	
P<0.0001;	 bias	 on	 Bland-Altman	 (BA)	 analysis	 0.18,	 95%	 CI	 -1.6-1.3).	 ECV	
demonstrated	the	best	linear	correlation	to	final	IS	at	a	threshold	of	>46%,	(R=0.92,	
95%	CI	0.86-0.95;	P<0.0001).	ECV-maps	demonstrated	better	agreement	with	final	
IS	 than	acute	 IS	 on	 LGE	 (ECV-maps:	 bias=1.9,	 95%	CI	 0.4-3.4	 versus	 LGE-imaging:	
bias=10,	95%	CI	7.7-12.4).	On	multiple	variable	regression	analysis,	the	number	of	
non-viable	segments	was	independently	associated	with	IS	by	ECV-maps	(beta=0.86,	
P<0.0001).	
-	98	-	
	
	
	
6.1.4 Conclusions	
ECV-maps	can	reliably	quantify	AAR	and	final	IS	in	reperfused	AMI.	Acute	ECV-maps	
were	superior	to	acute	LGE	in	terms	of	agreement	with	final	IS.	IS	quantified	by	ECV-
maps	are	independently	associated	with	viability	at	follow-up.		 	
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6.2 Introduction		
Infarct	 size	 (IS)	 and	 myocardial	 salvage	 are	 important	 determinants	 of	 clinical	
outcome	 after	 myocardial	 infarction	 and	 are	 most	 accurately	 assessed	 with	
cardiovascular	magnetic	resonance	(CMR)(Schulz-Menger	et	al.,	2013).	The	size	and	
extent	 of	myocardial	 infarction	 on	 late	 gadolinium	 enhancement	 (LGE)	 CMR	 has	
prognostic	 value	 in	 the	 chronic	 setting	 (Di	 Bella	 et	 al.,	 2013).	 Recent	 literature	
however	 suggests	 that	 infarct	 size	 on	 LGE-imaging	 has	 limited	 value	 in	 acute	
myocardial	infarction	(El	Aidi	et	al.,	2014)	and	overestimates	actual	IS	compared	to	
histopathology	(Saeed	et	al.,	2001;	Hammer-Hansen	et	al.,	2016;	Jablonowski	et	al.,	
2015).	Separately,	T2-weighted	(T2W)	imaging	can	be	used	after	acute	myocardial	
infarction	to	quantify	the	myocardial	area	at	risk	(AAR)	and	together	with	LGE	extent	
to	compute	the	myocardial	salvage	index.	
Commonly,	IS	and	AAR	are	derived	with	semi-automated	thresholding	methods,	but	
these	methods	have	important	limitations	(McAlindon	et	al.,	2015).	Semi-automated	
thresholding	 is	 dependent	 on	 several	 factors	 including:	 1)	 windowing	 by	 the	
operator	to	decide	where	the	region	of	interest	(ROI)	is	placed,	2)	the	variation	of	
signal	 intensity	 within	 the	 ROI	 and	 3)	 the	 size	 of	 ROI	 can	 also	 affect	 the	 signal	
intensity	variations	(Kwong	and	Farzaneh-Far,	2011). The	cumulative	effect	of	these	
factors	can	significantly	influence	quantification	and	intra-/inter-observer	variation	
of	the	measurements.	 
Parametric	mapping	methods,	in	particular	T1	mapping	and	the	derived	parameter	
of	extracellular	volume	(ECV),	allow	an	alternative	method	for	quantification	of	IS	
and	AAR	on	 an	 absolute	 scale	 (0%-100%).	 ECV	 has	 previously	 been	 shown	 to	 be	
increased	 in	 the	 AAR	 and	 infarcted	 myocardium	 (Ugander,	 Oki,	 et	 al.,	 2012;	
Jablonowski	et	al.,	2015;	Hammer-Hansen	et	al.,	2016),	but	thresholding	to	define	
cut-offs	of	ECV	to	quantify	AAR	and	IS	has	not	been	investigated.		
The	purpose	of	 this	 study	was	 to:	1)	determine	ECV	thresholds	 for	AAR	and	 IS	2)	
investigate	if	acute	ECV-maps	can	be	used	to	quantify	the	AAR	(determined	by	T2W	
images	during	acute	setting);	3)	determine	if	acute	ECV-maps	perform	better	than	
LGE-imaging	to	predict	actual	IS	at	3	months;	4)	investigate	the	association	of	acute	
ECV-maps	to	viability	at	3	months(Tarantini	et	al.,	2006).	
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6.3 Methods	
6.3.1.1 Cardiac	catheterization		
Coronary	angiography	and	revascularisation	were	performed	in	a	standard	fashion	
according	 to	current	best	practice	guidelines	 (Steg	et	al.,	2012).	TIMI	 flow	grades	
were	 assessed	 visually	 as	 described	 previously	 after	 coronary	 angioplasty(Anon,	
1985).	
6.3.2 CMR	protocol	
All	patients	had	CMR	imaging	at	either	1.5	Tesla	(Ingenia,	Philips,	Best,	Netherlands)	
or	 3.0	 Tesla	 (Achieva	 TX,	 Philips,	 Best,	Netherlands)	within	72-hours	 (median	48-
hours)	of	their	index	presentation	and	were	invited	to	attend	for	a	further	CMR	study	
at	 3-months	 follow-up.	 A	 dedicated	 cardiac	 phased	 array	 receiver	 coil	 was	 used	
(1.5T:	24-channel;	3T:	32-channel).		
Cine,	T2W-imaging,	LGE-imaging	were	performed	using	a	contiguous	stack	of	short-
axis	 slices	 covering	 the	 whole	 left	 ventricle	 for	 each	 acquisition.	 The	 same	 slice	
geometry,	 position	 and	 10mm	 slice	 thickness	were	 used	 for	 all	 pulse	 sequences.	
Native	 T1-maps	 and	 post-contrast	 T1-maps	 were	 performed	 using	 the	 ‘3-of-5’	
approach	by	acquiring	the	central	3	slices	of	5	parallel	short-axis	slices	spaced	equally	
from	the	mitral	valve	annulus	to	the	LV	apical	cap	(Messroghli	et	al.,	2005).		Post-
contrast	T1-maps	were	timed	at	15	minutes	after	contrast	administration	and	LGE-
imaging	was	performed	at	16-20	minutes.	 For	each	pulse	 sequence,	 images	with	
artefact	were	repeated	until	any	artefact	was	removed	or	minimized.	The	highest	
quality	images	were	used	for	analysis.		
6.3.3 Image	Analysis		
Cine,	 T2W-images,	 and	 LGE-images	 were	 evaluated	 offline	 using	 Mass	 research	
software	 (Leiden	 University	 Medical	 Center,	 The	 Netherlands).	 Left	 ventricular	
volumes	and	EF	were	analysed	from	cine	images	using	standard	methods	(Schulz-
Menger	et	al.,	2013).		
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Two	validated	methods	were	used	to	quantify	the	AAR	on	acute	CMR	scans:	1)	for	
T2W-imaging,	AAR	was	quantified	using	the	previously	published	full-width	at	half	
maximum	(FWHM)	thresholding	method	(Aletras	et	al.,	2006)	and	2)	for	native-T1	
maps	we	used	2	standard	deviation	(2SD)	thresholding	method	validated	by	Ugander	
et	al	(Ugander,	Bagi,	et	al.,	2012).	Infarct	location	was	determined	by	LGE-imaging,	
according	 to	 standard	guidelines	 (Cerqueira	et	al.,	2002).	Two	validated	methods	
were	used	to	define	acute	infarct	size	(IS):	1)	an	area	of	LGE	≥5	standard	deviations	
(SD)	above	remote	myocardium	(Bondarenko	et	al.,	2005;	Heiberg	et	al.,	2008)	and	
2)	the	FWHM	method	(Flett	et	al.,	2011;	Amado	et	al.,	2004).	To	decrease	variability	
in	 the	selection	of	 the	 region	of	 interest	 (ROI),	ROI-contours	were	kept	 the	same	
between	 two	methods.	 	 For	 the	 FWHM,	 infarct	 core	 ROI	 was	 added	 as	 per	 the	
previously	 published	 techniques	 (Amado	 et	 al.,	 2004).	 IS	 and	 AAR	 estimation	
included	any	hypo-intense	core	(MVO	with/without	IMH).	MVO	was	defined	visually	
as	the	hypo-intense	core	within	the	infarcted	zone	and	planimetered	manually.	IS,	
AAR	and	MVO	were	calculated	from	planimetered	areas	through	the	whole	short-
axis	LV	LGE	stack	by	the	summation	of	discs	method.	
6.3.4 Extracellular	volume	mapping	analysis	
ECV-maps	were	generated	for	the	3	slices	(base,	mid	and	apex)	by	super-imposing	
the	pre-/post-	contrast	T1-maps	and	haematocrit	values	using	standard	techniques	
(Moon	et	al.,	2013).	The	endo-	and	epi-cardial	contours	were	then	outlined	to	define	
myocardium	for	the	three	slices	(Figure	6.1).	Hypo-intense	core	of	MVO/IMH	was	
manually	contoured	to	be	included	in	the	IS	and	AAR	estimation.	
6.3.5 Validation	of	ECV	thresholds	
Approximate	ECV	thresholds	for	AAR	and	IS	were	derived	from	previously	published	
pre-clinical	and	clinical	studies(Ugander,	Oki,	et	al.,	2012;	Jablonowski	et	al.,	2015).	
In	a	study	by	Jablonowski	et	al,	the	mean	biopsy	confirmed	ECV	value	for	AAR	was	
33%	and	for	the	‘border-zone’	between	AAR	and	infarct	ECV	was	48.3%	±	4.4%	(7).	
AAR	quantified	by	T2W	imaging	on	acute	CMR	and	IS	quantified	by	LGE-imaging	on	
follow-up	scans	were	used	as	reference	measures	for	validation	in	10	cases.	For	the	
validation	 of	 AAR,	 thresholds	 between	 32%	 and	 34%	 were	 compared.	 For	 the	
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validation	of	IS,	values	of	44	to	52%	were	analysed,	representing	the	mean	and	SD	
of	the	measurements	in	infarct	border-zone	in	the	study	by	Jablonowski.	Thresholds	
were	defined	as	the	ECV	value	with	the	lowest	minimal	absolute	error	against	the	
standard	references.	These	thresholds	were	then	prospectively	applied	to	the	entire	
population.	
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Figure	6.1	AAR	and	IS	quantification	by	multiple	methods.		
Panel	A:	2	cases	of	AAR	quantification.	Case	1:	Inferior	AMI	and	Case	2:	Anterior	AMI	
by	 T2W-imaging	 (applying	 FWHM	 thresholding),	 native	 T1-maps	 (applying	 2SD	
thresholding)	 and	 ECV-maps	 (applying	 greater	 than	 33%	 threshold).	 The	 AAR	
quantified	 by	 all	 three	 methods	 is	 comparable.	 IS	 quantification	 (Panel	 B):	
Demonstrates	 two	 cases	 of	 IS	 quantification.	 In	 case	 1,	 acute	 IS	 by	 LGE-imaging	
appears	to	be	transmural	whereas	acute	ECV-maps	demonstrate	less	transmurality	
(red-zone	is	above	46%)	and	follow-up	LGE-imaging	confirms	viability	in	the	inferior	
segments	(<50%	transmural).	Case	2	demonstrate	transmural	infarct	acutely	on	LGE-
imaging	and	ECV-maps	and	also	on	follow-up	LGE-imaging.	
6.3.6 Follow-up	scans	
Follow-up	scans	were	planned	at	3-months	following	the	index	event.	Patients	were	
scanned	 at	 3-months	 at	 the	 same	 field	 strength	 as	 the	 baseline	 scan.	 IS	 was	
estimated	 using	 the	most	 validated	method	 to	 estimate	 chronic	 infarct	 size:	 the	
FWHM	 method(Flett	 et	 al.,	 2011).	 Segmental	 infarction	 using	 a	 16-segment	
model(Cerqueira	et	al.,	2002)	was	assessed	from	LGE	images	and	a	greater	than	75%	
volume	 of	 infarction	 per-segment	 was	 considered	 transmural	 and	 the	 segment	
classified	as	‘non-viable’(Choi	et	al.,	2001).	The	number	of	non-viable	segments	was	
recorded	for	each	patient.		
6.3.7 Statistical	analysis	
Agreement	 between	 the	 different	 tests	 for	 IS	 and	 AAR	 are	 expressed	 as	 bias	
according	to	Bland-Altman	analysis.	For	paired	comparison	of	the	IS,	non-parametric	
Wilcoxon	 test	 (paired	 samples)	was	 used.	 Univariate	 analysis	was	 performed	 for	
each	 variable	 separately.	 Step-wise	 multivariate	 linear	 regression	 was	 used	 for	
parameters	with	statistical	significance	from	one-way	analysis	(p<0.1).		
6.4 Results	
6.4.1 Patient	characteristics	
Seventy	patients	were	considered	for	inclusion,	of	which	50	had	baseline	and	follow	
up	CMR	(Figure	6.2).	Patient	demographics	are	presented	in	Table	6.1.		
-	105	-	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6.2	Recruitment	flowchart.	
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	 All	 patients	
(n=50)	
1.5	Tesla	
(n=32)	
3	Tesla	
(n=18)	
p-
value	
Age,	yrs	 59±11	 61±12	 57±11	 0.27	
Male	 42	 26	 16	 0.49	
BMI,	kg/m2		 28±4	 28±4	 28±3	 0.44	
Smoker	 30	 18	 12	 0.48	
Hypertension	 8	 6	 2	 0.49	
Hyperlipidaemia	 17	 10	 7	 0.59	
Diabetes	Mellitus	 6	 4	 2	 0.89	
Family	 History	 of	
Coronary	Heart	Disease	
21	 14	 7	 0.74	
	 	 	 	 	
Presenting	
Characteristics	
	 	 	 	
Systolic	Blood	Pressure,	
mmHg	
135±31	 138±35	 130±21	 0.41	
Heart	rate,	beats/min	 73±15	 76±14	 68±14	 0.06	
Time	 from	 onset	 of	 CP	
to	reperfusion,	min	
228(155-392)	 234(144-383)	 222(185-407)	 0.68	
Heart	 Failure	 Killip	
Class✝	
	 	 	 	
I	 46	 30	 16	 0.55	
II	 3	 2	 1	 0.92	
III	or	IV	 1	 0	 1	 0.19	
Ventricular	 fibrillation	
at	presentation	
3	 2	 1	 0.92	
	 	 	 	 	
Angiographic	
Characteristics	
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Number	 of	 diseased	
arteries∅	
	 	 	 	
1	 31	 18	 13	 0.27	
2	 10	 8	 2	 0.25	
3	 8	 5	 3	 0.93	
Left	Main	Stem	 1	 1	 0	 0.46	
Culprit	Vessel	 	 	 	 	
Left	 anterior	
descending	
29	 21	 8	 0.15	
Left	circumflex	 4	 3	 1	 0.64	
Right	coronary		 17	 8	 9	 0.08	
TIMI	coronary	flow	pre-
PCI	
	 	 	 	
0-1	 44	 28	 16	 0.59	
2-3	 6	 4	 2	 	
TIMI	 coronary	 flow	
post-PCI	
	 	 	 	
0-1	 1	 1	 0	 0.29	
2-3	 49	 31	 18	 	
	 	 	 	 	
Laboratory	results		 	 	 	 	
Haemoglobin,	
grams/litre	
146(136-151)	 144(135-150)	 149(142-155)	 0.15	
White	blood	cell,	
x109/litre		
11(10-13)	 11(10-13)	 11(10.4-12.5)	 0.40	
Creatine	kinase,	U/l	 1538(826-
2440)	
1627(906-
2485)	
987(553-
2120)	
0.57	
Troponin	I,	ng/L	 41466±16025	 44934±12473	 34938±19991	 0.04	
Estimated	glomerular	
filtration	rate,	
ml/min/1.73m2	
90(77-90)	 90(78-90)	 83(80-87)	 0.99	
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Table	6.1	Clinical	and	angiographic	characteristics.	
Values	are	mean±SD,	n	(%),	median	(IQR).	✝Killip	classification	of	heart	failure	after	
acute	 myocardial	 infarction:	 class	 I=no	 heart	 failure;	 class	 II=pulmonary	 rales	 or	
crepitations,	 a	 third	 heart	 sound,	 and	 elevated	 jugular	 venous	 pressure;	 class	
III=acute	pulmonary	edema;	and	class	IV=cardiogenic	shock.		
∅	 Multi-vessel	 coronary	 artery	 disease	 was	 defined	 according	 to	 the	 number	 of	
stenoses	of	at	least	50%	of	the	reference	vessel	diameter	by	visual	assessment	and	
whether	or	not	there	was	left	main	stem	involvement.		
Abbreviations:	 BMI,	 body	 mass	 index;	 CMR,	 cardiac	 magnetic	 resonance;	 ECV,	
extracellular	 volume;	 IQR,	 interquartile	 range;	 PCI,	 percutaneous	 coronary	
intervention;	STEMI,	ST-segment	elevation	myocardial	infarction;	TIMI,	Thrombolysis	
In	Myocardial	Infarction.	
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6.4.2 Validation	of	ECV	thresholds	
Validation	results	are	presented	in	Table	6.2.	For	the	quantification	of	acute	AAR,	all	
ECV	 thresholds	 (32%,	 33%	 and	 34%)	 were	 very	 similar	 when	 compared	 to	 the	
reference	method	of	T2W	imaging.	However,	ECV	threshold	of	33%	demonstrated	
the	least	absolute	error	and	coefficient	of	variability	(CoV).	For	the	quantification	of	
final	IS,	ECV	thresholds	of	46%	demonstrate	the	least	absolute	error	of	10.1%	when	
compared	to	the	final	IS	on	follow-up	LGE	imaging.	Therefore,	ECV	thresholds	of	33%	
and	46%	were	used	in	the	prospective	analysis	to	quantify	AAR	and	IS	respectively.			
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	 ECV	 Acute	ECV	
AAR	
T2-W	
(AAR)	
Paired	differences	 CoV	 Absolute	Error	(%)	
	 	 Mea
n	
SD	 Mean	 SD	 Mean	 SD	 95%	CI	 P	∞	 	 Median	 95%	CI	
AA
R	
	
32	 38.7	 20.4	 37.6	 15.1	 -1.1	 7.2	 -6.2	to	4.0	 0.64	 12.8	 12.0%	 2.2	to	28.5	
33	 35.9	 19.7	 37.6	 15.1	 1.7	 6.8	 -3.2	to	6.5	 0.45*	 12.8*	 11.5%*	 3.8	to	28.5	
34	 33.3	 19.0	 37.6	 15.1	 4.3	 6.5	 -0.3	to	8.9	 0.06	 15.0	 11.6%	 4.8	to	35.9	
	 Acute	ECV	
IS	
LGE	IS	
(Day	90)	
	
IS
		
44	 15.8	 12.6	 12.9	 9.8	 -2.9	 4.0	 -5.7	to	-0.1	 0.05	 23.6	 30.4%	 20.7	to	74.4	
45	 14.7	 12.0	 12.9	 9.8	 -1.7	 3.8	 -4.4	to	0.9	 0.18	 20.4	 17.0%	 12.6	to	74.1	
46	 13.2	 11.2	 12.9	 9.8	 -0.2	 2.9	 -2.3	to	1.8	 0.80*	 15.0*	 10.1%*	 5.1	to	70.7	
47	 12.2	 10.4	 12.9	 9.8	 0.8	 2.5	 -1.0	to	2.5	 0.36	 14.0	 19.8%	 3.8	to	56.5	
48	 11.2	 9.8	 12.9	 9.8	 1.8	 2.3	 0.1	to	3.4	 0.04	 16.5	 25.5%	 8.1	to	41.5	
49	 10.1	 9.1	 12.9	 9.8	 2.9	 2.4	 1.1	to	4.6	 0.00	 22.6	 25.9%	 9.3	to	49.2	
50	 9.1	 8.5	 12.9	 9.8	 3.8	 2.7	 1.8	to	5.7	 0.00	 29.6	 34.6%	 9.4	to	56.7	
51	 8.2	 7.9	 12.9	 9.8	 4.8	 3.2	 2.6	to	7.0	 0.00	 37.8	 43.4%	 19.2	to	64.4	
52	 7.3	 7.3	 12.9	 9.8	 5.7	 3.6	 3.2	to	8.3	 0.00	 46.5	 49.9%	 28.6	to	72.5	
	
Table	6.2	Validation	of	ECV	thresholding.	
∞	P-values	for	paired	sample	T-Test	for	each	thresholding	technique.		
*	Values	on	which	decision	to	choose	the	AAR	and	IS	ECV	thresholding	values.	
	
6.4.3 Myocardial	area	at	risk	(AAR)	characteristics		
AAR	characteristics	are	listed	in	Table	6.3.	The	AAR	estimated	by	the	FWHM	method	
on	T2W	imaging	demonstrated	excellent	linear	correlation	with	the	AAR	estimated	
by	the	2-standard	deviation	method	on	the	native-T1	maps	(R=0.97,	95%	CI	0.95-
0.98;	 P<0.0001).	 Additionally,	 the	 AAR	 estimated	 by	 T2W-imaging	 was	 not	
significantly	different	to	the	AAR	estimated	from	ECV-maps	at	a	threshold	of	33%	
(47.4±18%	 versus	 47.2±17.4%,	 P>0.5)	 and	 also	 demonstrated	 excellent	 linear	
correlation	to	it	(R=0.96,	95%	CI	0.93-0.98;	P<0.0001)	(Figure	6.3).	On	Bland-Altman	
analysis,	the	AAR	derived	from	ECV	maps	demonstrated	good	agreement	with	T2W-
imaging	derived	AAR	(Bias=0.18,	95%	CI	-1.6-1.3)	and	AAR	derived	from	native	T1-
maps	(Bias=1,	95%	CI	-0.37-2.4)	(Figure	6.3).		
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Figure	6.3	Comparison	of	established	quantification	methods	and	ECV-maps.	
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6.4.4 Infarct	Size	(IS)	characteristics	
Baseline	infarct	characteristics	are	listed	in	Table	6.3	and	did	not	differ	between	the	
two	field	strengths.	IS	estimated	from	LGE	images	at	the	acute	scan	using	the	5SD	
method	overestimated	final	IS	at	the	follow-up	scan	(P<0.0001).	IS	estimated	from	
acute	ECV-maps	using	a	46%	threshold	did	not	differ	significantly	from	LGE-defined	
IS	at	follow-up	(P=0.44).	The	IS	on	acute	ECV-maps	demonstrated	excellent	 linear	
correlation	(R=0.92,	95%	CI	0.86-0.95;	P<0.0001)	to	the	IS	at	follow-up.	IS	estimated	
by	acute	LGE-imaging	(FWHM)	also	correlated	with	final	infarct	size	but	with	a	lower	
r	value	than	ECV	maps	(R=0.82,	95%	CI	0.7-0.9,	P<0.01)	(Figure	6.3).	Moreover,	on	
Bland-Altman	analysis,	the	ECV-maps	demonstrated	superior	agreement	to	final	IS	
with	minimal	bias	and	narrow	limits	of	agreement	(Bias=1.9,	95%	CI	0.4-3.4)	when	
compared	 to	 the	 acute	 IS	 by	 LGE-imaging	 (Bias=10,	 95%	 CI	 7.7-12.4).	 Acute	 IS	
estimated	by	the	5-standard	deviation	method	on	LGE-imaging	demonstrated	the	
lowest	 linear	 correlation	 to	 IS	 at	 follow-up	 (0.76,	 95%	 CI	 0.61-0.86)	 with	 worst	
agreement	(Bias=11,	95%	CI	7.7-14).	
	 1.5	TESLA	
(N=32)	
3	TESLA	
(N=18)	
P-VALUE	
LVEDVI,	ML/M2	 82±14.7	 79.4±22.6	 0.65	
LVESVI,	ML/M2	 45.5±14.5	 41.3±8.1	 0.27	
LVMI,	GRAMS	 59.4±13.8	 55.3±10.8	 0.27	
EJECTION	FRACTION,	%	 45±11.1	 44±7.6	 0.72	
LGE	IS	(FWHM),	VOLUME	IN	%	 28.8±15.7	 25.2±12.2	 0.41	
LGE	IS	(5SD),	VOLUME	IN	%	 28.1±17	 28.6±16.5	 0.92	
MVO	SIZE,	VOLUME	IN	%	 4.9±5.4	 2.3±3	 0.06	
AAR,	VOLUME	IN	%	 47.3±19.2	 47.5±16.2	 0.96	
ECV	>33%,	VOLUME	IN	%	 46.8±18.7	 47.9±15.5	 0.82	
ECV	>46%,	VOLUME	IN	%	 20.4±13.7	 17.6±13	 0.49	
BORDER-ZONE	ECV,	%	 38.2±2.3	 39.4±2.5	 0.11	
Table	6.3	Baseline	infarct	characteristics	at	1.5T	and	3T.	Values	are	mean	±	SD.	LV	
measurements	 are	 indexed	 to	 body	 surface	 area	 (BSA),	 infarct	 volumes	 are	
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unindexed.	 LV	 EDVi	 Left	 ventricular	 end	 diastolic	 volume	 (indexed),	 LV	 ESVi	 Left	
ventricular	end	systolic	volume	(indexed),	LVM	left	ventricular	mass	(indexed).	
6.4.5 Per	segment	viability	characteristics	
Of	 the	 800	 segments	 32	 (4%)	were	 non-viable	 on	 follow-up	 LGE	 images.	 On	 per	
patient	based	analysis,	14	(28%)	patients	demonstrated	loss	of	viability	in	at	 least	
one	segment.	There	were	no	statistically	significant	differences	in	the	area	under	the	
curve	(AUC)	on	receiver	operator	characterises	curve	(ROC)	analysis	for	either	ECV-
maps	 IS	 or	 LGE-imaging	 IS	 to	 predict	 viability	 (AUC=0.94,	 95%	CI	 0.88	 –	 1	 versus	
AUC=0.93,	95%	CI	0.86-1;	P=0.82).	The	number	of	non-viable	segments	per	patient	
correlated	with	IS	by	ECV	(r=0.70,	P<0.0001)	and	LGE-imaging	(r=0.64,	P<0.0001)	and	
demonstrated	a	linear	trend	of	rise	of	these	parameters	(P<0.0001,	Figure	6.4).	
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Figure	6.4	Statistical	results.	Panel	A:	Dot	and	line	diagram	comparing	paired	IS	by	
acute	ECV-maps	and	LGE-imaging	to	actual	(follow-up)	IS	on	LGE-imaging	(FWHM).	
Panel	B:	Bar	chart	demonstrating	trend	of	increase	in	IS	with	increase	in	number	of	
non-viable	 segments.	 Even	 though	 the	 trends	 for	both,	acute	ECV-maps	and	LGE-
imaging,	 are	 statistically	 significant,	 ECV-maps	demonstrate	a	more	homogenous	
rise	than	the	LGE-imaging.	
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6.4.6 Regression	analysis	
Regression	 analysis	 is	 presented	 in	 Table	 6.4.	 On	multivariable	 linear	 regression	
analysis,	acute	IS	by	ECV-maps	was	independently	associated	with	follow-up	IS	(beta	
0.92;	P<0.0001)	and	not	acute	IS	by	LGE-imaging	(p=0.89).	Moreover,	the	number	of	
non-viable	 segments	 was	 independently	 associated	 with	 acute	 IS	 by	 ECV-maps	
(beta=0.70,	P<0.0001)	and	not	with	IS	by	LGE-imaging.		
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	 Follow-up	Infarct	size	 Number	of	non-viable	
segments	
Variable	 UV	 MV	 UV	 MV	
Age	 0.53	 	 0.92	 	
Gender	 0.69	 	 0.24	 	
Current	Smoker	 0.03	 	 0.04	 0.50	
Hypertension	 0.98	 	 0.57	 	
Hypercholesterolemia	 0.69	 	 0.66	 	
Diabetes	 0.44	 	 0.53	 	
Family	history	of	CAD	 0.47	 	 0.15	 	
Systolic	BP	 0.29	 	 0.96	 	
Heart	Rate	 0.22	 	 0.76	 	
TIMI	flow	pre-PCI	 <0.01	 0.37	 0.12	 	
TIMI	flow	post-PCI	 0.96	 	 0.95	 	
Door	to	Balloon	time	 0.20	 	 0.53	 	
LVEDV	 0.01	 0.98	 0.74	 	
LVESV	 <0.01	 0.91	 0.04	 0.16	
LV	Mass	 0.16	 	 0.89	 	
Ejection	Fraction	 <0.01	 0.37	 <0.01	 0.68	
MVO	 <0.01	 0.71	 <0.01	 0.75	
Acute	IS	(LGE	FWHM)	 <0.01	 0.89	 <0.01	 0.68	
Acute	IS	(ECV	>46%)	 <0.01	 <0.0001	
(0.92)	
<0.01	 <0.0001	
(0.70)	
Table	6.4	Predictors	of	follow-up	infarct	size	and	per	patient	number	of	non-viable	
segments	in	uni-/multi-	variable	regression	analysis.	
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6.5 Discussion	
The	present	 study	demonstrates	 that	acute	ECV-maps	offer	a	 robust	and	 reliable	
alternative	 to	 acute	 T2w-imaging	 and	 T1-maps	 to	 quantify	 the	 AAR	 (at	 an	 ECV	
threshold	of	33%)	and	to	acute	LGE-imaging	to	quantify	the	final	IS	at	follow-up	(at	
an	ECV	threshold	of	46%).	Secondly,	ECV-maps	are	superior	to	acute	LGE-imaging	in	
terms	of	agreement	with	final	IS.	Additionally,	IS	quantified	by	ECV	maps	is	strongly	
associated	the	number	of	non-viable	segments	at	3-months	follow-up.		
6.5.1 Multi-parametric	tissue	characterisation		
In	a	previous	pilot	study,	we	demonstrated	that	the	signal	intensity	on	LGE-imaging	
cannot	 be	 used	 to	 quantify	 the	 extent	 of	 extracellular	 matrix	 expansion	 (Garg,	
Kidambi,	Ripley,	et	al.,	2015).	Native	(non-contrast)	T1-maps	are	sensitive,	among	
others,	to	myocardial	oedema,	protein	deposition	and	changes	in	lipid/iron	content	
(Moon	et	al.,	2013);	native	T1	maps	do	not	inform	us	however	about	the	intra-/extra-	
cellular	composition	of	the	myocardium.	Moreover,	even	though	quantification	of	
native	T1	is	highly	reproducible,	it	varies	between	field	strengths,	vendor	platforms	
and	mapping	sequences	(Dabir	et	al.,	2014).	ECV	is	a	measure	of	extracellular	matrix	
expansion,	 which	 is	 adversely	 related	 to	 mechanical,	 electrical	 and	 vasomotor	
dysfunction	(Moon	et	al.,	2013).	Hence,	ECV-maps	add	incremental	diagnostic	value	
to	 quantify	 global/focal	 myocardial	 fibrosis,	 which	 is	 mainly	 a	 process	 in	 the	
extracellular	matrix.	Furthermore,	ECV	values	are	independent	of	the	field	strength	
of	the	CMR	scanners.		
6.5.2 ECV-mapping	in	acute	and	chronic	myocardial	infarction	
Previous	studies	have	explored	ECV	in	both	acute	and	chronic	myocardial	infarction	
(Hammer-Hansen	et	al.,	2016;	Jablonowski	et	al.,	2015;	Ugander,	Oki,	et	al.,	2012;	
White	et	al.,	2013).	In	a	porcine	model	of	acute	myocardial	infarction,	Jablonowski	
et	al	demonstrated	that	LGE-imaging	overestimated	infarct	size	by	23%	as	compared	
to	histopathological	findings,	and	that	this	overestimation	is	due	to	higher	ECV	in	the	
peri-infarct	 region,	 or	 the	 border-zone	 between	 necrosed	 and	 oedematous	
myocardium	(Figure	6.5)	(Jablonowski	et	al.,	2015).		
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Figure	 6.5	 Short-axis	 illustration	 of	 the	 LV.	 This	 illustration	 demonstrates	 acute	
infarct	size	 is	overestimated	by	acute	LGE-imaging.	On	ECV-maps,	 it	 is	possible	 to	
differentiate	three	zones	in	the	territory	of	AMI:	the	AAR,	the	border-zone	(zone	with	
extensive	peri-infract	oedema	and	possible	islets	of	cell	injury,	which	recovers	over-
time)	 and	 the	 actual	 infarcted	 zone	 (necrosed	myocardial	 tissue,	 which	 does	 not	
recover	on	follow-up).	
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They	reported	that	the	ECV	in	this	border-zone	was	significantly	different	to	the	ECV	
in	the	remainder	of	the	AAR	region	(48.3±4.4%	vs.	32.4±3.2%;	P<0.01).	The	border-
zone	ECV	in	the	present	clinical	study	(38.6±2.4%)	was	lower	than	in	this	previous	
study	even	though	we	ran	validation	tests	to	define	the	ECV	thresholds	informed	by	
their	biopsy	findings.	 	This	can	potentially	be	explained	by	the	fact	that	pigs	were	
imaged	far	more	acutely	than	our	patient	cohort	(6hrs	versus	>24hrs).	ECV	in	the	
border-zone	drops	very	rapidly	in	the	first	few	days	post-acute	myocardial	infarction	
as	oedema	regresses(Jablonowski	et	al.,	2015).	 In	a	more	 recent	study,	Hammer-
Hansen	and	colleagues(Hammer-Hansen	et	al.,	2016)	demonstrated	that	the	extent	
of	gadolinium	enhancement	in	acute	myocardial	infarction	patients	is	modulated	by	
the	 extracellular	 space	 and	 the	 contrast	 kinetics	 in	 the	 injured	myocardium	 and	
consequently	 contributes	 to	 the	 over-estimation	 of	 IS	 by	 LGE-imaging.	 Another	
pertinent	finding	was	that	the	ECV	of	the	infarcted	myocardium,	computed	using	the	
different	post-contrast	T1-maps	at	different	time	points,	ranging	from	5-20	minutes	
after	 the	 contrast	 injection,	 remained	 similar.	 This	may	explain	why	 ECV	 is	more	
reliable	to	quantify	the	IS	acutely	versus	the	LGE-imaging,	which	heavily	depends	on	
timing	of	the	acquisition	post-contrast	delivery.		
Ugander	 et	 al	 explored	 the	 utility	 of	 ECV	 in	 chronic	 infarct	 patients	 and	
demonstrated	significantly	higher	ECV	(51±8%)	in	the	infarct	zone(Ugander,	Oki,	et	
al.,	2012).	Another	key	finding	of	their	study	was	that	remote	myocardial	ECV,	where	
there	was	no	hyper-enhancement	on	 LGE-imaging,	 increased	concurrently	with	a	
decrease	in	ejection	fraction	(r=-0.50,	P=0.02),	suggesting	that	ECV	provides	insights	
into	 sub-clinical	 myocardial	 pathology.	 	 This	 study	 raises	 the	 possibility	 that	 the	
pattern	of	ECV	in	the	infarcted	and	remote	myocardium	changes	from	the	acute	to	
the	chronic	setting.		
More	recently,	in	a	study	which	recruited	131	acute	STEMI	patients,	Carberry	et	al	
confirmed	that	remote	zone	ECV	(assessed	by	ROI)	is	 inversely	related	to	ejection	
fraction	(P<0.001)	and	delta-ECV	of	the	remote	zone	was	associated	 left	ventricle	
volume	at	follow-up.	Bulluck	et	al	investigated	the	utility	of	automated	segmental	
ECV	in	acute	myocardial	infarction	and	additionally	demonstrated	that	patients	with	
higher	 remote	 myocardial	 ECV	 on	 acute	 presentation	 were	 more	 likely	 to	 have	
adverse	 remodelling	 of	 their	 left	 ventricle.	 Moreover,	 recent	 evidence	 from	 our	
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group	suggests	that	the	actual	expansion	 in	the	extracellular	matrix	of	the	 infarct	
core	 quantified	 by	 ECV-maps	 predicts	 functional	 recovery	 better	 than	 any	 other	
imaging	 parameter(Kidambi	 et	 al.,	 2015).	 Therefore,	 post-acute	 myocardial	
infarction,	ECV-maps	measure	the	extent	of	damage	within	the	infarct	zone,	while	
AAR	and	remote-zone	predict	the	likelihood	of	functional	recovery	and	adverse	left	
ventricular	remodelling.		
The	present	study	adds	 to	 this	existing	evidence	and	shows	that	acute	ECV-maps	
offer	 a	 new	 quantitative	 thresholding	 tool	 to	 quantify	 both	 AAR/	 IS	 reliably	 and	
accurately.		
6.5.3 Limitations	
The	present	study	has	limitations.	The	sample	size	in	the	present	study	is	not	large,	
nevertheless	is	comparable	to	published	research	studies	in	this	patient	population	
and	also	inter-/intra-observer	variations	are	very	low	for	multi-parametric	CMR.	Of	
the	70	patients	identified	at	initial	recruitment,	we	managed	to	recruit	50	patients,	
possibly	 introducing	a	selection	bias.	Equilibrium	contrast	ECV	estimation	may	be	
more	exact	for	high	ECV	values	than	a	bolus	method	(White	et	al.,	2013);	however,	
the	 bolus	method	 used	 in	 this	 study	 can	 be	more	 easily	 integrated	 into	 existing	
clinical	 protocols.	 The	 results	 from	present	 study	 cannot	 be	 applied	 in	 not-acute	
infarct	cases	and	non-ST	elevation	MI.		
6.6 Conclusion	
This	 study	demonstrates	 that	 ECV-maps	 in	patients	with	 acute	 reperfused	 STEMI	
permit	reliable	quantification	of	AAR	and	final	IS	at	follow-up.	Furthermore,	acute	IS	
by	ECV-maps	are	independently	associated	with	the	number	of	non-viable	infarcted	
segments	 at	 follow-up.	 Therefore,	 acute	 ECV-maps	 offer	 enhanced	 early	 tissue	
characterisation,	quantification	and	clinically	relevant	prognostic	information	over	
standard	LGE-imaging.		
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7 Study	5–	 Comparison	of	Acceleration	Algorithms	 in	
Whole-Heart	 Four-Dimensional	 Flow	 for	
Cardiovascular	 Applications:	 Two-centre,	 1.5T,	
Phantom	and	In-vivo	Validation	Study.	
7.1 Abstract		
7.1.1 Aims	
Validation	of	 four-dimensional	 (4D)	 flow	CMR	accelerated	 acquisition	methods	 is	
needed	to	make	 it	more	robust	 for	clinical	applications.	Our	aim	was	to	compare	
three	 widely-used	 acceleration	 methods	 in	 4D	 flow	 CMR:	 4D	 segmented	 fast-
gradient-echo	 (4D-	 turbo-field-echo,	 4D-TFE),	 4D	 non-segmented	 gradient-echo	
with	echo-planar	imaging	(4D-EPI)	and	4D-k-t	BLAST	(Broad-use	Linear	Acquisition	
Speed-up	Technique)	accelerated	TFE.			
7.1.2 Methods	
CMR	was	performed	in	two	institutions	(Leeds	and	Leiden)	on	identical	1.5T	systems.	
Accelerated	methods	were	compared	in	a	phantom	and	25	volunteers.	In	volunteers,	
the	CMR	protocol	included:	cines,	2D	phase	contrast	(PC)	at	the	aortic	valve	(AV)	and	
mitral	 valve	 (MV)	 and	 three	 whole-heart	 free-breathing	 (no	 respiratory	 motion	
correction)	4D	flow	CMR	sequences.	Field-of-view,	slices,	phases	(30),	voxel	size	and	
VENC	were	the	same	for	each	subject.	In	volunteers,	net	acquisition	time	for	each	
4D	flow	sequence	was	recorded,	as	well	as	a	visual	grading	of	 image	quality	on	a	
four-point	scale:	0,	no	artefacts	to	3,	non-evaluable.			
7.1.3 Results	
For	the	pulsatile	phantom	experiments,	the	mean	error	for	4D-TFE	was	4.9±1.3%,	
for	4D-EPI	7.6±1.3%	and	 for	4D-k-t	BLAST	4.4±1.9%.	 In	vivo,	acquisition	 time	was	
shortest	 for	 4D-EPI	 at	 7min59s±2min30s.	 4D-EPI	 and	 4D-k-t	 BLAST	 had	 minimal	
artifacts.	For	4D-TFE,	40%	of	AV	and	MV	assessments	were	non-evaluable	because	
of	phase	dispersion	artefacts.	Peak	velocity	assessment	using	4D-EPI	demonstrated	
best	correlation	to	2D	PC	(AV:	r=0.78,	p<0.001;	MV:	r=0.71,	p<0.001).	Coefficient	of	
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variability	 (CV)	 for	 net	 forward	 flow	 (NFF)	 volume	was	 least	 for	 4D-EPI	 (7%)	 (2D	
PC:11%,	4D-TFE:	29%,	4D-k-t	BLAST:	30%,	respectively).	
7.1.4 Conclusions	
Mean	error	for	all	4D	flow	CMR	sequences	with	respect	to	flow	volume	assessment	
were	 within	 reasonable	 limits	 for	 clinical	 applications.	 In	 vivo,	 4D-EPI	 had	 the	
shortest	 acquisition	 time,	 best	 agreement	 with	 2D	 PC,	 best	 internal	 consistency	
between	MV	and	AV	NFF	and	the	lowest	CV.	4D-k-t	BLAST	demonstrated	significant	
underestimation	 of	 peak	 velocities,	 NFF	 and	 CV	 was	 poor.	 4D-TFE	 was	 most	
susceptible	to	artefacts.	
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7.2 Introduction		
Four-dimensional	 flow	 cardiovascular	 magnetic	 resonance	 (4D	 flow	 CMR)	 is	
increasingly	being	used	in	clinical	and	research	applications	for	complex	aortic	and	
intra-cardiac	 flow	 assessment.	 4D	 flow	 CMR	 is	 essentially	 a	 three-dimensional	
phase-contrast	magnetic	resonance	imaging	(PC	MRI)	method	with	three-directional	
(3D)	 velocity	 encoding	 allowing	 post-hoc	 time-resolved	 3D	 visualisation	 and	
retrospective	quantification	of	blood	flow	at	any	location	in	a	3D	volume.	4D	flow	
CMR	enables	a	wide	variety	of	options	for	visualization	and	quantification	of	intra-
cardiac	flow,	ranging	from	basic	aspects	such	as	flow	volume	and	peak	velocity	to	
more	complex	analyses	such	as	the	estimation	of	hemodynamic	effects	at	the	vessel	
wall	and	myocardium,	as	well	as	visualization	of	flow	pathways	in	the	heart	and	great	
vessels	(Dyverfeldt	et	al.,	2015).	Integrating	4D	flow	CMR	in	routine	clinical	protocols	
has	 been	 challenging	 in	 part	 due	 to	 long	 scan	 times	 (acquisition	 of	 3D	 velocity	
encoded	CMR	data	along	all	the	three	dimensions).	Scan	times	can	be	reduced	with	
numerous	 data	 acceleration	methods,	 including	 radial	 under-sampling,	 k-t	 Broad	
Linear	 Acquisition	 Speed-up	 Technique	 (BLAST)	 (Philips),	 k-t	 Sensitivity	 encoding	
(SENSE)	 (Philips),	 generalised	 auto-calibrating	 partially	 parallel	 acquisitions	
(GRAPPA)	 (Siemens),	 echo-planar	 imaging	 (EPI),	 Iterative	 self-consistent	 parallel	
imaging	 reconstruction	 (L1-SPIRiT)	 and	 5-point	 PC-vastly	 undersampled	 isotropic	
voxel	radial	projection	imaging	(VIPR)	(General	Electrics,	GE	Systems)	(Baltes	et	al.,	
2005;	Moftakhar	et	al.,	2007;	Stadlbauer	et	al.,	2010;	Lustig	et	al.,	2007;	Davis	et	al.,	
1994;	Debatin	et	al.,	1995;	Zaman	et	al.,	2015;	Lustig	and	Pauly,	2010;	Johnson	and	
Markl,	2010).		
With	the	use	of	accelerated	acquisition	methods	free-breathing	whole-heart	4D	flow	
CMR	can	be	performed	in	a	total	scan	time	of	5-10	minutes	depending	on	size	of	the	
heart	and	patient	habitus	(Calkoen,	Roest,	et	al.,	2015;	Calkoen,	de	Koning,	et	al.,	
2015;	Zaman	et	al.,	2015).		
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7.3 Acceleration	methods	
For	4D	 flow	CMR,	 three	acceleration	methods	are	widely	available	on	 the	Philips	
systems:	4D-TFE,	4D-EPI	and	4D-k-t	BLAST.		
A	recently	published	consensus	document	recommends	the	use	of	fast	gradient	echo	
(4D-TFE,	turbo	field	echo)	pulse	sequences	for	4D	flow	CMR	with	a	segmentation	
factor	of	2	based	on	the	experience	of	research	institutions	(Dyverfeldt	et	al.,	2015).	
Retrospectively-gated,	4D-TFE	is	currently	available	as	a	product	on	Philips	systems	
for	intra-cardiac	flow	assessment.		
Previous	research	work	from	our	institution	has	demonstrated	that	demonstrated	
the	reliability	of	intra-cardiac	flow	assessment	using	the	respiratory	navigated	4D-k-
t	BLAST	acquisition	(Zaman	et	al.,	2015).	However,	this	technique	uses	prospective	
ECG	gating	and	does	not	acquire	crucial	flow	data	towards	end-diastole.		
Restrospectively	gated,	4D-EPI	has	also	been	used	by	some	research	institutions	to	
investigate	 clinical	 applications	 for	 this	 novel	 technique	 (Elbaz	 et	 al.,	 2014;	
Westenberg	et	al.,	2008).	
However,	head-to-head	validation	of	these	three	accelerated	algorithms	for	whole-
heart	 acquisition	 in	 clinical	 applications	 is	 needed	 for	 both	 clinical	 and	 research	
applications.	 Therefore,	 the	 aim	 of	 the	 present	 study	 was	 to	 1)	 validate	 three	
commonly	applied	acceleration	methods	in	4D	flow	CMR:	4D	turbo-gradient-echo	
(4D-TFE),	4D	echo-planar	imaging	(4D-EPI)	and	4D	k-t	BLAST	(4D-k-t	BLAST)	in	static	
and	pulsatile	flow	phantoms,	and	2)	compare	these	three	acceleration	methods	in-
vivo	 in	healthy	volunteers	for	quality,	consistency	and	reliability	to	quantify	 intra-
cardiac	flow	velocity	and	volumes.				
7.4 Methods	
The	study	was	conducted	across	two	centres,	in	Leeds,	UK	and	Leiden.		
7.4.1 Static	and	pulsatile	phantom	
Static	 and	 pulsatile	 flow	 phantom	 experiments	 were	 carried	 out	 at	 the	 Leiden	
University	 Medical	 Center	 using	 48	 ml	 diluted	 gadolinium	 based	 contrast	 agent	
(Dotarem,	 Guerbet,	 Gorinchem,	 The	 Netherlands)	 dissolved	 in	 6	 l	 water.	 The	
contrast	agent	had	a	concentration	of	0.5	mmol/ml	and	relaxivity	of	3.4	mmol-1.l.s-1,	
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resulting	in	a	theoretical	T1	of	112	ms	(Westenberg	et	al.,	1999).	A	silicon	tube	with	
1	cm	luminal	diameter	was	led	through	the	wall	of	the	MRI	room	towards	the	CMR	
machine.	Static	or	pulsatile	 flow	was	applied	from	outside	the	MRI	room,	using	a	
Sarns	centrifugal	pump	which	was	connected	to	a	Sarns	Delphin	power	supply	and	a	
3M	 Sarns	 control	 module	 (3M	 Health	 care,	 Borken,	 Germany)	 (Figure	 7.1A).	
Approximately	3	meters	supplying	and	3	meter	returning	tube	was	required	to	led	
the	 flow	 in	 and	 out	 or	 the	MRI	 room.	 The	 tube	was	 placed	 inside	 a	water	 tank,	
submerged	under	static	water	and	positioned	in	the	iso-center	of	the	CMR	gantry.	
In	the	static	phantom	setup,	six	static	flows	ranging	from	2.52	l/min	to	6.50	l/min	
were	 applied.	 Cardiac	 triggering	 was	 physiologically	 simulated	 by	 the	 scanner	
software	at	120	beats/minute	and	for	all	4D	flow	CMR	and	2D	PC	CMR	sequences,	
10	cardiac	phases	were	reconstructed.	Next,	six	pulsatile	flow	settings	were	applied,	
ranging	from	2.25	l/min	to	5.20	l/min	with	a	frequency	of	61	cycles/minute.	CMR	
triggering	was	 realised	by	 an	external	 transistor-transistor-logic	 TTL	 trigger	 signal	
sent	 from	 the	 pump	 control	 unit	 to	 the	MRI	 computer.	 For	 each	 acquisition,	 30	
phases	were	reconstructed,	unless	the	required	amount	of	data	to	be	collected	did	
not	 allow	 reconstruction	 of	 this	 many	 phases	 without	 making	 changes	 to	 the	
acceleration	 parameters	 (i.e.	 for	 4D-k-t	 BLAST	 and	 4D-TFE	 acquisition).	 In	 those	
cases,	the	maximal	amount	of	reconstructed	phases	was	selected	and	a	2D	PC	CMR	
acquisition	was	repeated	with	the	same	number	of	reconstructed	phases.	
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Figure	 7.1	 Phantom	 illustrations.	 Panel	 A:	 Illustration	 to	 demonstrate	 static	 and	
pulsatile	flow	phantom	setup.	Flow	of	water	was	applied	by	a	computer	controlled	
pump.	For	pulsatile	flow,	ECG	triggering	was	controlled	by	the	pump	connected	with	
the	CMR	computer.	Flow	of	water	was	led	through	the	wall	to	the	CMR	machine.	A	
tank	filled	with	static	water	was	positioned	in	the	iso-center	of	the	magnet.	The	tube	
was	led	through	the	tank.	The	returning	tube	was	led	out	of	the	CMR	room	through	
the	wall.	Distal	to	this	returning	tube,	time	beaker	measurements	were	performed	to	
calibrate	flow	volume.	Panel	B:	Illustration	to	demonstrate	the	identical	3D	volumes	
of	the	4D	flow	CMR	acquisitions	covering	1.35	cm	(i.e.,	9	slices	of	1.5	mm	thickness	
each)	of	the	tube.	The	2D	imaging	plane	of	the	2D	PC	CMR	positioned	in	the	center	
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of	the	4D	flow	CMR	volume.	For	all	acquisitions,	only	through-plane	flow	velocity	was	
analysed.	Panel	C:	Example	of	contour	definition	in	the	velocity	encoded	images	of	
the	phantom.	The	yellow	contour	surrounding	the	cross-sectional	lumen	of	the	tube	
is	 used	 for	 background	 correction.	 The	 red	 contour	 segmenting	 the	 lumen,	 is	 a	
predefined	circular	ROI	with	a	fixed	0.79	cm2	area.		
	
In-plane	resolutions	for	2D	PC	and	the	three	4D	flow	sequences	for	the	in-vitro	setup	
were	equal	(1.5×1.5	mm2),	and	through-plane	resolution	for	4D	flow	was	also	1.5	
mm	 (i.e.,	 isotropic	 data),	 but	 for	 2D	 PC,	 slice	 thickness	 was	 8	 mm.	 Other	 scan	
parameters	 were	 equal	 to	 the	 in	 vivo	 acquisitions	 (see	 below).	 To	 minimize	
angulated	flow,	the	tube	was	positioned	straight	in	the	scanner,	parallel	in	feet-head	
direction	with	water	flowing	from	feet	to	head.	The	3D	volumes	of	the	4D	flow	CMR	
acquisitions	were	identically	planned	(Figure	7.1B),	covering	1.35	cm	(i.e.,	9	slices	of	
1.5	mm	thickness	each)	of	the	tube,	and	with	the	2D	imaging	plane	of	the	2D	PC	CMR	
positioned	 in	 the	 center	 of	 the	 4D	 flow	 CMR	 volume	 (Figure	 7.1B).	 For	 all	
acquisitions,	only	through-plane	flow	velocity	was	analysed.		
Before	and	after	each	MRI	acquisition,	a	time-beaker	measurement	was	performed	
distal	 to	 the	 phantom,	 at	 the	 end	 of	 the	 returning	 tube	 (Figure	 7.1A)	 where	
volumetric	collection	was	performed	for	30	seconds.	The	flow	rate	was	determined	
by	averaging	both	time-beaker	measurements.	
7.4.2 Cardiac	Magnetic	Resonance	Imaging	
All	 volunteers	 underwent	 CMR	 imaging	 on	 identical	 1.5T	 systems	 at	 both	 sites	
(Ingenia,	Philips,	Best,	The	Netherlands).	
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The	CMR	protocol	is	detailed	in	Table	7.1.		
CMR	Protocol	
	 Sequences	 Details	
1.	 Survey	 	
2.	 Cine	 images:	 2ch,	 3ch,	 4ch,	
short-axis	 contiguous	 LV	
volume	stack	
	
3.	 2D	PC	flow:	AV,	MV	 	
4.	 4D-	k-t	BLAST		 Once	FOV	planned	at	step	(4);	exactly	same	
used	for	step	(5)	and	(6)	
All	 three	 done	 with	 M.P.S.	 reconstruction	
pre-selected		
Free-breathing	
5.	 4D-TFE		
6.	 4D-EPI		
7.	 End	of	CMR	scan	 Volunteer	removed	from	magnet	bore	
8.	 4D	flow	data	reconstruction	 Done	 on	 the	 raw	 data	 on	 scanning	
workstation	
9.	 End	of	protocol	 	
Table	7.1	CMR	Protocol	in	healthy	volunteers	
	
Field	 of	 view	 (FOV),	 number	 of	 slices	 (35-40),	 phases	 (30),	 voxel	 size	 (isotropic;	
3×3×3mm3)	and	maximum	velocity	encoding	(VENC,	150cm/s)	were	kept	the	same	
for	the	three	4D	pulse	sequences	for	each	subject.	Flip	angle	was	10º,	echo	time	(TE)	
and	repetition	time	(TR)	were	selected	as	shortest	and	number	of	signal	averages	
was	 1.	 Free	 breathing	was	 allowed	 during	 acquisition	 and	 no	 respiratory	motion	
correction	was	used.	For	4D-TFE	and	4D-EPI	accelerated	techniques,	retrospective	
electrocardiographic	 (ECG)	 gating	 was	 used	 and	 the	 4D-k-t	 BLAST	 accelerated	
technique	used	prospective	ECG-triggering.	In	4D-TFE,	TFE	factor	of	2	was	used	and	
in	4D-EPI,	an	EPI	factor	of	5	was	used.	4D-k-t	BLAST	used	5-fold	acceleration	with	11	
lines	of	training	data	in	both	the	ky	and	kz	directions.	Net	acquisition	time	for	each	
of	the	4D	flow	sequences	was	recorded	during	the	scans.	The	2D	PC	sequence	was	a	
segmented	TFE	method	with	350mm	field-of-view,	 in-plane	acquisition	resolution	
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2.5×2.5mm,	slice	thickness	8mm.	TE	and	TR	were	shortest,	flip	angle	10º,	number	of	
signal	averages	was	2.	A	TFE	factor	of	4	was	used.	For	both	phantom	data	as	well	as	
in	 vivo	 data,	 gradient	 non-linearity	 correction	 and	 Maxwell	 correction	 were	
compensated	by	the	CMR	scanner.	Remaining	phase	background	errors	(e.g.	due	to	
eddy	currents)	were	corrected	by	background	subtraction	sampled	near	the	area	of	
interest.	For	phantom	experiments,	background	correction	was	performed	from	a	
background	 ROI	 (indicated	 by	 the	 yellow	 contour	 in	 Figure	 7.1C)	 enclosing	 the	
luminal	ROI	 (indicated	by	 the	 red	 contour)	 and	 for	 in	 vivo	experiments	 from	ROI	
positioned	in	myocardium.	
7.4.3 Image	analysis	
Image	analysis	of	phantom	data	as	well	as	in	vivo	cines,	2D	PC	flow	quantification	
and	 4D	 flow	quantification	was	 performed	 offline	 using	MASS	 research	 software	
(Version	2016EXP,	Leiden	University	Medical	Center,	Leiden,	The	Netherlands).	For	
both	static	as	well	as	pulsatile	phantom	measurements,	an	a	priori	circular-shaped	
luminal	ROI	was	a	defined,	static	for	all	phases,	with	an	area	size	 imposed	by	the	
phantom	specifications	 (i.e.	 0.79	 cm2).	 This	ROI	was	manually	placed	on	 the	 first	
phase	of	a	time	series	and	copied	to	subsequent	phases.	For	all	phantom	4D	flow	
data	 sets,	 image	 analysis	 was	 performed	 for	 the	 three	 center	 slices	 and	
measurements	were	averaged	among	the	three	samples.	
For	each	4D	 flow	CMR	sequence,	quality	 checks	were	performed	by	 J.J.M.W.,	 an	
experienced	researcher	in	this	field	of	CMR	with	greater	than	15	years’	experience.	
Visual	 grading	 of	 image	 quality	 was	 done	 on	 a	 four-point	 scale:	 0;	 no	 artefacts	
present,	1;	good	quality	but	with	some	blurring	artefacts	on	magnitude	images	but	
none	 on	 velocity	 images,	 2;	 moderate	 quality	 with	 substantial	 blurring	 on	 both	
magnitude	and	 velocity	 images,	 3;	 severe	 artefacts	with	phase	dispersion	on	 the	
velocity	images	present	in	the	region	of	interest,	leading	to	non-evaluable	data.	
In	volunteers,	valvular	stroke	volumes	(SV)	at	the	mitral	valve	(MV)	and	the	aortic	
valve	(AV)	were	calculated	using	validated	techniques	including	retrospective	valve	
tracking,	with	measurement	planes	positioned	perpendicular	to	the	inflow	direction	
on	2-	and	4-chamber	cines	(Roes	et	al.,	2009).	Contour	segmentation	was	performed	
manually.	 Peak	 velocities	 at	 AV	 (peak	 systolic)	 and	MV	 (early	 filling	 phase)	were	
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obtained	 from	 reformatted	 planes	with	 identical	 orientation	 and	 position	 as	 the	
static	2D	PC	MRI	planes.	Background	correction	was	used	from	the	velocity	sampled	
in	the	myocardium	and	phase	unwrapping	was	performed	on	source	images	when	
aliasing	occurred	in	the	area	of	interest.		
7.4.4 Statistical	analysis	
To	 investigate	 linear	 correlation	 between	 two	 methods,	 Pearson's	 correlation	
statistics	 was	 used	 to	 derive	 correlation	 coefficient	 (r)	 and	 its	 significance.	
Agreement	between	to	methods	was	expressed	as	bias	according	to	Bland-Altman	
analysis.	All	statistical	tests	were	2-tailed;	p	values	<0.05	were	considered	significant.		
7.5 Results	
7.5.1 Phantom	Experiments	
The	 mean	 error	 in	 flow	 volume	 assessment	 (compared	 to	 time	 beaker	
measurements)	 for	 the	 2D	 PC	 sequence	 was	 -0.8±1.2%	 (p=0.22)	 for	 the	 static	
experiments	 and	 -1.0±1.1%	 (p=0.001)	 for	 the	 pulsatile	 experiments.	 For	 static	
experiments,	 the	 mean	 error	 for	 4D-TFE	 was	 -5.2±1.1%	 (p=0.003),	 for	 4D-EPI	 -
7.1±1.9%	 (p=0.001)	 and	 for	 4D-k-t	 BLAST	 -4.9±3.8%	 (p=0.03).	 For	 the	 pulsatile	
experiments,	 the	 mean	 error	 for	 4D-TFE	 was	 -4.9±1.3%	 (p=0.002),	 for	 4D-EPI	 -
7.6±1.3%	 (p<0.001)	 and	 for	 4D-k-t	 BLAST	 -4.4±1.9%	 (p=0.008).	 For	 these	
measurements,	the	mean	error	(compared	to	the	2D	PC	acquisition)	in	peak	velocity	
assessment	for	4D-TFE	was	-3.2±1.2%	(p<0.001),	for	4D-EPI	-5.3±2.2%	(p=0.01)	and	
for	4D-k-t	BLAST	-8.8±2.3%	(p<0.001).	
7.5.2 Healthy	Volunteers	
Twenty-five	(n=25,	11	at	Leeds,	14	at	Leiden)	healthy	volunteers	were	recruited	for	
the	in-vivo	study.	We	recruited	only	adult	volunteers	(age	greater	than	18-years	old)	
for	this	study.		
Baseline	volunteer	demographics	and	CMR	parameters	are	detailed	in	Table	7.2.	17	
(68%)	of	the	volunteers	were	male	and	the	mean	age	of	all	volunteers	was	38±14	
years.	There	were	no	significant	differences	 in	characteristics	between	volunteers	
from	Leeds	and	Leiden.		
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	 All	(n=25)	 Leiden	(n=14)	 Leeds	(n=11)	 p-value	
Age,	years	 37.6±14.5	 38±14.7	 38.9±14.7	 0.61	
Male	 17(68%)	 10	(71%)	 7	(64%)	 0.69	
Weight,	kg	 76±13	 76.6±14	 75.5±12	 0.83	
Height,	cm	 171±8	 173±7	 169±8	 0.15	
Heart	rate,	bpm	 63±9	 63±10	 63±9	 0.94	
	 	 	 	 	
LVEDVi*,	ml/m2	 90.4±16.6	 90.4±2	 90.5±12.3	 1	
LVESVi†,	ml/m2	 34.4±11	 35.2±13.4	 33.3±7.5	 0.66	
SVi,	ml/m2	 56±8	 55±8	 57±8	 0.55	
LV	Massi,	g	 53.6±10.5	 54±12	 53±9	 0.88	
Ejection	Fraction,	%	 63±6	 62±6.7	 63±5	 0.62	
Mitral	 Regurgitation	
fraction,	%	(number	of	
volunteers)	
1.6±1.4	
(18)	
2±2	(11)	 1±1(7)	 0.17	
Aortic	 Regurgitation	
fraction,	%	(number	of	
volunteers)	
0.6±1	(9)	 0.9	(7)	 1.1	(2)	 0.20	
Table	 7.2	 Demographics	 and	 CMR	 scan	 parameters.	 Values	 are	 mean	 ±	 SD.	 LV	
measurements	are	indexed	to	body	surface	area	(BSA).	*LV	EDVi	Left	ventricular	end	
diastolic	volume	(indexed),	†LV	ESVi	Left	ventricular	end	systolic	volume	(indexed),	SV	
Stroke	volume.	
7.5.3 Acquisition	time	and	image	quality	assessments	
The	 acquisition	 time	 was	 shortest	 for	 4D-EPI	 and	 it	 was	 statistically	 significantly	
shorter	than	for	4D-TFE	(7min59s±2min30s	versus	9min8s±2min46s,	p<0.01).	Even	
though	the	acquisition	tome	for	4D-k-t	BLAST	was	not	statistically	different	to	4D-
EPI	(7min59s±2min30s	versus	8min50s±2min46s;	p=0.29),	it	was	on	average	almost	
1-minute	longer.	Image	quality	across	mitral	and	aortic	flows	was	similar	for	4D-EPI	
and	4D-k-t	BLAST	(MV;	p=0.43	and	AV;	p=0.16)	(Figure	7.2	and	7.3).	However,	4D-
TFE	acquisition	was	of	inferior	quality	when	compared	to	4D-EPI	(MV;	p<0.001	and	
AV;	 p<0.001)	 and	 4d-k-t	 BLAST	 (MV;	 p<0.001	 and	 AV;	 p<0.001).	 Additionally,	 10	
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(40%)	 4D-TFE	 mitral	 and	 aortic	 flows	 were	 of	 very	 poor	 quality	 rendering	 their	
analysis	impossible.		
	
Figure	7.2	Image	quality	of	mitral	and	aortic	valve	flow	acquisitions.	
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Figure	 7.3	 Bland	 Altman	 and	 scatter	 plots	 analysis	 for	 the	 assessment	 of	 peak	
velocity.	
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7.5.4 Intra-cardiac	peak	velocity	assessment	
7.5.4.1 Mitral	Valve	inflow	
Peak	MV	early	diastolic	inflow	velocity	(E)	by	4D-EPI	demonstrated	good	correlation	
to	 2D	 PC	 acquisition	 (r=0.71,	 p=0.001)	 whereas	 4D-TFE	 derived	 E-velocity	 had	
modest	correlation	(r=0.59,	p=0.01).	4D-k-t	BLAST	derived	E-velocity	demonstrated	
the	poorest	correlation	(r=0.42,	p=0.03).		
7.5.4.2 Aortic	Valve	outflow	
Peak	systolic	AV	outflow	velocity	by	4D-EPI	demonstrated	best	correlation	to	2D	PC	
acquisition	 method	 (r=0.78,	 p<0.001).	 4D-TFE	 and	 4D-k-t	 BLAST	 demonstrated	
modest	 correlation	 to	 2D	 PC	 acquisition	 (4D-TFE:	 r=0.56,	 p=0.04;	 4D-k-t	 BLAST:	
r=0.59,	p=0.002)	(Table	7.3).		
	
Peak	 velocity	 assessment	 for	 both	 MV	 and	 AV	 by	 4D-EPI	 demonstrated	 best	
correlation	 to	 the	 reference	 2D	 PC	 acquisition	 (4D-EPI:	 r=0.89,	 p<0.001;	 4D-TFE:	
r=0.78,	p<0.001;4D-k-t	BLAST:	r=0.81,	p<0.001)	(Figure	7.3).	The	overall	bias	for	peak	
velocity	assessment	was	lowest	for	4D-EPI	(-2	cm/s,	95%	CI	-7	to	2	cm/s;	p=0.21)	with	
a	CV	of	9.8%.	The	other	acquisition	methods	demonstrated	significant	bias	and	CV	
(4D-k-t	BLAST:	bias=10	cm/s,	95%	CI	5	to	15	cm/s;	p<0.001	and	CV	14.3%,	4D-TFE:	
bias=-22	cm/s,	95%	CI	-31	to	12	cm/s;	p<0.001	and	CV	21.4%)	(Table	7.3)	(Figure	7.3).		
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	 Mean	 SD	 Pearson’s	
Correlation	
(r	value,	p-
value)	
Bias	
(95%	CI)	
Paired	
Student	
T-Test	
(p-value)	
CV	
(%)	
Net	Forward	Flow	
(ml)	
	 	 	 	 	 	
2D	PC	AV		 95.3	 18.0	
0.83,	p<0.001	
-9.16	
(-14	to	-4)	
<0.01	 11	
2D	PC	MV		 104.5	 19.8	
4D-TFE	AV		 85.5	 16.2	
0.58,	p=0.02	
-5	
(-14	to	4)	
0.28	 29	
4D-TFE	MV		 89.2	 20.1	
4D-EPI	AV	 91.0	 18.2	
0.94,	p<0.001	
-2	
(-5	to	1)	
0.14	 7	
4D-EPI	MV		 93.0	 17.3	
4D-k-t	BLAST	AV		 82.6	 15.2	
0.57,	p=0.003	
12	
(6	to	18)	
<0.01	 20	
4D-k-t	BLAST	MV		 70.5	 17.6	
Peak	velocity	
(cm/s)	
	 	 	
	 	 	
2D	PC	AV	 127.6	 19.6	 …	 …	 …	 …	
2D	PC	MV	 81.7	 17.2	 …	 …	 …	 …	
4D-TFE	AV	 151.7	 23.9	 0.56,	p=0.04	 -22	
(-31	to	12)	
<0.001	 21.4	
4D-TFE	MV	 98.2	 35.2	 0.59,	p=0.01	
4D-EPI	AV	 130.7	 22.1	 0.78,	p<0.001	 -2	
(-7	to	2)	
0.21	 9.8	
4D-EPI	MV	 83.8	 22.0	 0.71,	p<0.001	
4D-k-t	BLAST	AV	 117.8	 22.4	 0.59,	p=0.002	
10	
(5	to	15)	
<0.001	 14.3	4D-k-t	BLAST	MV
	 	 	
72.6	 13.8	 0.42,	p=0.03	
	
Table	 7.3	 Consistency	 and	 variability	 of	 mitral	 and	 aortic	 flow	 measurements.	
Abbreviations:	2D,	two-dimensional;	4D-EPI,	four-dimensional	echo	planar	imaging;	
4D-k-t	BLAST,	four-dimensional	kt-Broad-use	Linear	Acquisition	Speed-up	Technique;	
4D-TFE,	four-dimensional	turbo	field	echo;	AV,	aortic	valve;	MV,	mitral	valve.	
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7.5.5 Consistency	of	flow	volume	assessment	
Net	 forward	 flow	 (NFF)	 (or	 effective	 stroke	 volume)	 through	 the	 MV	 and	 AV	
correlated	 best	 for	 4D-EPI	 with	 lower	 correlation	 for	 the	 other	 4D	 acquisition	
methods	and	2D	PC	(4D-EPI:	r=0.94,	p<0.001	versus	2D	PC:	r=0.83,	p<0.001	versus	
4D-TFE:	r=0.58,	p=0.02	versus	4D-k-t	BLAST:	r=0.57,	p=0.003)	(Figure	7.4).	Bias	for	
NFF	between	the	valves	was	significant	for	2D	PC	(bias=-9	ml,	95%	CI	–14	to	-4	ml;	
p<0.01)	and	4D-k-t	BLAST	(bias=12	ml,	95%	CI	6	to	18	ml;	p=0.01)	acquisitions	(Table	
7.3).	Bias	and	CV	for	the	NFF	were	lowest	for	the	4D-EPI	(bias=2	ml,	95%	CI	–5	to	1	
ml;	p=0.135;	CV=7%;).	The	CVs	were	very	high	for	the	4D-k-t	BLAST	(20%)	and	the	
4D-TFE	(29%)	acquisitions.			
	 	
-	137	-	
	
	
	
	
	 Mean	 SD	 Paired	Student	
T-Test	compared	to		
2D	PC	
Paired	Student	
T-Test	 compared	
to	4D-EPI	
2D	Phase	Contrast	 	 	 	 	
E,	cm/s	 81.7	 17.2	 …	 …	
A,	cm/s	 48.8	 9.6	 …	 …	
E	volume,	ml	 77.8	 17.8	 …	 …	
A	volume,	ml	 25.00	 6.7	 …	 …	
E/A	 1.8	 0.6	 …	 …	
PEFR,	ml/s	 602.7	 150.9	 …	 …	
PLFR,	ml/s	 300.8	 77.2	 …	 …	
4D-TFE	 	 	 	 	
E,	cm/sec	 112.3	 26.4	 0.000	 <0.001	
A,	cm/sec	 69.4	 24.4	 0.003	 <0.001	
E	volume,	ml	 67.8	 16.9	 0.004	 0.549	
A	volume,	ml	 22.3	 6.5	 0.051	 0.321	
E/A	 1.8	 0.5	 0.725	 0.052	
PEFR,	ml/s	 494.7	 127.1	 0.000	 0.368	
PLFR,	mL/s	 277.5	 71.5	 0.148	 0.253	
4D-EPI	 	 	 	 	
E,	cm/s	 90.0	 21.4	 0.035	 …	
A,	cm/s	 48.4	 11.8	 0.861	 …	
E	volume,	ml	 69.7	 15.3	 0.012	 …	
A	volume,	ml	 21.9	 6.3	 0.012	 …	
E/A	 1.9	 0.6	 0.057	 …	
PEFR,	ml/sec	 508.1	 99.5	 0.001	 …	
PLFR,	ml/sec	 269.6	 80.5	 0.043	 …	
4D-k-t	BLAST	 	 	 	 	
E,	cm/s	 73.1	 13.2	 0.041	 <0.001	
E	volume,	ml	 66.6	 17.4	 0.007	 0.366	
PEFR,	ml/s	 414.6	 116.6	 <0.001	 <0.001	
Table	7.4	Diastolic	flow	assessment	using	all	acceleration	methods.		
2D	 PC	 acquisition	 was	 assessed	 in	 fixed	 plane	 and	 the	 4D	 flow	 techniques	 were	
assessed	using	retrospective	valve	tracking	for	flow	quantifications.	
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Figure	7.4	Scatter	plots	of	net	forward	flow	(NFF)	through	the	mitral	and	aortic	valve.	
7.5.6 Diastolic	flow	assessment		
Assessment	of	diastolic	function	parameters	from	the	transmitral	flow-time	curves	
using	2D	PC	acquisition	with	static	plane	differed	significantly	to	retrospective	valve	
tracking	assessment	for	all	the	three	4D	flow	acquisitions	(Table	7.4).	The	mean	peak	
E	velocity	was	significantly	higher	for	4D-EPI	than	for	2D	PC	acquisition	(90±21cm/s	
versus	82±17cm/s;	p=0.03).	The	mean	peak	E	velocity	was	lowest	for	4D-k-t	BLAST	
at	73±13cm/s.		
Overall,	there	were	no	significant	differences	in	E/A	ratio	between	different	methods	
(2D	 PC	 versus	 4D-EPI;	 p=0.06	 and	 versus	 4D-TFE;	 p=0.72,	 4D-EPI	 versus	 4D-TFE,	
p=0.05).	Because	of	the	use	of	prospective	ECG	triggering	and	the	consequent	lack	
of	data	for	the	full	cardiac	cycle,	4D-k-t	BLAST	could	not	estimate	peak	late	diastolic	
mitral	inflow	(A)	velocity.		
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7.6 Discussion	
The	 present	 study,	 involving	 in	 vitro	 and	 in	 vivo	 experiments	 to	 investigate	
robustness,	accuracy	and	applicability	of	accelerated	methods	of	4D	flow	CMR	for	
whole-heart	imaging	and	valvular	flow	assessment	demonstrated	the	following:	1)	
When	 comparing	 three	 previously	 used	 acceleration	 methods	 for	 4D	 flow	 CMR	
acquisition,	 4D-EPI	 requires	 the	 shortest	 acquisition	 time	 versus	 segmented	 fast-
gradient	echo	(TFE)	and	k-t	BLAST	acceleration,	and	4D-EPI	results	in	adequate	image	
quality	for	analysis.	2)	In	phantoms,	4D-EPI	showed	the	largest	error	in	in-vitro	flow	
and	 velocity	 assessment,	 but	 errors	 were	 small	 and	 within	 clinically	 acceptable	
margins	of	less	than	10%.	4)	In-vivo,	4D-EPI	demonstrated	best	correlation	and	least	
bias	for	intra-cardiac	peak	velocities	to	the	reference	method	of	2D	PC	acquisition	
and	4)	4D-EPI	demonstrated	the	best	agreement	between	aortic	valve	net	forward	
flow	 and	 mitral	 valve	 net	 forward	 flow	 and	 therefore,	 showed	 highest	 internal	
consistency.	
4D	flow	CMR	has	evolved	in	recent	years	as	a	clinical	application	for	evaluating	intra-
cardiac	 flow.	 The	 use	 of	 modern	 data	 acceleration	 methods	 to	 speed	 up	 data	
acquisition	in	particular	has	allowed	a	wider	application	of	this	technique	in	clinical	
research	 studies.	 Several	 studies	 have	 investigated	 accelerated	methods	 for	 flow	
assessments	 (Hsiao	 et	 al.,	 2015;	 Frydrychowicz	 et	 al.,	 2013;	 Tariq	 et	 al.,	 2013;	
Westenberg	et	al.,	2008;	Roes	et	al.,	2009;	Wentland	et	al.,	2013;	Hanneman	et	al.,	
2014;	Nett	et	al.,	2012;	Roldán-Alzate	et	al.,	2013;	Brix	et	al.,	2009).	These	studies	
have	not	only	used	different	accelerated	methods,	but	also	different	flow-encoding	
schemes	(symmetric,	asymmetric,	Hadamard	4-point	encoding,	5-point-encoding	or	
multipoint	encoding),	different	field	strengths	(mainly	1.5T	or	3T	systems),	different	
scan	 parameters	 (FOV,	 spatio-temporal	 resolution	 etc.)	 and	 not	 necessarily	 with	
intra-cardiac	 assessment	 for	 quality	 and	 consistency	 of	 flow.	 Vender-specific	
accelerated	 algorithms	 have	 been	 investigated	 by	 several	 research	 groups	 to	
investigate	consistency	and	reliability	of	intra-cardiac	flow	assessment	using	4D	flow	
CMR.	One	of	these	studies	used	GRAPPA	(Hanneman	et	al.,	2014),	three	studies	used	
EPI	 (Brix	et	al.,	2009;	Westenberg	et	al.,	2008;	Roes	et	al.,	2009),	 two	studies	L1-
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SPIRiT	 (Hsiao	 et	 al.,	 2015;	 Tariq	 et	 al.,	 2013),	 two	 studies	 compared	 k-t	 BLAST	
acceleration	and	TFE	(SENSE)	acceleration	(Carlsson	et	al.,	2011;	Zaman	et	al.,	2015)	
and	one	study	used	TFE	(SENSE)	(Kanski	et	al.,	2015).	As	far	as	we	know,	a	direct	
comparison	between	acceleration	algorithms	with	respect	to	robustness,	reliability	
and	applicability	of	4D	flow	CMR	has	not	been	published.	The	consensus	statement	
recently	 published	 recommends	 the	 use	 of	 segmented	 fast-gradient	 echo	 (TFE)	
methods	combined	with	2-fold	parallel	imaging	(SENSE)	(Dyverfeldt	et	al.,	2015).	We	
compared	this	approach	with	two	other	acceleration	techniques,	EPI	and	k-t	BLAST,	
which	 have	 also	 been	widely	 used	 in	 clinical	 research	 studies.	 In	 vitro	 validation	
showed	 that	 2D	 PC	was	 very	 accurate	 with	 respect	 to	 flow	 volume	 assessment,	
presenting	 an	 error	 of	 1%.	 All	 4D	 flow	 CMR	 assessments	 showed	 a	 significant	
underestimation	 of	 flow	 volume,	 with	 EPI	 presenting	 the	 highest	 error	 (7%)	
compared	 to	 TFE	 and	 k-t	 BLAST	 (5%).	 These	 errors,	 while	 being	 statistically	
significant,	are	all	within	clinically	acceptable	margins	of	less	than	10%.	
Our	 in-vivo	 results	 showed,	 as	 expected,	 substantial	 bias	 for	 internal	 flow	
consistency	between	AV	and	MV	flow	2D	PC	CMR,	as	the	acquisition	plane	in	this	
approach	remains	fixed	during	the	acquisition	and	MV	flow	volume	is	overestimated	
compared	to	AV	flow.	This	is	in	agreement	with	previously	published	results	(Roes	
et	al.,	2009;	Westenberg	et	al.,	2008).	Furthermore,	internal	consistency	was	poor	
for	4D-k-t	BLAST,	as	this	acquisition	uses	prospective	triggering	and	as	a	result,	part	
of	diastole	is	missing	resulting	in	an	underestimation	of	MV	flow	volume.	In	line	with	
previously	published	 results	 (Roes	et	al.,	2009;	Westenberg	et	al.,	2008),	 internal	
consistency	was	high	for	4D-EPI	in	our	in	vivo	studies.	4D-TFE	showed	more	variation	
and	less	correlation,	and	therefore	had	a	poorer	overall	performance	than	4D-EPI.	
Also,	direct	assessment	of	peak	velocity	for	4D-EPI	was	in	good	agreement	with	2D	
PC,	while	the	other	two	techniques	showed	substantial	bias,	moderate	agreement	
and	higher	variation.	
Initial	studies	using	4D-k-t	BLAST	demonstrated	underestimation	of	flow	because	of	
time	 blurring	 issues	with	 prospective	 gating	 (Carlsson	 et	 al.,	 2011).	 Zaman	 et	 al.	
demonstrated	 that	 using	 contemporary	 coil	 systems,	 this	 can	 be	 mitigated	 and	
reliable	peak	velocity	and	stroke	volume	assessment	can	be	made	using	respiratory	
navigated	 4D-k-t	 BLAST	 acquisition	 (Zaman	 et	 al.,	 2015).	 However,	 our	 study	
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contradicts	this,	and	again	motivates	the	concern	initially	raised	by	Carlesson	et	al	
that	 4D-k-t	 BLAST	demonstrated	underestimation	of	 flow	 in-vivo	 (Carlsson	 et	 al.,	
2011).	Zaman	et	al.	used	respiratory	navigation	for	all	their	accelerated	algorithms,	
however,	 the	 present	 study	 did	 not	 use	 respiratory	 navigation.	 Hence,	 the	
underestimation	of	flow	velocities	and	poor	CV	in	the	present	study	may	be	due	to	
the	4D-k-t	BLAST	acquisition	being	more	susceptible	to	respiratory	artefacts	because	
of	under	sampling	in	k-space	and	temporal	window.	Additionally,	Zaman	et	al.	did	
not	investigate	mitral	inflow	which	has	an	important	role	for	intra-cardiac	diastolic	
and	 multi-parametric	 4D	 flow	 assessments.	 It	 would	 be	 plausible	 to	 imply	 that	
without	 respiratory	navigation;	4D-k-t	BLAST	 is	not	 suitable	 for	 intra-cardiac	 flow	
quantification.		
Prospectively	 ECG-triggered	 GRAPPA	 and	 more	 advanced	 kt-GRAPPA	 have	 been	
validated	 for	 their	 reliability	 for	 the	 assessment	 of	 aortic	 and	 pulmonary	 flows	
(Hanneman	et	al.,	2014;	Schnell	et	al.,	2014).	As	these	are	prospectively	triggered	
accelerated	methods	of	acquisition,	they	also	have	temporal	blurring	similar	to	4D-
k-t	BLAST	and	hence	their	reliability	to	quantify	intra-cardiac	diastolic	flow	indices	
may	be	questionable.	
More	recently,	Petersson	et	al.	demonstrated	that	retrospectively	gated	intracardiac	
4D	 flow	 MRI	 can	 be	 sped	 up	 without	 the	 use	 of	 accelerated	 algorithms	 using	
respiratory	navigated	spiral	trajectories	(Petersson	et	al.,	2016).	This	method	does	
not	 compromise	 in	 spatio-temporal	 windows	 and	 demonstrates	 reliability	 and	
consistency	 for	 intracardiac	 flow	 quantification	 including	 diastolic	 inflow	 indices.	
However,	mean	scan	times	for	this	spiral	acquisition	in	their	study	were	higher	(13	±	
3	minutes)	than	the	most	reliable	accelerated	technique	in	the	present	study,	4D-
EPI	 (8	 ±	 2	 minutes),	 most	 likely	 because	 Petersson	 used	 respiratory	 navigation.	
Moreover,	 the	 present	 study,	 which	 was	 done	 without	 respiratory	 navigation,	
demonstrated	similar	robust	linear	correlation	between	NFF	through	the	mitral	and	
aortic	valves	(this	study:	r2=0.87	versus	Petersson	study:	r2=0.90).		
7.6.1 Limitations		
The	 in-vitro	 validation	of	 the	 various	 2D	 and	4D	 flow	acquisition	 techniques	was	
performed	 using	 a	 straight	 tube	 with	 a	 laminar	 flow,	 creating	 idealized	 flow	
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conditions.	The	use	of	a	more	realistic	heart	phantom	model	would	provide	more	
complex	 intra-cardiac	 flow	patterns	 that	would	probably	give	more	 insight	 in	 the	
performance	 of	 the	 various	 CMR	 flow	 acquisition	 techniques	 under	 more	
physiological	conditions.	
In	this	study	all	healthy	volunteers	had	very	stable	resting	heart	rates	of	63±9	beats	
per	minute	 (bpm).	Additionally,	 the	present	study	did	not	 investigate	the	relative	
performance	 of	 the	 methods	 in	 the	 presence	 of	 minor	 arrhythmias	 (sinus	
arrhythmias,	isolated	ventricular	ectopics	etc.).	Additionally,	even	though	we	tried	
to	 keep	 all	 acquisitions	 parameters	 similar	 for	 the	 three	 4D	 flow	 methods,	
occasionally,	 one	method	would	 need	 slight	 adjustment	 of	 the	 field	 of	 view,	 the	
number	of	slices	or	phases.		
7.7 Conclusion	
Of	 the	 three	 4D	 flow	 CMR	 methods	 tested,	 4D-EPI	 demonstrated	 the	 least	
susceptibility	to	artefacts,	good	image	quality,	modest	agreement	with	the	current	
reference	standard	for	peak	intra-cardiac	velocities	and	the	highest	consistency	of	
intra-cardiac	flow	quantifications.	We	recommend	4D-EPI	acceleration	method	for	
future	clinical	and	research	applications	on	1.5	Tesla	scanners.		
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8 Final	Conclusions	
Multi-parametric	tissue	characterisation	by	CMR	is	a	well-established	to	guide	the	
diagnosis	in	patients	presenting	with	acute	chest	pain.	There	is	increasing	evidence	
that	 CMR	 can	 provide	 accurate	 quantification	 of	 LV	 longitudinal	 function	 and	
myocardial	 deformation	 in	 both	 health	 and	 disease.	 Detection	 of	 reduced	 LV	
longitudinal	function	has	both	diagnostic	and	prognostic	potential	that	has	until	now	
primarily	been	used	in	research	but	in	the	coming	years	will	likely	be	integrated	into	
clinical	practice.		
In	this	thesis,	we	have	used	tissue	characterisation	by	T2W,	T2*,	T1-mapping,	EGE	
and	LGE	to	detect	alterations	in	myocardial	tissue	composition	and	also	define	how	
this	affects	myocardial	deformation.	We	have	also	developed	methods	to	quantify	
AAR	and	IS	by	acute	ECV-maps	in	STEMI	patients.	In	the	last	chapter,	we	aimed	to	
investigate	 and	 validate	 different	 acceleration	methods	 for	 4D	 flow	 CMR	whole-
heart	 clinical	 applications.	 To	 pursue	with	 research	work	 on	 this	 thesis	 we	 have	
carried	out	CMR	studies	on	a	wide	range	of	subjects	including	patients	with	acute	
STEMI,	suspected	CAD	and	asymptomatic	healthy	volunteers.	
	
	
The	main	findings	were:	
8.1 Effect	of	MVO/	IMH	on	Myocardial	Deformation	
i. Longitudinal	LV	function	measured	by	averaged	MAPSE	on	CMR	is	strongly	
associated	with	the	presence	of	MVO	and	IMH	
ii. The	size	of	MVO	adversely	affects	averaged	MAPSE	
iii. Myocardial	deformation	 imaging	by	CMR	reliably	detects	changes	 in	acute	
infarct	patients	versus	healthy	controls	
iv. The	presence	of	MVO	or	 IMH	 in	 acute	 reperfused	 STEMI	 is	most	 strongly	
associated	with	GLS	
v. GLS	showed	modest	association	with	adverse	LV	remodelling	
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8.2 Effect	of	Myocardial	Hyperaemia	on	Myocardial	deformation	
i. At	peak	myocardial	 hyperaemia	GLS	 is	 reduced	 in	patients	with	perfusion	
defects	on	simultaneously	acquired	first-pass	perfusion	CMR		
ii. Among	 several	 strain	 parameters	 tested,	 stress	 GLS	 is	 most	 strongly	
associated	with	the	presence	of	a	perfusion	defect		
iii. A	cut-off	value	of	-19.8%	for	stress	GLS	demonstrates	77%	sensitivity	and	73%	
specificity	for	the	presence	of	a	perfusion	defect	
8.3 Quantification	of	AAR	and	IS	by	ECV-maps	
i. Acute	ECV-maps	offer	a	robust	and	reliable	alternative	to	acute	T2w-imaging	
and	T1-maps	to	quantify	the	AAR	(at	an	ECV	threshold	of	33%)	
ii. Acute	ECV-maps	offer	a	robust	and	reliable	alternative	to	acute	LGE-imaging	
to	quantify	the	final	IS	at	follow-up	(at	an	ECV	threshold	of	46%)	
iii. ECV-maps	are	superior	to	acute	LGE-imaging	in	terms	of	agreement	with	final	
IS	
iv. IS	quantified	by	ECV-maps	is	strongly	associated	the	number	of	non-viable	
segments	at	3-months	follow-up	
8.4 Validation	 of	 whole-heart	 4D	 Flow	 CMR	 acceleration	
methods	
i. 4D-EPI	showed	the	largest	error	in	in-vitro	flow	and	velocity	assessment,	
but	errors	were	small	and	within	clinically	acceptable	margins	of	less	than	
10%			
ii. 4D-EPI	requires	the	shortest	acquisition	time	versus	segmented	fast-
gradient	echo	(TFE)	and	k-t	BLAST	acceleration		
iii. 4D-EPI	demonstrated	best	correlation	and	 least	bias	 for	 intra-cardiac	peak	
velocities	to	the	reference	method	of	2D	PC	acquisition		
iv. 4D-EPI	demonstrated	the	best	agreement	between	aortic	valve	net	forward	
flow	 and	 mitral	 valve	 net	 forward	 flow	 and	 therefore,	 showed	 highest	
internal	consistency	
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8.5 Future	directions	
The	work	in	this	thesis	informs	potential	future	studies.	
8.5.1 Myocardial	deformation	in	coronary	artery	disease		
In	this	thesis,	we	have	demonstrated	that	CMR	feature	tracking	derived	longitudinal	
functional	 parameters	 of	 the	 left	 ventricle	 such	 as	 GLS	 are	 associated	 with	
pathologies	predominantly	in	the	sub-endocardium	and	could	be	used	as	a	surrogate	
imaging	markers.		
Post-STEMI,	bedside	echocardiography	remains	the	first-line	non-invasive	 imaging	
modality.	Strain	 imaging	packages	have	become	standard	plug-ins	provided	by	all	
vendors	and	allow	rapid	bedside	assessment	of	GLS.	Data	from	thesis	suggest	that	
post	STEMI,	GLS	can	inform	on	the	likelihood	of	MVO	or	 IMH.	These	patients	can	
then	be	offered	CMR	to	clarify	the	diagnosis.	Importantly,	even	though	both	MVO	
and	IMH	are	poor	prognostic	markers	specific	target	treatments	are	still	lacking	and	
future	research	should	be	directed	at	this	clinical	problem.	
In	patients	with	suspected	CAD,	rest-GLS	and	stress-GLS	offer	an	additional	tool	to	
identify	patients	with	significant	coronary	disease.	Future	studies,	with	angiographic	
fractional	 flow	 reserve	 as	 the	 reference	 standard	 are	 needed	 to	 investigate	 the	
incremental	value	of	strain	imaging	over	first-pass	perfusion	CMR	and	whether	it	can	
improve	the	sensitivity	and	specificity	for	the	diagnosis	of	CAD.	We	speculate	that	if	
this	was	proven,	it	would	further	enhance	the	diagnostic	accuracy	of	equivocal	first-
pass	perfusion	cases.		
8.5.2 ECV-maps	in	acute	myocardial	infarction	
In	 this	 thesis,	 we	 have	 demonstrated	 that	 using	 semi-automated	 thresholding	
applied	to	ECV-maps	can	be	used	to	quantify	AAR	and	IS.	ECV	thresholds	of	33%	and	
46%	 proved	 to	 be	 accurate	 post-acute	 infarction	 for	 AAR	 and	 final	 infarct	 size.	
Furthermore,	there	is	a	growing	body	of	literature	that	ECV	maps	add	incremental	
diagnostic	benefit	in	acute	chest	pain	syndromes	(Haaf	et	al.,	2016).	In	this	thesis,	
we	only	 investigated	 functional	 recovery	as	 an	outcome	measure.	 Future	 studies	
investigating	 incremental	 benefit	 of	 using	 ECV	 maps	 in	 infarct	 patients	 should	
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explore	 additional	 clinical	 outcomes	 including	 adverse	 LV	 remodelling	 and	 hard	
clinical	end-points	including	short-term	and	long-term	cardiovascular	mortality.	
8.5.3 Whole	heart	4D	flow		
Current	two-dimensional	methods	of	blood	flow	quantification	cannot	fully	assess	
the	complex,	three-dimensional	and	multi-directional	nature	of	intra-cardiac	flow.	
Examining	 these	 intricate	 fluid	 dynamics	 has	 the	 potential	 to	 further	 our	
understanding	of	the	principles	of	cardiovascular	health	and	disease.		
In	this	thesis,	we	demonstrated	that	4D	flow	using	EPI	is	the	most	robust	and	reliable	
acceleration	 method	 for	 whole-heart	 flow	 assessment	 using	 a	 free-breathing	
sequence	 with	 scanning	 times	 of	 5-8	 minutes,	 suggesting	 potential	 for	 clinical	
application	in	both	stable	and	more	acute	scenarios.	Whole	heart	4D	flow	has	several	
advantages	 over	 echocardiography	 or	 even	 2D	 PC	 acquisitions.	 These	 primarily	
include:	both	right	and	left	ventricular	flow	can	be	investigated	for	‘same	averaged	
cardiac	 cycles’,	 using	 retrospective	 valve	 tracking,	 accurate	 stroke	 volume	 and	
regurgitation	 volumes	 can	 be	 computed	 and	 it	 allows	 for	 3D	 flow	 visualisation	
including	vortex	formation	within	cardiac	chambers.	While	this	thesis	demonstrated	
feasibility	 of	 the	method,	 larger,	 hypothesis	 driven	 clinical	 studies	 using	 4D	 flow	
parameters	against	standard	flow	parameters	are	warranted.		
We	speculate	that	4D	flow	derived	quantitative	flow	parameters	will	provide	very	
accurate	and	precise	quantification	of	 intra-cardiac	 flow	 indices	 in	routine	clinical	
practice	in	the	near	future.		
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